Hyaluronan hydrogels, 3-dimensional scaffolds for ex vivo maintenance of human hepatic stem cells and hepatoblasts by Turner, William S.
 
 
 
 
 
Hyaluronan Hydrogels, 3-Dimensional Scaffolds for Ex Vivo 
Maintenance of Human Hepatic Stem Cells and Hepatoblasts 
 
 
 
 
William S. Turner 
 
 
 
 
A dissertation submitted to the faculty of the University of North Carolina at Chapel 
Hill in partial fulfillment of the requirements for the degree of Doctor of Philosophy 
in the department of Biomedical Engineering. 
 
 
 
 
 
Chapel Hill 
2007 
 
 
 
Approved by 
 
 
Advisor: Professor Lola M Reid, Ph.D. 
  
 
Reader:  Professor Jeffrey M. Macdonald, Ph.D. 
 
 
Reader:  Professor John Sheehan, Ph.D. 
 
 
Reader:  Professor Edward Salmon, Ph.D 
 
 
Reader:  Professor Robert Dennis, Ph.D. 
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©2007 
William S. Turner 
ALL RIGHTS RESERVED 
ii 
  
 
ABSTRACT 
William S. Turner:  Hyaluronan Hydrogels, 3-Dimensional Scaffolds for Ex Vivo 
Maintenance of Human Hepatic Stem Cells and Hepatoblasts 
 (Under the direction of Lola M. Reid, Ph.D.) 
 
Sourcing of human liver cells has remained a challenge obviating ex vivo 
studies of human cells and clinical therapies such as cell transplantation and assist 
devices using bioartificial livers.  The expansion potential of human hepatic 
progenitors under appropriate conditions can overcome this problem, and the 
potential medical applications include the treatment of liver disease by cell therapies 
such as cell transplantation and/or bioartificial livers.    
Human hepatic stem cells (hHpSCs) in vivo are located in ductal plates in 
fetal livers and neonatal livers and in canals of Herring in pediatric and adult livers, 
are ~9 µm in diameter, can be isolated by immunoselection for epithelial cell 
adhesion molecule (EpCAM) or neural cell adhesion molecule (NCAM), and 
constitute ~ 0.5-1.5% of parenchymal cells in non-ischemic livers of all donor ages. 
They express cytokeratins 8, 18 and 19, CD133/1, CD44H, telomerase, NCAM, 
weakly express albumin, are negative for ICAM-1, for markers for adult liver cells 
(e.g. P450s), hemopoietic cells (e.g. CD45, CD34), endothelia (e.g. VEGFr, Van 
Willebrand Factor), and other mesenchymal cells (α-smooth muscle actin, desmin, 
CD146) and for α-fetoprotein (AFP). Self-replication (also called self-renewal) ex 
vivo occurs in hHpSCs cultured in a serum-free medium tailored for hepatic 
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progenitors, “Kubota’s Medium” (KM), yielding doubling times of ~35 hrs (plastic) 
or <24 hrs (type III collagen) and a stable phenotype for more than 150 population 
doublings.  Colonies of hHpSCs are in close association with angioblasts and hepatic 
stellate cell precursors; elimination of them results in slowed growth and reduced 
viability.   
Ex vivo expansion conditions comprise serum-free KM with varying soluble 
signal supplements in combination with monolayer substrata versus 3-dimensional 
(3-D) scaffolds of purified extracellular matrix components (used individually or in 
combinations).  The best of the 3-D scaffolds for the hHpSCs and their progeny, 
hepatoblasts, and committed progenitors have thus far proven to be complexes of 
chemically modified hyaluronans combined with other matrix components.  The 
precise mix of matrix molecules with the hyaluronans enables the cells to be in a 3-
dimensional format and yet kept in an undifferentiated state (certain combinations) 
versus driven to differentiate (other combinations).  The hydrogels offer stable 
support of the cells with ex vivo maintenance for longer than four weeks in culture.  
Human hepatic progenitors cultured in the hydrogels and in KM have been 
characterized by classic cell biological techniques including growth analyses,  
immunohistochemistry and RT-PCR.  In parallel,  nuclear magnetic resonance 
spectroscopy (NMR) has been used to monitor the cells without the use of 
techniques that destroy them.   Metabolomic profiling of the cells within their 3-D 
microenvironment has allowed tracking of metabolites such as glucose, lactate, 
glutamine, alanine and others which allows for the elucidation of the cellular 
regulation of glycolysis, the Krebs cycle and other unique metabolic pathways.
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1  Chapter I:  Background 
1.1 Epithelial Mesenchymal Relationships 
The liver is similar to all metazoan tissues in that the epithelial-mesenchymal 
relationship constitutes the organizational basis for the tissue[1-4]. Epithelia 
(hepatic, lung, pancreas, etc.) are wed to a specific type of mesenchymal cells 
(endothelia, stroma, stellate cells, smooth muscle cells), and dynamic interactions 
between the two are mediated by a set of soluble signals (both autocrine and 
paracrine) and a set of insoluble signals found on the lateral borders of homotypic 
cells (the lateral extracellular matrix) and on the basal borders (the basal 
extracellular matrix) between heterotypic cells.[5-13] Furthermore, endocrine (i.e. 
systemic) regulation and modulation is achieved, in part, by regulating some aspect 
of the epithelial-mesenchymal relationship.[14]  Normal epithelial cells will not 
survive for long and will not function properly unless epithelial cells and appropriate 
mesenchymal cells are co-cultured.[3, 15-17]  To escape from the need for co-
cultures, one can place the cells of interest in contact with appropriate extracellular 
matrix components and in medium containing the soluble signals (either defined 
components or “conditioned medium”) produced by interactions between epithelia 
and mesenchymal cells.[5, 18-20] 
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In recent years, there has been recognition that the epithelial-mesenchymal 
relationship is lineage dependent.[5, 21-23] Epithelial stem cells are partnered with 
mesenchymal stem cells, and their differentiation is co-ordinate [1, 24-26].  In the 
liver, the lineages begin with the hepatic stem cells (hHpSCs) and with their 
mesenchymal partners, angioblasts [27] that interact with multiple forms of 
paracrine signals [28].  These two give rise to descendents in a step-wise, lineage-
dependent fashion, and their descendents remain in a partnership throughout 
differentiation (Table 1). Tissue engineering involves the mimicking of the liver’s 
epithelial-mesenchymal relationship with recognition of the lineage-dependent 
phenomena [20, 29]. 
Table 1. Epithelial-Mesenchymal Partners in Liver (known or assumed) 
Lineage Stage (#): Epithelia Mesenchymal Cells 
Stem Cell Niche: Ductal Plates (fetal/neonatal livers)/ Canals of Herring (pediatric/adult livers) 
(1)  Hepatic Stem Cells 
       [pluripotent] 
Angioblasts 
(2) Hepatoblasts 
       [bipotent] 
Activated angioblasts and hepatic stellate cells 
Immediately outside the stem cell niche  
(3A) Committed 
Hepatocytic  Progenitors 
           [unipotent] 
Endothelial cell 
precursors 
(3B) Committed 
Biliary Progenitors    
[unipotent] 
 
Stromal cell 
precursors 
Zone 1  Parenchymal Cells of the Liver Acinus 
  3 
 
(4A) “Small” hepatocytes 
[diploid ] 
Continuous 
Endothelia 
(4B) Bile Duct 
Epithelium [diploid] 
Stroma 
Zone 2  Hepatocytes  
the Liver Acinus 
“Zone 2” Bile duct* 
Not known: Hypothesized to be 
Immediately Outside of Liver 
(5A) Zone 2 hepatocytes 
(ploidy profile depends on 
the species) 
Continuous 
Endothelium 
(5B) Bile Duct 
Epithelium (ploidy 
profile not known) 
Stroma 
Zone 3 Hepatocytes,  
Near Central Vein 
“Zone 3” Bile duct* 
Not known. Hypothesized to be after gall 
bladder and connecting to gut 
(6A) Zone 3 
Hepatocytes (polyploid; 
ploidy profile depends on 
species) 
Fenestrated Endothelia (6B) Bile Duct 
Epithelium 
Stroma 
7A) Apoptotic 
hepatocytes 
(polyploid; DNA 
fragmentation) 
Fenestrated Endothelia Apoptotic Bile Duct 
Epithelium 
Stroma 
 
The lineage stages noted above are proven for the hepatocytes and their 
associated mesenchymal cells.  *It is hypothesized that there are equivalent 
maturational lineage stages for the bile duct epithelia; yet these lineage stages have 
yet to be defined. There are recent studies supportive of this assumption [30-33] 
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1.2 Stem Cells and Maturational Lineage Biology  
1.2.1 General Comments 
 Quiescent tissues (liver, brain), as well as rapidly renewing tissues 
(skin, intestine), are organized as precursor cell populations (i.e. stem cells and 
committed progenitors) that yield daughter cells undergoing a maturational process 
ending in apoptotic cells [23, 34-39].  The different maturational stages of cells 
within the maturational lineages are distinct phenotypically and in their 
requirements for ex vivo maintenance [40].   Therefore, it is ideal to purify specific 
subpopulations of cells at distinct maturational stages in order to have cells that 
behave uniformly under specified culture conditions.  Purification of the cells 
involves enzymatic dissociation of the tissue followed by fractionation methods that 
can include immunoselection technologies [26, 41-44]. Most of the culture 
conditions required for the different maturational stages of liver cells have been 
defined and involve the use of entirely purified soluble signals and extracellular 
matrix components [27, 40, 45-47].  Certain conditions can be used to maintain the 
cells with reproducible growth properties and others used to put the cells into a state 
of growth arrest and with expression of particular tissue-specific genes.  
 Each cellular subpopulation at a specific maturational stage (e.g. stem 
cells, committed progenitors, diploid adult cells, polyploid adult cells) has a unique 
phenotype (antigenically, biochemically, morphologically) with its own distinct set of 
conditions for ex vivo growth versus differentiation.  For example, hHpSCs must be 
co-cultured with their natural partners, angioblasts; hepatoblasts with hepatic 
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stellate cells (hHpSTCs) ; hepatocytes with endothelia; and biliary epithelia with 
stroma [25].   If the paracrine signals mediating the epithelial-mesenchymal 
relationship are known, they can be used to prepare completely defined culture 
conditions.  If they are not known, then co-culturing of the epithelia and 
mesenchymal subpopulations is required for full extent of functioning.  
  
1.2.2 Cellular Components of Stem Cell Niches 
 A survey of stem cell niches described to date indicates certain 
paradigms.  As shown in Table 2, the cellular components in all stem cell niches 
include an epithelial stem cell, angioblasts (precursor for endothelia), and a “nurse” 
cell that is pigmented or steroidogenic.  In the liver these include the hepatic stem 
cells (hHpSCs), the angioblasts, and hepatic stellate cells. In addition, there are 
hemopoietic progenitors in the stem cell niche, especially in fetal livers.  We have 
been working towards being able to isolate and to purify each of these 
subpopulations, to have wholly defined culture conditions for them, and then to co-
culture and/or utilize defined paracrine signals from the subpopulations to maintain 
the one(s) of interest. 
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Table 2.  Known Cellular Components in Stem Cell Niches (with focus on 
endodermal tissues) 
               Cellular Components 
Mesenchymal Cells 
 
 
Germ 
 Layer 
 
Represen
-tative 
Tissue 
Types 
 
 
Epithelial 
Stem Cells*  
Blood 
Vessel 
Precursors 
Pigmented/ 
steroidogenic 
“Nurse” 
Cells** 
 
 
Other 
Skin Epidermal 
stem cells  
Angioblasts Melanocytes ---  
Ectoderm 
Brain Neuronal stem 
cells 
Angioblasts Ependymal 
Cells 
--- 
Gut Intestinal stem 
cell 
Angioblasts Paneth Cells --- 
Pancreas Pancreatic 
stem cells 
Angioblasts Pancreatic 
Stellate Cells 
--- 
Liver Hepatic stem 
cells  
Angioblasts Hepatic Stellate 
Cells 
Hemopoietic 
Stem Cells 
Endoderm 
Lung Lung stem 
cells  
(Clara cells) 
Angioblasts Pulmonary 
Neuroendocrine 
cells 
 
        --- 
Mesoderm Bone 
Marrow 
Hemopoietic 
Stem Cells 
Angioblasts Adipocytes Osteoblasts 
Ovary Oogonia Angioblasts Granulosa cells ---- Mixed germ 
layer origins Testis Spermatogonia Angioblasts Sertoli cells ---- 
*All of the stem cells are “label retaining cells” that retain label in pulse chase labeling studies indicating that they 
divide very slowly.  They do not respond to mild or moderate injuries to the tissue but rather only to massive loss of mature 
cells in the tissue.  The cells responding to mild or moderate injuries are “transit amplifying” cells that are the immediate 
descendents of the stem cells.  In the liver these are the hepatoblasts with their signature feature of α-fetoprotein.   
**It is unknown if the pigmented cells found in stem cell niches are themselves stem cells.  Typically they produce 
steroidogenic signals, retinoids, a variety of growth factors and matrix molecules.   
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1.2.3 Strategies influenced by the knowledge of lineage biology  
 Whereas all forms of progenitors are found in embryonic tissues, most 
adult tissues contain only determined stem cells and/or committed progenitors [48].  
The known properties of the different maturational lineage stages of cells help to 
define their potential in academic, clinical or industrial programs.  Of the types of 
progenitors studied (e.g. mesenchymal, neuronal, muscle, epidermal, hepatic), all 
have been found to be readily cryopreserved [49-51] and expanded ex vivo [43, 52, 
53].  However, the embryonic stem cells are especially notable for their ability to 
survive freezing and to expand without differentiating if maintained under precise 
culture conditions [49, 54-57].  By contrast, attempts to cryopreserve adult liver cells 
(predominantly the polyploid cells), have met with limited success, and even that 
limited success is achieved only by embedding the cells in alginate or a form of 
extracellular matrix [58-61].  Significant ex vivo expansion and the ability to 
subculture adult liver cells have been observed only with the so-called “small 
hepatocytes” [62-64], a diploid subpopulation of liver cells.  Typically, the mature 
cells undergo one or two rounds of division and then survive for a matter of days in 
culture, or for a few weeks when supplied with the appropriate extracellular matrix 
and medium conditions [40, 65].  
 The ability of totipotent cells and embryonic stem cells to give rise to 
all, or almost all, possible adult fates makes them appealing as a possible “one serves 
all” approach for cell therapies and makes them the most exploitable of the classes of 
stem or progenitor cells [57, 66-68].  However, their use in cell transplantation for 
patients is precluded by their tumorigenic potential [69-72].  The tumorigenicity of 
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ES cells when injected at ectopic sites is being investigated extensively, especially by 
biotechnology companies [70, 72], in hopes that it can be controlled to enable ES 
cells to reach their full potential both industrially and clinically. Until this is solved, 
the ES cells will become an excellent choice for pharmaceutical/biotechnology 
companies and for bioartificial organs but cannot be used for cell therapies.  
 While determined stem cells are more restricted in their adult cell 
fates, they have not been found to be tumorigenic, making them the first choice for 
clinical programs in cell transplantation or for bioartificial organs.[23, 66, 73]  Bone 
marrow and cord blood transplants, which represent the first forms of progenitor 
cell therapies, have been performed for years.[74, 75]  More recently, other forms of 
progenitor cell therapies are being tested in clinical trials; these include 
mesenchymal progenitor cells,[52, 76, 77] neuronal progenitor cells,[53, 78] and 
fetal pancreatic islet cell transplants,[79, 80] and the early data from these trials are 
very encouraging for the future of progenitor cell therapies as a class. 
 The problems with determined stem cells include a) availability of 
tissues, a particular problem for organs that until now have derived only from brain-
dead, but beating-heart donors; b) the need for the development of purification 
schemes for isolation of the cells; c) identification of optimal cryopreservation 
conditions; and d) defining the ex vivo expansion and differentiation conditions. 
 
1.3 Human Liver Maturational Lineage 
 The development of a tissue begins with the zygote, a fertilized egg, It 
is, of course, a totipotent stem cell.  In human embryogenesis, it undergoes 3 equal 
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divisions to give rise to 8 equal cells, all of which are “totipotent”, meaning that they 
can give rise to all cell types within the embryo and also to the amnionic membrane 
and placenta.  
 
Totipotent stem cells= zygote or cells of the morula (resulting from the 
first 3 cell divisions).  These can produce all the extraembryonic and embryonic cell 
types.  
Pluripotent embryonic stem (ES) cells=ES cells can give rise to any of 
the daughter cells of the 3 germ layers: ectoderm, mesoderm and endoderm but 
cannot give rise to extraembryonic tissue (e.g. amnion) [69, 81-83]. 
 
Determined Stem Cells in liver?hepatic  stem  cells (hHpSCs) are  
pluripotent cells that give rise to hepatoblasts and to committed biliary progenitors 
[27, 28, 45].  Their known antigenic profile is summarized in brief in Table 2 and is 
given in more detail elsewhere [46].  Unique defining markers include EpCAM+, 
NCAM+, Claudin 3+, and CK19+.  They can be expanded ex vivo only when co-
cultured with angioblasts or early stage endothelia [25] or with appropriate matrix 
and soluble signals mimicking the hHpSC-angioblast relationship.[45, 47] These 
conditions have been defined and include a serum-free medium, “Kubota’s Medium” 
(KM), designed for hepatic progenitors,[43] that can be used in combination with 
matrix components and that include type III collagen [47] and hyaluronans.[45]  The 
division rate under optimal conditions has been found to be a division every ~26 
hours. 
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Hepatoblasts (bipotent) are derived from hHpSCs. They have a phenotype 
that overlaps extensively with that of the hHpSCs[46] with the qualifiers that they 
express ICAM-1 but not NCAM, fetal forms of P450s (e.g. human P450-3A7),  high 
levels of AFP, elevated levels of albumin and have lost expression of claudin 3.  The 
division rate for hepatoblasts is estimated to be a division every ~40-50 hours under 
the conditions tested to date.  
 
Committed progenitors are unipotent precursors for a single cell type. 
They include biliary committed progenitors (CK19+, ALB-) and hepatocytic 
committed progenitors (CK19-, ALB+).  The culture conditions for these cells overlap 
extensively with that of the hHpSCs and hepatoblasts.  The division rate for these is 
not known.  
 
Adult diploid cells All fetal and neonatal tissues contain only diploid cells, 
and these cells are able to undergo complete cell divisions both in vivo and in vitro.  
The number of divisions possible for adult diploid cells is estimated to be 5-8 
divisions.[43, 62, 84, 85]  The clonogenic expansion conditions that are successful 
with hHpSCs and hepatoblasts are permissive for colony formation of diploid 
hepatocytes though the cells divide much more slowly, a division every ~60  
hours,[43] and show limited ability to be passaged.   
 
 
 
 Table 3. Ploidy Profiles of Parenchymal Cells 
Rodents Humans** 
Fetal and neonatal: entirely diploid Fetuses, neonates, and children up to teenage years: 
entirely diploid 
Young adults: 4-5 weeks of age:  10% 
diploid; 80% tetraploid; 10% octaploid 
Young adults: 20-40 years of age mostly diploid with 
perhaps up to 30% tetraploid 
6 months and older: <5% diploid; 
>95% polyploid 
Polyploid cells are a mix of 
mononucleated and binucleated cells 
Older adults: steady increase of polyploid cells with 
age; polyploid cells are mostly (entirely?) 
binucleated, tetraploid cells 
 
**Estimates of ploidy profiles in human parenchyma vary due to the effects of ischemia: 
polyploid cells are lost selectively with ischemia, especially warm ischemia[86] 
Adult polyploid cells. Polyploid cells appear in liver tissue within a few 
weeks of postnatal life in mice or rats or by teenage years in humans.[87-91] The 
majority of the human liver’s polyploid cells are tetraploid, whereas higher levels of 
ploidy have been observed in murine hepatocytes (up to 32 N) and rat hepatocytes 
(up to 8N) [92, 93].  The percentage of polyploid cells increases with age[42, 91, 94-
96] and after partial hepatectomy [42] and is achieved by cells undergoing nuclear 
division without cytokinesis.[91]  By approximately six weeks of age, adult rats have 
livers in which the extent of polyploidy is at least 90% comprising 80% tetraploid 
cells and 10% octaploid cells.  Published data on ploidy in human liver varies greatly, 
and the interpretations to date are suspect due in some studies to the methods used 
for analyzing ploidy, in others to the sampling methods used, and in all of them to 
the sparse number of human liver samples analyzed.  Prior to the 1970’s, some 
investigators used the assumption that cells with multiple nuclei are polyploid and 
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those with a single nucleus are diploid and defined the extent of polyploidy using 
that as a guide in analyses of  histological sections of tissue.  Since it is now well 
known that polyploid cells can be mononucleated, the data from these older studies 
must be re-evaluated.  In more recent studies using valid methods for analyzing  
ploidy, the authors have used a small piece of the liver or even a needle aspirate [89, 
94, 97-99].  Considering the heterogeneous nature of liver cells [100-103], such small 
samples are unlikely to be representative of the tissue as a whole.  All studies on 
human liver are made difficult by the extremely limited supply of reasonable quality 
samples and usually of only certain ages.  Altogether these difficulties may explain 
the wide variations in findings on the extent of polyploidy in adult human livers.  
Some have claimed as few as 10%, others about 30%, and the highest numbers 
reported are up to 60% of the cells as polyploid.  All agree that the percentage of 
polyploid liver cells increases with age, and that that percentage increases with  
special significance after 60 years of age.[87, 89, 94, 98, 99, 104]   In summary, a 
rigorous analysis of polyploidy in human liver and the data correlated with age of 
donor has yet to be done.  
The properties of the diploid versus polyploid cells are quite distinct. Whereas 
diploid cells have been found capable of colony formation [43, 62, 64, 84, 105], the 
tetraploid cells are able only to go through one or two complete cell divisions 
represented by the customary findings of studies on routine primary cultures of 
adult liver cells [106, 107].  Tetraploid cells are thought incapable of clonogenic 
growth, an assumption that has yet to be tested rigorously.  Instead, they are ideal 
for an analysis of highly differentiated functions, some of which are expressed only 
in the polyploid cells such as certain of the cytochrome P450’s [108].   
 
 
Table 4. Comparison of Maturational Lineages varying in Kinetics 
Rapidly Regenerating Tissues  (rapid 
kinetics) 
Quiescent Tissues (slow kinetics) 
Turnover in  days to weeks 
% polyploid cells low (e.g. 5-10%) 
Representative tissues 
• Hemopoietic Cells 
• Epidermis 
• Intestinal Epithelia  
• Hair 
 
Turnover in months to years 
% polyploid cells intermediate (e.g. 30%) to 
high levels (e.g. 95%) 
Representative tissues 
• Lung, liver, pancreas, other internal 
organs 
• Blood vessels 
• Skeletal muscle 
• Nerve cells - including the brain 
• Heart muscle 
Hypothesis: Kinetics of lineage inversely correlated with extent of polyploidy 
 References: [94, 109-112] 
 
 
Table 5:  Summary of Lineage Stages within Liver for Representative Species 
Maturational Lineage 
Stage 
Mouse Rat Human 
1. Hepatic Stem Cells Class I MHC 
negative  
 
Class 1 
MHC 
negative 
EpCAM+, NCAM+, claudin 3+,  
Class I MHC antigens negative, 
AFP-, Hedgehog proteins and 
their  receptor, Patched, 
Telomerase 
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 2. Hepatoblasts 
(probable transit amplifying 
cells) Parenchyma of 
fetal/neonatal livers; tethered 
to ends of canals of Herring 
in pediatric and adult livers. 
~10-12 µm, diploid 
Class 1 MHC 
negative, 
ICAM+, 
AFP++ 
Class 1 
MHC 
negative, 
ICAM+, 
AFP++ 
EpCAM+, ICAM+, Class I MHC 
antigens negative, AFP++, 
Hedgehog proteins and 
Patched; Telomerase, P450 3A7 
3.Unipotent Progenitors 
(rare except in fetal/neonatal 
livers),  
~12-15 µm/ diploid 
Committed Biliary Progenitors: CK19+, ALB- 
 
Committed Hepatocytic Progenitors: CK19-, ALB+ 
4. Diploid Hepatocytes 
(“Small hepatocytes”) 
~18 µm 
 
~5% of adult 
hepatocytes 
all in zone 1 
~10% of 
adult 
parenchyma, 
all in zone 1 
Zone 1 and 2 hepatocytes. 
Gluconeogenesis;  
Connexins 26, 32 
5. Diploid 
Cholangiocytes 
Zone 1 of liver acinus 
Aquaporins, DPPIV, various pumps associated with bile production 
(e.g. MDR3) 
 
6. Tetraploid 
Hepatocytes 
 
 
Zone 2 
parenchyma 
Zone 2. The 
majority of the 
parenchyma 
(~80%) 
Zone 3.  10% to 50% of adult 
parenchyma depending on donor 
age; express late genes such as 
P450 3A1 
6B Polyploid 
biliary epithelia (?) 
Unknown if they exist, or if they do then their location is unknown.  
We hypothesize that they do exist and are probably in the bile duct 
external to the liver 
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 7. Hepatocytes of 
higher ploidy (8N 
to 32 N) 
Zone 2/3 
~ 10-20 % of 
adult 
parenchyma 
Zone 3 (~10% 
of adult 
parenchyma; 
 
Not present 
8. Apoptotic Cells Next to central vein.  Markers for apoptosis evident.   
1.3.1 Key Markers for Hepatic Stem Cells and Hepatoblasts.   
In Table 6 are summarized major markers used for hepatic stem cells and 
hepatoblasts.  These markers are among those that were used to identify and isolate 
the stem cells and progenitors and/or to define the cells when under specified 
culture conditions. 
 
Table 6.  Markers for Hepatic Stem Cells and Other Hepatic Progenitors 
Marker Species Comments/References 
A. Hepatic Stem Cell/Progenitor Cell  Markers that are cloned and 
sequenced 
Albumin 
 
All species Found weakly expressed in HpSCs; steady 
increase in level with hepatoblasts and with the 
differentiation of cells of the hepatocytic lineage 
[27, 113, 114] 
Alpha-fetoprotein (AFP) All species AFP is not expressed by HpSCs[22, 27] but 
rather by hepatoblasts.[115]  A variant form of 
α-fetoprotein is expressed by hemopoietic 
progenitors[116] and is identical to that in 
hepatic cells except for exon-1 encoded 
sequences 
Cytokeratin (CK) 7/19 All species CK 7/19 are found in the hepatic stem cells, the 
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 hepatoblasts and in some mature biliary 
epithelia but not the mature hepatocytic 
parenchyma.[27, 117-121] 
Claudin 3 Humans Present in hHpSCs but not in hepatoblasts or 
later hepatocytic stages.[46]  Expression in 
biliary lineage  
CD133/1 (prominin) Humans A transmembrane protein found on hepatic, 
endothelial, and hemopoietic stem cells [27, 
122-124] 
Epithelial cell adhesion 
molecule (EpCAM) 
Humans Present on hHpSCs, hHepatoblasts and some 
committed progenitors but not on mature 
hepatocytes[27, 28, 44, 125] 
Table 6 Continued 
CD44H (hyaluronan receptor) Rats and 
humans 
Present on hepatoblasts and on 
hHpSCs and hHepatoblasts [43, 45]. 
MDR1  
(multidrug resistance gene) 
Rats, mice Present on murine and rodent 
hepatoblasts [126, 127]. [not yet tested 
in humans but hypothesized to be 
present in hHpSCs and hHepatoblasts] 
ICAM1 (intercellular cell adhesion 
molecule) 
Rats and 
humans 
Present on hepatoblasts, committed 
progenitors and mature parenchymal 
cells; not expressed by hHpSCs.[27, 43] 
NCAM (neuronal cell adhesion 
molecule) 
Humans  Present on hHpSCs but not 
hHepatoblasts[27, 32, 128]. 
NCAM was first identified in neuronal 
cells; its functions in neurons include 
interactions with the fibroblast growth 
factor receptor (FGFR) through the 
p59Fyn signaling pathway. Its 
functions in HpSCs are unknown.  
Delta-like/Preadipocyte factor-1 
(DLK-Pref-1) 
Mice Transmembrane protein that contains 
epidermal growth factor-like repeats 
related to notch/delta/serrate family of 
proteins.[117, 129, 130] 
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1.3.2 Sourcing of Human Livers  
1.3.2.1 Fetal Livers 
 
Human fetal livers can be obtained from organizations affiliated with abortion 
clinics.  Once the application process is completed, then the agencies procure the 
tissue and ship them to investigators.  Most of the studies done for this thesis 
involved use of fetal liver samples.  However, sufficient studies were done with 
postnatal livers to warrant some background on their sourcing.  
1.3.2.2 Pediatric and Adult Human Livers 
 
Pediatric and adult human livers are from brain-dead-but-beating-heart 
donors, since the donor organ is procured for organ transplantation, and the liver’s 
exquisite sensitivity to ischemia necessitates that the procurement process occurs at 
the moment of death.  The organ is removed from the donor and placed into 
transport buffer (typically University of Wisconsin solution, “UW” solution; also 
called Viaspan available commercially from UpJohn).  In the U.S., only 1-2% of the 
deaths are those who have undergone brain death prior to heart arrest.  Thus, the 
number of donor organs/year is very small, on average ~5000 per year.  Over 95% of 
these are used successfully for organ transplantation. The remaining 5% of the donor 
organs, or up to ~ 250 livers/year, are livers rejected for organ transplantation for a 
variety of reasons including infections that result in the liver going to investigators 
studying that type of infection or ischemia, high  percentage of fat or other 
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conditions resulting in the liver going to diverse academic or industrial investigators.  
The rejected livers are shunted to federal agencies that handle the distribution 
process to researchers.  These livers, ranging in weight from 1500 to 2500 grams, 
can be shipped as intact organ to groups that can afford them or, more commonly 
due to  the costs, shipped as sections of liver, partitioned by federal agency staff 
members to maximize the number of researchers receiving samples. The sample is 
shipped to the investigators within ~10-20 hours from the time of removal from the 
donor or the “clamp time”. The samples arrive flushed with the transport buffer, 
bagged and on ice. If one receives a portion of a partitioned liver, one receives a piece 
that is usually about 100-200 grams and that must be perfused through cut blood 
vessels exposed on the surface of the sample. The conditions prior to death and the 
cold ischemia associated with the transport conditions of the liver or portion of a 
liver can result in the deterioration of the sample. Thus, the quality of the starting 
material is extremely variable.   
For donor organs, the overall organ integrity and functions begin to 
deteriorate after 18 hours post-clamp; such organs will not be used for transplant 
after this time. This cut-off timing for transplantation is under extensive 
investigation by groups trying to prolong the time, and, therefore, increase the 
numbers of organs that might be transplanted.  In our experience, the quality of the 
cells prepared from donor organs that have been procured >18-20 hours reflect this 
general phenomenon of deterioration, and lower yields and viability of the polyploid 
cell populations are observed compared with fresher organs or tissue.  In general, 
organs received more than 24 hours after clamp time often do not yield cells of 
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adequate quality; nor are the cells able to attach efficiently to culture substrata.  
However, the time threshold after which a particular organ cannot produce cells of 
adequate quality is affected by multiple factors including age of the donor, 
proficiency of organ preservation, the quality of the tissue perfusion, and disease 
state of the organ (e.g., extent of cirrhosis and steatosis).   
Mature parenchymal cells in pediatric and adult livers are very sensitive to 
ischemia, even cold ischemia, and begin dying soon after cardiac arrest. With every 
hour after death, more mature liver parenchymal cells die such that by the latest 
time points tested, the only cells left are the stem cells and other early progenitors, 
the subpopulations most tolerant of ischemia [86].   Although the stem cells can 
survive many hours, the dying mature cells release lytic enzymes that can damage 
the stem cells.  Empirically, one can find stem cells and other early progenitors from 
livers of asystolic donors for up to ~4-5 hours. They are recognizable by their 
expression of stem cell markers such as epithelial cell adhesion molecule, 
EpCAM.[27, 44]  The EpCAM+ cells obtained from such livers are viable and will 
attach and grow in culture if the correct culture conditions are used for them and 
that include substrata of embryonic matrix components (type III collagen, type IV 
collagen, laminin, hyaluronans).  However, the studies on them to date have been 
very limited.  So, it is unknown if they have the potential to differentiate to fully 
mature parenchymal cells.  Needed are studies defining the extent of ischemia (cold 
or warm) to which they can be subjected and still leave the stem cells with full 
differentiation potential 
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1.3.2.3 Neonatal Livers 
Neonatal livers are from infants who die within the first year of life.   It is not 
possible to define brain death in a neonate, since the posterior skull of a neonate 
does not close until 8 weeks and the anterior for up to 18 months after birth.  
Consequently, neonates can suffer significant brain damage resulting in swelling of 
the brain and yet recover. For them, death is defined always as cardiac arrest 
resulting in the fact that neonatal tissues are always from asystolic donors. Since 
neonatal organs and tissues are comprised predominantly of stem cells and 
progenitors, the entire organ as an organ survives for hours (up to ~8 hours!).  
Therefore, the stem/progenitors can survive even longer than those in adult livers 
given that the extent of mature cells dying is minimal (so, low levels of enzymes 
released).   
 TABLE 7. SOURCING OF HUMAN LIVERS 
? Fetal Livers (14-20 weeks gestation) 
? High percentage of stem cells, hepatoblasts and committed progenitors 
? Ease in isolation 
? Ability to obtain and use them depends on political and cultural attitudes 
 
? Liver Resections 
? Neonatal, pediatric and adult livers 
? Difficult to obtain; highly variable quality of tissue; small amounts 
 
? Organ donors (“Brain-dead but beating heart donors”) : cold ischemia   
?  ~ 1-2% of deaths; ~ 5000/year in United States 
? Pediatric and adult livers 
? Most used for transplantation; must compete for the small numbers of 
rejected livers ~100-200/year 
? Highly variable quality of tissue 
 
? Cadaveric Livers (asystolic donors): warm and cold ischemia 
? All neonatal deaths and 98-99% of pediatric and adult deaths 
? Neonatal, pediatric and adult livers 
? Cannot be used for transplantation, so all available for research and cell 
therapy programs 
? Pediatric and Adult Livers--mature liver cells die within ~1 hour of death; 
stem cells (EpCAM+ cells) survive for 6-8 hours but with increasing damage 
to the stem cells due to enzymes released by dying cells 
? Neonatal livers are ideal since so rich in stem cells and progenitors.  
Can isolate viable cells from neonatal livers for up to 7-8 hours after 
death. 
 
Consequently, neonatal livers are an ideal source of highly viable parenchymal cells 
for some hours after death [27, 86].   Procurement of neonatal livers by organ 
procurement organizations (OPOs) began in 2001 after years of efforts of LM Reid 
and two transplant surgeons, Jeff Fair and David Gerber.  The program for 
procurement of neonatal organs was transferred from UNC to a biotechnology 
company, Vesta Therapeutics (Research Triangle Park, NC), that now works with 
OPOs to obtain the neonatal tissues.  At present it is the only company procuring and 
processing neonatal livers, though surely this will change in the coming years.  There 
are rough estimates that at least one neonate dies on a medical center’s neonatal 
  21 
 
  22 
 
intensive care unit (NICU) every week, and there are many such NICU units within 
the United States.  Even conservative estimates suggest several thousand neonatal 
deaths/year in the United States, and, at present, only a handful of these neonates 
have been donors for tissue/organs procured by OPOs.  Thus, there is considerable 
potential for tissue and organs from neonates who have died to become a major new 
source of high quality tissue for use for both research and clinical programs.   
 
1.3.3 Processing Human Liver Tissue and Liver Cell Isolation  
The quality of the liver cell preparation is a reflection of the quality of the 
starting tissue.  As such, the best sources of tissue for the isolation of liver cells are 
freshly resected biopsy samples, freshly preserved donor organs (<12 hours from 
clamp time), and neonatal livers.  Of course, these sources of tissue are rarely 
available to the average academic or industrial investigator. There are a number of 
methods described in the literature for the isolation of human liver cells from partial 
biopsy segments and from whole lobes [131-133].  These approaches are essentially 
modified versions of the original two-step perfusion methods developed by Seglen 
and others[134] for the isolation of liver cells from rat livers.  In addition, we have 
established a novel method for fractionating liver cell suspensions from liver sections 
or whole livers  and that involves fractionation with Optiprep (60% solution of 
Iodixanol, Accurate Chemicals, Westbury, NY) used for live-dead fractionation in 
combination with a Cobe cell washer[135].  The Optiprep fractionation results in 
preservation of the hepatic progenitors within the live fraction.  The progenitors can 
be immunoselected from the cell suspensions.  
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1.3.4 Ex Vivo Maintenance of Cells 
 For detailed descriptions and discussions of classical cell culture 
methods, see recently published book on cell culture [136].  All methods of preparing 
cells for culture start with the disruption of the tissue and its dispersal into chunks or 
single-cell suspensions.  In classical cell culture, the dispersed tissue or cells are 
plated onto an inflexible plastic substratum that has been exposed to a cationic 
ionizing gas making the polystyrene in the dishes polarized to reveal a negatively 
charged layer.  Cells attach to the dishes via that negatively charged surface and 
subsequently form a more complicated adhesion surface with secreted forms of 
extracellular matrix complemented by matrix components from serum.  The cells are 
suspended in or covered with a liquid medium consisting of a basal medium of salts 
and nutrients supplemented with a biological fluid such as serum We have prepared 
a serum-free, hormonally defined medium (HDM) for liver cells and have found that 
some requirements are generic for all the maturational lineage stages and others are 
lineage-stage specific.  Below is provided general information about the media 
requirements and then are given tables of serum-free conditions for ex vivo 
maintenance of liver cells.  
 
Basal Medium.  The basal media that are commonly used (e.g., RPMI, 
DME, BME, Waymouth’s) were developed originally for cultures of fibroblasts [136].  
Although most of the constituents in these basal media are requirements for both 
epithelial cells and fibroblasts, some aspects of the basal media have had to be been 
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redefined for the needs of epithelia [136].  Two examples are trace elements and 
calcium levels.  Highly differentiated epithelia require various trace elements or 
other factors that act as cofactors for the enzymes associated with their tissue-
specific functions [137-139].  With respect to the calcium, its level in many of the 
commercially available media is above 1 mM, concentrations permissive for growth 
of fibroblasts, but that have been shown to be inhibitory to most epithelial cell types 
[140].  This problem is exacerbated by culturing the cells in serum-supplemented 
media, since serum also contributes significantly to the calcium level.  Most normal 
epithelial cells can grow in calcium concentration of approximately 0.4 mM.[140, 
141]  
  
Serum.  Since the 1950s, the primary form of biological fluid used for 
supplementation of the basal media has been serum obtained from animals taken to 
commercial slaughterhouses. Some investigators utilize serum autologous to the cell 
types to be cultured.  However, it is more common that the serum derives from 
animals that are routinely slaughtered for commercial usage, such as cows, horses, 
sheep, or pigs.[136]  Fibroblasts (stroma and other mesenchymal cell types) do well 
in serum-supplemented media (SSM).  By contrast, epithelial cell types such as liver 
parenchymal cells dedifferentiate rapidly, within hours to a few days, in SSM and 
then die, usually within 5-7 days when on culture plastic or within 7-14 days when on 
various matrix substrata[18]. Over the last about 20 years, the need for serum 
supplementation has been reduced or eliminated through numerous efforts by many 
investigators.  The serum supplementation has been replaced with mixtures of 
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defined and purified hormones and growth factors as proposed by the pioneering 
strategies of Gordon Sato [137-139]. 
 
Lipids. All cells require lipids, but mature hepatocytes are capable of 
converting linoleic acid into most lipid derivatives.  This is not true for progenitors.  
They must be provided with a mixture of free fatty acids, bound to an appropriate 
carrier molecule (e.g. albumin) and supplied also with high density lipoprotein (10 
µg/ml) for long-term management of uptake and release of lipids by the cells.   The 
preparation of a mixture of free fatty acids is described originally by Chessebeuf and 
associates [142].  The mixture can be combined with albumin (bovine, human, etc.) 
to prevent the free fatty acids from being toxic.  The fatty acids are a strict 
requirement for the progenitor subpopulations.   
 
Soluble Signals: Autocrine, Paracrine, and Endocrine Factors 
(Hormonally defined Media, HDM)  An approach to defining the soluble 
signals from cell-cell interactions has been to replace the serum supplements in 
medium with known and purified hormones and growth factors to yield a serum-
free, hormonally defined medium or “HDM” as summarized in recent reviews[20, 
40].  Such media have been developed for many cell types enabling investigators to 
have greater control over cells being maintained ex vivo.  Use of HDM results in 
selection of the epithelial cell type of interest from primary cultures containing 
multiple cell types.  Almost all of the published HDM are optimized for cell growth.  
To observe optimal expression of differentiated functions, the HDM must be 
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retailored [37, 143].  Each tissue-specific function requires a discrete set of hormones 
and growth factors, often at concentrations that differ from those required for cell 
growth. For example, insulin levels required for growth are typically about 1-5 µg/ml, 
whereas those needed for optimal expression of connexins are 50-100 ng/ml [144-
146].  Thus, some of the hormones conducive to growth can markedly inhibit tissue-
specific functions.  A rule of thumb is to develop an HDM for growth of cells and 
then use it as a starting point for identifying the conditions needed for differentiation 
of those cells. Detailed protocols for the development of an HDM for a cell type at a 
given lineage stage have been described elsewhere and will not be presented 
here.[40]   
Purified hormones and growth factors are prepared individually and aliquoted 
as 1000 x stocks.  They are added to the basal medium and then filtered through a 
sterilization filtration unit that is low protein binding. In the tables below are the 
serum-free conditions (media used in combination with feeders or with matrix 
substrata) found useful for hepatic progenitors and their associated mesenchymal 
companion cells.  
The basal media given in the tables below is RPMI 1640.  It can be replaced 
with any of a number of basal media (DME/F12, William’s, etc.) with the qualifier 
that the medium must be chosen to be rich in amino acids, with a calcium 
concentration below 0.5 mM for growth versus greater than 0.5 mM for 
differentiation, and with copper avoided for stem cell cultures that are being kept in 
self-replicative mode.   
 
 Table  8 Serum-free Conditions for Expansion of hHpSCs and 
Hepatoblasts 
Basal Media RPMI 1640 + nicotinamide (4.4 mM) + L-glutamine (2 mM)  
High density lipoprotein, HDL (10 µg/ml) + Free fatty acids bound 
to purified human albumin (0.2% w/v) and at 7.6 µEq of a mixture 
of free fatty acids 
Lipids 
Free fatty acids Mixture: see Materials and Methods 
Hormone 
requirements  
Insulin (5 µg/ml), transferrin/fe (5 µg/ml) 
Trace elements* selenium: 3 x 10-10 M; zinc sulfate: 5 X 10-11 M 
Calcium ~0.3 mM 
Feeders (these can 
be replaced, in part, 
by the matrix 
substrata given 
below) 
Angioblasts/endothelia for self-replication 
Activated hepatic stellate cells for expansion with lineage restriction 
to hepatoblasts  
STO cells for expansion of rodent hepatoblasts and for 
differentiation of human hHpSCs and hepatoblasts[25] 
Matrix Substrata Type III collagen or hyaluronans for self-replication[45, 47]; type IV 
collagen and/or laminin for lineage restriction to hepatoblasts[25] 
Representative 
Known Soluble 
Signals from feeders 
Angioblasts: LIF[147] 
Activated hepatic stellate cells: HGF[26] 
Table  9 Serum-free conditions for Differentiation of hHpSCs (or 
of hepatoblasts) 
Basal Media RPM 1640 + nicotinamide (4.4 mM) + L-glutamine (2 mM)  
 
Lipids High density lipoprotein, HDL (10 µg/ml) + free fatty acids bound 
to purified human albumin (0.2% w/v) and at 7.6 µEq  of a free 
fatty acid mixture 
 Free Fatty Acid Mixture: see Materials and Methods 
Shared Hormone 
requirements  
Insulin (5 µg/ml),  transferrin/fe (5 µg/ml) 
Trace elements* Selenium: 3 x 10-10 M; zinc sulfate: 5 X 10-11 M; copper sulfate: 10-10 
M 
Calcium ~0.6 mM 
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 Hormones/Growth 
Factors  
EGF (50 ng/ml), T3 (10 -9M), hydrocortisone (10-8 M) 
Heparins or Heparin 
proteoglycans 
10 µg/ml (heparins) or 1-5 ng/ml (Heparin PGs) 
Feeders For hHpSCs, one can use STO feeders; unknown for rodent or 
murine hHpSCs or hepatoblasts 
Matrix Substrata Plating on or embedding in type I collagen gels[25, 47] 
 
Table 10. Serum-free Conditions for Mature Parenchymal Cells [6, 20, 40] 
Components Concentrations 
Basal Media RPMI 1640`+ Nicotinomide (4.4 mM) + L-glutamine (2 mM) 
Trace Elements Selenium: 3 x 10-10 M; zinc sulfate: 5 X 10-11 M; copper sulfate:  
10-10 M 
Lipids High Density Lipoprotein (10 µg/ml) 
Free Fatty Acids Linoleic acid, 2.7 x 10-6 M; [Mature parenchyma can survive on 
linoleic acid alone; however, the cells do better if given the 
entire mixture of free fatty acids as described in Materials and 
Methods] 
Calcium 0.6 mM 
Hormones/growth factors 
 
Insulin (5 µg/ml), epidermal growth factor (50 ng/ml), Tri-
iodothyronine or T3 (10 -9M), hydrocortisone (10-8 M) 
Matrix substrata Ideal is to let the cells be 3-dimensional (spheroids).  Partial 
effects are observed with cells embedded in type I collagen 
especially if combined with heparin proteoglycan  
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3. Influence of Serum-free Hormonally Defined Media on Epithelial Cells in 
Culture 
Serum-free, hormonally defined media have been found to select for 
parenchymal cells even when the cells are on tissue culture plastic [20, 43, 139]  This 
results, within a few days, in cultures that are predominantly the cell type for which 
the HDM was developed.  However, if the cultures are plated onto tissue culture 
plastic and in HDM, the life span of the primary cultures has been found to be 
approximately 1 week, at which time, the cells peel off the plates in sheets.  
Achievement of longer culture life spans under serum-free conditions has been 
found to be dependent upon using substrata of matrix components or extracts 
enriched in extracellular matrix in combination with the serum-free, hormonally 
defined medium[20]. 
 
Table 11 Serum-free conditions used for rodent hepatic stellate 
cells, rHpSTCs[26] 
Basal medium RPMI 1640 (GIBCO) + L-glutamine (1 mM, GIBCO) 
Lipids High density lipoprotein (10 µg/ml) + mixture of free fatty acids  
bound to albumin 
Free Fatty Acids See preparation of these in Materials and Methods 
Trace Elements Selenium: 3 x 10-10 M; zinc sulfate: 5 X 10-11 M; copper sulfate:  
10-10 M 
Hormones and  
Growth Factors  
Insulin (5 µg/ml), transferrin/fe (5 µg/ml); EGF (10ng/ml; Pepro 
Tech, Inc.); LIF (10 ng/ml; StemCell Technologies, Inc.),  
Antimicrobials Antibiotics from GIBCO 91%)  
Feeders STO Feeders (Mitomycin C-treated)  
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Tissue-specific gene expression is dramatically improved in cultures under serum-
free conditions and especially with serum-free medium supplemented with only the 
specific hormones needed to drive expression of a given tissue-specific gene[148, 
149].  However, mRNA synthesis of tissue-specific genes is not restored by serum-
free medium or by any known combination of hormones and growth factors; rather, 
the improved tissue-specific gene expression in serum-free media or in hormonally 
defined media is due to posttranscriptional regulatory mechanisms, often an 
increase in stability of specific mRNA species[18].  Restoration of mRNA synthesis  
occurs only with serum-free media or with a serum-free, hormonally defined media 
containing the specific hormones or factors found to influence a given gene and 
presented in combination with tissue-specific forms of heparin proteoglycans or  
Table 12 Partially Defined Medium used for human angioblasts 
and endothelia[25]  
Basal medium RPMI 1640 (GIBCO) + L-glutamine (1 mM, GIBCO) 
Lipids High density lipoprotein (10 µg/ml) + mixture of free fatty acids 
bound to albumin 
Free Fatty Acids See Materials and Methods 
Trace Elements Selenium: 3 x 10-10 M; zinc sulfate: 5 X 10-11 M; copper sulfate: 10-
10 M 
Hormones and  
Growth Factors  
Insulin (5 µg/ml), transferrin/fe (5 µg/ml); EGF (10 ng/ml; Pepro 
Tech, Inc.); LIF (10 ng/ml; StemCell Technologies, Inc.),  VEGF 
(10 ng/ml; Sigma) ; basic FGF (10 ng/ml; Sigma)
Antimicrobials Antibiotics from GIBCO 
Substratum Type III collagen 
Other 2-mercaptoethanol (0.1 mM), knockout serum (I15%, In 
Vitrogen) 
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their glycosaminoglycan chains, heparins[146, 150, 151].  Heparins are often 
bleached in commercial processes to eliminate the brown coloration that is due to 
iron deposits; the bleaching process is destructive to heparin’s biological activity on 
gene expression, so use unbleached fractions. At present one cannot obtain the most 
potent matrix components regulating tissue-specific gene expression: the tissue-
specific forms of proteoglycans.  Efforts are ongoing in a number of laboratories to 
isolate and characterize them.  It is hoped that they will become available 
commercially in the near future.   
 
 
Table 13.   Ex Vivo Growth Potential for the Known Lineage Stages 
Hepatic Stem Cells 
 
Division rates of ~1/26 hours under optimal conditions; can 
be subcultured repeatedly [27, 47].  One cell can generate 
>40,000 daughter cells in ~15 days [28] 
Hepatoblasts and 
committed progenitors 
Division rates of ~1/40-50 hours; rodent 
hepatoblasts have been found to undergo ~12 divisions in 3 
weeks and with one hepatoblast generating 4,000 - 5,000 
daughter cells in 3 weeks [43].  The division rates possible for 
human hepatoblasts are not known though estimated to be 
similar probably to that of the rodent hepatoblasts. Addition 
of various mitogens (e.g. HGF) can dramatically affect their 
division potential. 
Diploid adult cells 
[“small hepatocytes”] 
One cell yields  ~130 daughter cell in 3 weeks (~ 5-7 divisions 
total); limited ability to be subcultured[43] 
Polyploid adult cells Attach, survive; DNA synthesis but limited or no 
cytokinesis[91] 
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 Table 14. Requirements for Tissue-specific Gene Expression (both transcriptional 
and post-transcriptional) 
Basal Media: nutrient rich.  One option= RPMI 1640 (GIBCO) + L-
glutamine (1 mM, GIBCO) 
Calcium ~0.6 mM 
Trace Elements:  
 
Selenium: 3 x 10-10 M; zinc sulfate: 5 X 10-11 M; 
copper sulfate: 10-10 M 
Lipids 
 
High density lipoprotein (10 µg/ml) + mixture of 
free fatty acids  bound to albumin 
Free Fatty Acids See details for preparation of these in Appendix 2 
Hormones Insulin (5 µg/ml), tri-iodothyronine or T3 (10 -9M), 
hydrocortisone (10-8 M) 
Requirements for 
all genes 
Proteoglycan/ 
GAGs 
Heparin proteoglycan (ideally liver-specific) (1-5 
ng/ml) or can see partial effects with bovine lung 
heparin (5-10 µg/ml); intestinal heparin is weaker 
(15-20 µg/ml) 
Albumin Epidermal growth factor (50 ng/ml) 
Connexins Epidermal growth factor (50 ng/ml); glucagon (10 
µg/ml) 
Additional 
Requirements for 
Representative 
Genes IGF II Prolactin (2 mU/ml), growth hormone (10 µU/ml) 
References [146, 150, 151] 
 
Table 15. Feedback Loop:  Relevance to Studies Tissue Engineering of Liver 
whether ex vivo or in vivo 
Findings Hypothesis Predictions 
Stem cells or 
progenitors do not 
grow ex vivo when 
co-cultured with 
mature 
parenchymal cells 
Mature parenchymal cells 
(e.g. polyploid cells) 
produce soluble signals 
constituting feedback loop 
that regulates stem cell 
compartment 
• The signals do not exist in peritoneum; 
site is permissive for expansion and 
maturation of human liver cells 
• Other hosts (e.g. sheep, pig) that have 
higher proportion of diploid cells will 
be better models for studies of human 
hepatic progenitors.  
• Strategies for clinical programs must 
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1.3.5 Extracellular Matrix  
Extracellular matrix is essential, especially for normal cells to survive and 
function.[6, 7, 152] The chemistry and physical features of extracellular matrix are 
known to regulate gene expression and influence cell morphology in all tissues 
including liver[5, 6, 145, 150, 153-155].  The extracellular matrix is a complex 
mixture of molecules between and around cells made insoluble by crosslinking.   
There are many types of matrices, each with distinct chemical composition, 
contributed to by all of the cells within the tissue, and changing quantitatively and 
qualitatively with changes in physiological states or pathological condition.  
Excellent reviews are available on its chemistry and functions.[8, 10, 65, 153, 156-
159]   
In the past, the extracellular matrix was thought to play an entirely mechanical 
role binding together cells in specific arrays. Now it is realized that it is a dynamic 
chemical scaffold that confers persistent signaling in combination with mechanical 
effects.  The matrices mechanical effects influence genetic expression within the cell 
via attachment through specific integrin complexes and through them to cells’ 
or with conditioned 
medium from the 
mature cells 
take feedback loops into account 
• Transplant purified human hepatic 
stem cells or progenitors (therefore 
avoiding feedback loop from mature 
human cells) 
• Hosts with high polyploidy will require 
liver injury to mature cells (zones 2/3) 
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cytoskeleton and associated networks.  Another role for the matrix is as a storage 
depot for soluble signals both in that some of its components have amino acid 
sequences encoding soluble signals and in the ability of matrix to bind soluble 
signals, thereby sequestering them in the matrix.   Extracellular matrix components 
and their synergistic effects with soluble paracrine signals mediate the regulation of 
the cell’s morphology, growth and gene expression.[6, 10, 37, 145, 156, 157, 160-165] 
1.3.5.1 Overview of Paradigms in Extracellular Matrix in Tissues 
In order for the cell type of interest to mimic its in vivo counterpart in a specific 
physiological or pathological state, the associated matrix chemistry must be 
identified.  One is helped by the understanding that there is a paradigm to how all 
types of extracellular matrix are made, and by the numerous studies identifying the 
matrix chemistry in various tissues. 
All cells produce an extracellular matrix, and the extracellular matrix in between 
any given set of cells contains components derived from all the cell types in contact 
with the matrix.   The matrix components present on the lateral borders between 
homotypic cells includes cell adhesion molecules or “CAMs”[11, 12, 166] and 
proteoglycans[14, 167-169] and will be referred to as the “lateral matrix”. That between 
the epithelium and a mesenchymal cell partner will be referred to as the basal matrix.  
It consists of basal adhesion molecules (laminins, fibronectins) that bind the cells to 
collagen scaffolding; in addition there are other matrix molecules such as 
proteoglycans that are attached in many ways to the plasma membrane surface, to the 
basal adhesion molecules and/or to the collagens.    
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The matrix chemistry in all tissues changes during development.  Thus, embryonic 
or fetal tissues are comprised of a mixture of matrix components that differ 
qualitatively and/or quantitatively with that found in the adult tissues.  They have the 
common feature that those found in fetal tissues are less stable and turnover more 
readily than those in mature tissues.  Below are provided brief summaries about each 
of the categories of matrix components found in tissues, including liver, and have been 
molecules of interest for the research studies completed.   
1.3.5.2 Collagens   
Collagens are a centerpiece of metazoan development.  There are more than 
25 families of collagens, all of them having molecules with the features of 1) 
numerous repeats of glycine-proline-X, where X is an amino acid defining a specific 
collagen type; 2) each molecule being 3 amino acid chains braided together and 
deriving from one to three separate genes; 3) aggregation of molecules into fibrils 
depending on the exact amino acid sequence of the molecules.[8, 170-173]  They 
contribute to the major scaffolding sources for the basal matrix.  Although almost all 
culture studies using collagens have only made use of  type I collagen, a type found in 
vivo in tendons, bones, and in the most mature portions of tissues, there have been 
increasing efforts to give recognition to the diverse collagen types that are present in 
tissues and that confer critical facets of the cells’ functions. We have found that 
specific collagens are requisite for the cells to expand versus differentiate.   Model 
systems such as the lineage state and disease state systems inherently focus on the 
changes of matrix in time with a change in capacity for the cells. Such is the case of 
certain liver diseases in which collagens as well as non-collagenous extracellular 
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matrix components change in their ratios or in facets of posttranslational 
modifications.[174]
The forms produced by cells are distinct in embryos versus mature tissues.  
Those in embryos and fetal tissues have a chemistry that makes them less stable 
and/or they turn over more frequently, whereas those in adult tissues are very stable, 
and some of them have large numbers of molecules/fibril (e.g. type I), a factor in 
their stability.  
1.3.5.2.1 Type III collagen: 
Type III collagen is a fibrillar forming collagen comprising three α1(III) 
chains and is expressed in early embryos and throughout embryogenesis; it is critical 
for formation of blood vessels and works in conjunction with type I collagen in adult 
tissues in the formation of the cardiovascular system. In adult mammals, type III 
collagen is a major component of the extracellular matrix in a variety of internal 
organs and skin. Mutations in the COL3A1 gene are associated with aortic rupture in 
early adult life.[174] Type III collagen has been shown to be the substratum of choice 
for hepatic stem cells to elicit self-replication.[47] 
 
1.3.5.2.2 Type IV collagen .    
Type IV collagen is the only collagen molecule in which aggregation of 
molecules results in end-on-end aggregation to make a network or chicken-wire-like 
structure that is a single molecular thick.[175-178] Cells are bound to type IV 
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collagen via laminin bridges.  It is present in early embryos or in epithelial-
endothelial relationships (eg. liver, kidney, endocrine organs). 
1.3.5.2.3 Type VI collagen 
Type VI collagen filaments are found associated with interstitial collagen 
fibers, cells in contact with endothelial cells’ matrix and with co-distribution of type 
VI and type IV collagen.[179, 180] 
 
1.3.5.3  Basal Adhesion Molecules 
1.3.5.3.1 Laminins 
Laminin, composed of 3 polypeptide chains is a major component of the 
basement membrane helping assembly creating tissue architecture and is uniquely 
shaped like a cross. Physically, it creates a somewhat regular lattice much like, but 
distinguishable from type IV collagen, although it can associate with it via entactin 
and perlecan. Domain affinities also exist for heparan sulfates and nidogen [181-
188].  Each trimer is assembled from alpha, beta, and gamma chain subunits of 
which in mammalian systems there have been five alpha, three beta, and three 
gamma subchains identified.  In addition there are suspected variants to these in 
alternatively spliced forms.[189-192] 
In non-diseased liver, laminin is present in the basement membrane of blood 
vessels and ducts and spottedly in the Space of Disse    [153, 158, 176, 186, 193-195].  
Laminin is produced by epithelial cells, both vascular and biliary, lipocytes and 
hepatocytes in ex vivo cultured conditions[153, 158, 186, 196-198] posses the ability 
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to self assemble like many other known matrix components.  They bi-functionally 
bind to scaffold components, like heparan sulfates, and cells, interacting by integrins 
and specific receptors such as beta-1/beta-4 integrins and tyrosine phosphatase 
receptor.[192, 199, 200] The forms of the laminin as composed by the 3 trimers 
change in expression over embryogenesis, and there are noted changes within the 
specific tissues such as the liver where niche components are located at higher levels.  
For example, Laminin 1, composed of alpha 1, beta 1, and gamma 1 is present during 
embryogenesis as early as the blastocyst, but is absent in the majority of most adult 
tissues;[192, 201-207]  It has been noted that hypatocytes have a high affinity for the 
attachment of laminin and their fragments.[186, 193, 208] 
1.3.5.3.2 Fibronectins 
Fibronectins are large glycoproteins composed of two chains connected by a 
disulfide bridge, which helps to maintain the stability of the extracellular matrix by 
acting as an attachment site for both cells and other matrix components.  
Functionally it is interactive with itself, and a site for binding of other matrix 
components such as heparan sulfates and heparins.[209]  Small functional domains 
have been identified by denaturing of the fibronectin. It has been identified in a 
regulatory role in cell migration and cellular cytoskeleton organization[210].  
 
1.3.5.3.3 Proteoglycans  
(PGs) are among the most complicated of the matrix components having 
effects through their core proteins as well as their carbohydrate side chains.  
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Examples of biologically active core proteins are the transferrin receptor (Tf-R) and 
colony stimulating factor receptor (CSF-R).  The forms in the liver include glypicans 
bound to the cell surface via linkage with phosphotidyl inositol (PI) and syndecans, 
heparan sulfate-PGs with transmembrane core proteins  connected intracellularly to 
cytoskeletal elements and extracellularly having glycosaminoglycan (GAG) chains, 
heparan sulfates or heparins, that bind and stabilize soluble signals.  The GAG chains 
can  influence receptor binding of the signal and receptor and ligand turnover rates. 
The mechanisms are not fully understood, but empirically it has been found that the 
signals bound to poorly sulfated GAGs (e.g. heparan sulfates and chondroitin 
sulfates) behave as mitogens, whereas the same signals when bound to the highly 
sulfated GAGs (e.g. dermatan sulfate-PGs, heparin-PGs) behave as differentiation 
mediators. 
 
1.3.6 Impact of Matrix chemistry to Growth and Differentiation 
Achieving liver histological structure and possibly organotypic functions is 
important for expression of tissue-specific functions of cells cultured under ex vivo 
conditions  and requires substrata of appropriate forms of extracellular matrix [211-
213].   
Different modifications of substrata for culturing hepatic cells have been tried, 
including collagens, laminins, and fibronectins.[214] Coating of these matrix 
molecules on tissue culture plastic results in discrete behavioral and phenotypic 
responses of  hepatocytes [159, 162, 193, 214-217].  The matrix substrata have been 
characterized under monolayer culture conditions and are now being evalulated in 3-
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D culture systems.  Interestingly, cells such as parenchymal cell lineages are 
relatively static ex vivo, whereas they are much less static in vivo.  As pointed out by 
Allen and others, there is limited information on the matrix regulation of hepatocyte-
specific functions in vivo.  To further complicate matters, a comparison between 3-D 
cultures and hepatocytes in vivo  is difficult in attempts to recapitulate the 
extracellular system where microenvironment causes specific effects such as 
secretion of albumin, urea synthesis and P450 activity.[218]  Furthermore, how 
these events influence lineage state of parenchymal cells is not known and comprises 
studies in their infancy.  Recent findings suggest that proteoglycans are imperative to 
fate commitments by stem cells.   
Some matrix components (e.g. laminin) influence specific biological functions 
such as adhesion to endothelial cells through functional peptide sequences found on 
the individual chain trimers.[192] Laminin has been shown to be a central 
component  to cellular differentiation, regulation of growth, movement, morphology, 
and survival.[186, 219]  As it is deposited intermittently along the Space of Disse but 
only in the periportal region[186, 193, 195, 220] it potentially plays key roles in the 
regulation of stem cells, progenitors and the early lineage stages of adult 
parenchymal cells offering a microenvironment paralleling embryonic conditions. 
Laminin-1 has been shown through culture to be involved in organ 
development and cell migration[192, 203, 221-224]  Effects of the components of the 
ECM can be regulated by the proteoglycan components as seen as heparin 
concentrations that influences laminin polymerization through binding and bridging 
the G domain, a functional domain of the laminin structure.[192, 225] Furthermore, 
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as the chemistry of matrix molecule interactions are further studied, functional 
domains of these varied molecules are able to replace whole segments in end 
specified goals.  Improvement of understanding and application of defined culture 
conditions of hepatic cells enhances the ability to steer the cells through 
growth,[214] and through differentiation.[27] 
Biological activities of hyaluronans (more described below) has been linked to 
cell differentiation, development, and proliferation, in addition to cell homing, 
locomotion and immune response.[226]  It is recognized, especially for hyaluronans, 
that oligomer length is implicated in physiological results.  In vivo cells maintain the 
ability to modify the extracellular matrix, and there are known hyaluronidases which 
degrade HA, and thus create a cascade of physiological responses.   
 
1.3.7 The Matrix Chemistry in Liver and Changes with Development 
The chemistry of the extracellular matrix in the liver changes during 
development with various types of matrix molecules dominant in fetal tissues and 
others dominant in adult tissues.  The stem cell niche for human livers is the ductal 
plate (also called limiting plate) in fetal and neonatal livers that is the antecedent to 
the Canals of Herring in pediatric and adult livers [128]. The known matrix 
chemistry in the liver’s stem cell niche is comprised of type III and IV collagen, 
laminin, hyaluronans and specific forms of chondroitin sulfate proteoglycan[11, 227, 
228] [227]( Dr. Bruce Caterson, Cardiff, England, personal communication). Two 
forms of hyaluronan receptors have been found: CD44 found on the hepatic stem 
cells[45] and LYVE-1 found on the angioblasts.[229]  The integrins found in ductal 
plate and associated with the hepatic stem cells, the multipotent progenitors in the 
liver,  include: α2, α3, α6, and β4, but no α1 or β1; those associated with 
hepatoblasts, the liver’s bipotent progenitors, are α1, α5, α6, α9, and β1 but no β4; 
with maturation towards hepatocytes, there is a disappearance of integrin receptors 
that bind to laminin, whereas maturation towards biliary is associated with a 
maintenance of laminin-binding integrin receptors.[228] 
Outside the liver’s stem cell niche, the basal matrix components are found in 
the Space of Disse, the layer between the parenchymal cells and their mesenchymal 
partners: the endothelium for the hepatocytes and the stroma for the biliary cells 
[153, 157]  The chemistry within the Space of Disse transitions in gradient fashion 
from that in zone 1 (periportal zone next to the portal triads) to that in zone 3 in 
contact with the most mature parenchymal cells in zone 3 (next to the central vein). 
That within zone 1 (periportal zone) and associated with periportal hepatocytes 
consists of laminin, type IV collagens, hyaluronans, chondroitin sulfate (CS)-PGs 
and weakly sulfated heparan sulfate (HS)-PGs.[10, 156, 157, 230-232] This 
transitions to that found in Zone 3 (pericentral zone): collagen I, small amounts of 
type III collagen, fibronectin, and highly sulfated proteoglycans such as heparin 
(HP)-PGs and a complete absence of type IV, laminin and hyaluronans.[91, 233]  In 
addition, there are components of undulin, elastin, forms of dermatan sulfate-PGs. 
[5, 10, 156, 157, 167, 234],[5, 235-238].   
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Table  16.  Lineage-dependent Matrix Chemistry within the Liver Acinus** 
Category of 
Matrix 
Molecules 
Stem Cell 
Niche 
Zone 1 
parenchyma 
(Periportal) 
Zone 2 
hepatocytes 
(mid-acinar) 
Zone 3 
hepatocytes 
(Pericentral) 
Collagens Type III, IV, 
(some type VI) 
Type III, IV Type III Type I, small 
amounts of III 
Laminins Laminin Small amounts  none None 
Fibronectin None Mesenchymal cells Mesenchymal 
cells 
Mesenchymal 
cells 
Plasma 
fibronectin 
Proteoglycans/ 
GAGs 
Hyaluronans;  
Poorly 
HS-PGs (glypicans, 
syndecans) 
HS-PGs 
CS-PGs 
HP-PG 
DS-PG   43 
 
sulfated CS-
PGs 
More highly 
sulfated CS-PGs 
Hyaluronans Present Present None None 
Hyaluronan 
receptors 
CD44 
RHAMM 
LYVE1 
+ 
Appears with HA 
+ 
None 
 
++ 
None 
 
+++ 
Integrins** α6β4, α2, α3 α1,α5, α9, α6, β1 α1, α5, α9, β1 
References [228, 239-241] [153, 156, 178, 193, 235-237, 241-244],[245, 246] 
*Stem Cell Niche= ductal plate in fetal and neonatal livers; Canals of Hering in pediatric and adult livers. HS-
PGs=forms of heparan sulfate proteoglycan (PG); CS-PGs= chondroitin sulfate-PGs; DS-PG=dermatan sulfate proteoglycan 
**The biliary lineage comprises two stages of cells that are intrahepatic, small and large cholangiocytes, and then 
multiple stages that are extrahepatic and connecting the liver to the gut. Very little is known about them with respect to matrix 
molecules or receptors.  What has been reported is that definitive bile ducts express β1, β4, α2, α3, α5, α6, α9, and αV. 
 
1.3.8 Availability of Extracellular Matrix Components 
Many of the extracellular matrix components can now be purchased 
commercially including many of the collagens (e.g. types I, III, IV), basal adhesion 
proteins (laminins, fibronectins), a few proteoglycans (heparan sulfate proteoglycans 
or HS-PGs and chondroitin sulfate proteoglycans or CS-PGs) and various 
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glycosaminoglycans (chondroitin sulfates, heparan sulfates, dermatan sulfates, 
heparins).  Commercially available matrix substrata also include tissue extracts 
enriched in matrix (e.g. Matrigel). Tissue extracts enriched in extracellular matrix 
(“ECM”, biomatrix, Matrigel, amniotic matrix) can also be prepared with protocols 
that take advantage of the relative insolubility of extracellular matrix 
components[20, 40, 152].   
 
1.4 Hyaluronan Chemistry and Biology 
HAs are one of the families of glycosaminoglycans (GAGs), all being polymers 
of uronic acid and an amino sugar.  Other GAG families include chondroitin sulfates, 
keratin sulfates, heparan sulfates, and heparins, all following the same “equatorial 
bonding scheme.”[247]   A possible similar genetic lineage for the family of proteins 
has been discussed with the origin of chondroitins and keratins derived from 
polylactose, heparan sulfates from polymaltose, and hyaluronans from cellobiose 
[247].  The chemistry of hyaluronans (HAs) is described most simply as  “Hyaluronic 
acid is a glycosaminoglycan characterized by a disaccharide unit linked with a Beta 1-
4,Beta 1-3 bonds between glucosamine and glucuronic acid moieties respectively.”  
However, as biologists, chemists and engineers are exploring the nature and 
potential uses of the molecules, it is becoming evident that hyaluronans are more 
complex than has been realized heretofore.  Biologically, the polymeric glycan is 
composed of linear repeats of a few hundreds to as many as 20,000 or more 
disaccharides units.[226]  It is found in extracellular matrix, on the cell surface and 
inside the cell.[248]  Hyaluronic acid  may prove to be a key element in defining the 
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extracellular matrix (ECM) for clonal growth of soft tissue adherent type cells.  
Attention is focused on this particular molecule over others of the ECM, because HAs 
are present in greater quantities at times of cellular expansion/proliferation[249, 
250] such as embryogenesis,[251] wound repair[252, 253], and organ 
regeneration.[253]  There is a change over in matrix chemistry as liver parenchymal 
cells differentiate through their maturational lineage stages.HA performs a host of 
noted tasks within the ECM other than those already stated: matrix structure 
stabilization and integrity, water and protein homeostasis, tissue protection, 
separation and lubrication, facilitation of cell movement/migration and cancer 
metastasis, transport regulation including steric exclusion, anchoring of hormones 
as a reservoir and integration of the immune inflammation response.[249, 251, 252, 
254, 255]   Endothelial cells within the lymphatic system posses a large quantity of 
LYVE-1 to that of CD44, creating a basis for lymphatic recognition and motility of 
cells within the system.[256, 257].  Some have shown that  HA is prominent in early 
liver injury models. Hepatic stellate cells produce it in primary cultures and in liver 
injury.  Their production of HA increases in parallel with expression of CD44.[258]  
Some of these characteristics have been implied to change along with exon variants 
of the major receptor CD44 [258].  In addition there is evidence of inhibitory effects 
of HA including the inhibition of cellular differentiation.[253] Shepard et al 1996,  in 
a series of experiments have shown that cellular expansion can be facilitated by HA 
without scarring in wound healing responses.  
     Hyaluronic acid was first discovered by Meyer and Palmer in 1934.  They 
named the polysaccharide with a Greek-based derivative “hyalos” meaning glassy 
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since they first extracted it from the vitreous of bovine eyes.[259]  Over the century, 
new methods for acquiring HAs have been developed including extraction from 
cock’s combs and bacteria.  Endre Balaz, who has studied the polysaccharide, coined 
the term hyaluronan to include the different forms of the molecule such as the salt 
forms that are present at physiological pH [260].  HAs are high-molecular weight 
polysaccharides estimated to be in amounts found in the average human body of 
anywhere from 11 to 17 grams [257, 261]  HA turnover rate is much greater than that 
of other extracellular matrix components [257].  As a part of the ECM [262], HAs 
exist as a nonsulfated glycosaminoglycan (GAG) [254], [255], [263] [251] unlike 
most other members of GAG families. In vivo, synthesized HA is linear [264] 
unbranched [265] and has a mass between 100 thousand (1E5) to 10 billion (1E10) 
Daltons depending on the species[250]  [Laurent, et al quote naturally occurring 
numbers to be from 1000 to 10,000,000 Daltons[251], with the size of the 
polysaccharide being 200 to 10,000 repeating units[266]]   Tammi, et al, report the 
size of hyaluronans generally in the mass range of about 105 to 107 Daltons, 
depending upon the tissue type.  Depending on the physiology and pathological 
conditions, the HA oligomer can be fractioned into much smaller fragments[248].  It 
does not undergo post-polymerization modification, as it is produced at the site of 
the outer cell wall and pushed into the extracellular space[267].    
HAs are central to many functions in development and homeostasis and 
activated by regulation of their production, turnover and size within a given tissue 
[248]  Interestingly, deletion of either CD44 or RHAMM1 receptors in mice is not 
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lethal.[248]  So, either there is redundancy with another entity handling the role(s) 
of these receptors or their relevance comes into question.   
Biological functions of hyaluronan have been investigated greatly, and the 
nature of the highly conserved molecule in relation to function has been central to 
many studies and subsequent papers, including process of morphogenesis of the 
heart, ovulation and fertilization [248]. Published reviews show how the prevalence 
of HA in protein interactions, signaling pathways, and pathologies [248] [268-
270]The primary biological function assigned to the GAG is one of mediating 
hydration in vertebrate tissues [253].  HA is found in all tissues and body fluids, and 
most abundant in soft connective tissue [271, 272]That natural water carrying 
capacity lends itself to speculation to other roles to be discussed subsequently 
including influences of tissue form and function..  As stated before, HA is anionic 
and bears a negative charge [250]  This in turn becomes basic chemistry as it attracts 
the positive charged hydrogen of water molecules.  There is overwhelming evidence 
hyaluronic acid HA is particularly conducive to migration.[269] 
     The bifunctionality of the HA within the body maintains that removal and 
synthesis can be equally important in both morphogenesis and tissue homeostasis.  
Although most cells are capable of synthesizing HA, the highest concentrations are 
found in the mesenchymal tissues.[273]  The relationship between liver and 
hyaluronan is not clear.  However, levels of HA in the blood have been correlated to 
hepatic regeneration.[274]  This seems reasonable since the liver is a major site for 
removal of HA as is the lymphatic system.  Catabolic clearance of HA seems to be the 
preferred method for eliminating it from the body.[257]  The estimated amount of 
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HA carried to the blood from the lymphatic system in a healthy adult is between 20 
and 40 milligrams per day.[265]  In humans, about 5 grams or one third of the total 
body weight is replaced daily.  This in fact facilitates many known properties, such as 
cell differentiation and development, cell proliferation, recognition, locomotion and 
the immunological responses.[226, 248]  In the liver, HA is cleared by a receptor-
mediated uptake by endothelial cells via a HA receptor, LYVE-1.  As indicated by 
McCourt et al, the likelihood that disposal of HA without receptor mediated 
specificity is highly unlikely due to high levels of fluid transfer needed to move the 
macromolecules across the cell membrane against electrolyte gradients.[257]  
Radiolabeled HA was found to pool in the non-parenchymal cells.[265]  Removal of 
HA is achieved by endocytic uptake.[248]  Hyaluronan concentrations correlate with 
extent of cellular proliferation and migration.  The derived metabolites of endothelial 
cells are acetate and lactate, which can be degraded by other resident cells of the liver 
into simple carbon dioxide and water.[265]  The pathways as described by Laurent et 
al[265]  describes HA as being transported to the lysosomal bodies after receptor-
mediated uptake.  There it is broken into metabolites and excreted into the 
cytoplasm.  The glucuronic acid is degraded via the gulonic acid pathway and a 
deacetylase degradation occurs to the N-acetylglucosamine. [257] [275]“Both acetate 
and lactate have been detected in liver after degradation of HA.”   They are 
transported out of the lysosomes for further degradation in the cytoplasm.  
Glucuronic acid is degraded via the gulonic acid pathway.  N-acetylglucosamine 6-
phosphate deacetylase degrades the N-acetylglucosamine.  This enzyme is present in 
large amounts in the mature liver endothelial cells and Kuppfer cells, but not in the 
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hepatocytes. [265]  Information and speculation of the role(s) of HA in normal 
developmental processes implicates important facets of  embryogenesis.  Obviously 
implications are made about the regulation of cell adhesion and motility to its 
effects.[266] 
 Karvinen, et al have linked increased HA gene expression in 
karytinocytes to cell motility in wound healing.[276]  A plausible hypothesis is that 
an abundance of HA within a tissue allows for the creation of highly hydrated areas.  
These areas, lacking sufficient ECM for cells to attach become a region of low cell 
density.  Low cell density is correlated with cellular proliferation through several 
mechanisms including decreased paracrine signaling, negation of feedback loops, 
and cell adhesion and structural changes leading to phenotypic regulation.  Soluble 
signals within the intracellular space help organize a variety of cellular events 
including “proliferation, communication, and transformation” [264]. The 
detachment of adherent type cells may be directly linked to the use of hyaluronan as 
a substrate before divisions.[259]  The concentration of HA in amniotic fluid at 
approximately 16 weeks gestation time in humans averages to 20 milligrams per 
liter.  By birth it is 1 milligram per liter.[273] 
 
1.4.1 Receptor Binding and Cell Mediated Attachment  
     A key to figuring out the mode in which the HA polysaccharide influences a 
tissue is to define the method of attachment to cells and to the ECM. HA binds 
proteins in the ECM, on the cell surface and in the cytosol [251]. Fibroblasts have 
been shown to proliferate at a faster rate when exposed to higher concentrations of 
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hyaluronans[253].  Two cell-surface hyaluronan receptors, CD44 and RHAMM, have 
a direct role for hyaluronans in regulating cell motility, invasion and 
proliferation.[248]  CD44, a cell surface protein mediates cellular attachment of the 
parenchymal progenitors to HA components of the ECM.  It has also been known as 
Prp-1, ECMR III, and Hermes antigen [277].  CD44 is well characterized as a major 
receptor for HA.  It is a single, 50 kilobases gene.  However, there are a large number 
of variants formed by alternative splicing of a 10 exon region.[258]  Although the 
expression of CD44 is prevalent in almost all tissues, not all forms of CD44 bind 
HA.[257, 278] It is for this reason that the elucidation of the CD44 regulatory 
process remains poorly defined as do the roles of ligand and growth factor 
signaling[248].  In addition physiological responses have been reported through the 
hyaluronan mediated motility (RHAMM) receptor, ICAM-1, and LEVY-1[266, 279].  
ICAM-1 was later shown not to be a binding receptor for HA, and nomenclature has 
changed for the other receptor to LYVE-1.  It is thought that LYVE-1 acts as an 
anchor for HA, upon which lymphocytes with activated CD44 can move.[280]   
Hyaluronan receptors related to the link protein family, but unrelated to CD44 or 
RHAMM, have been described but their function is not yet known.[248]  Along with 
CD44, the (RHAMM) receptor are the two most studied and characterized for HA 
attachment.[250]  Like most integral protein receptors, CD44 spans the outer 
membrane of a cell[250, 277] and aligns a hexasaccharide element in order to bind 
HA.[277]  On the interior side of the membrane, CD44 can link directly to 
cytoskeletal elements, thus mechanically triggering signal transduction.  This unique 
position has been studied for effects on cellular adhesion and motility.[250] 
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 Hyaluronate is principally recognized by the CD44 receptor, but there 
is nonspecific binding of sulfated and non-sulfated forms of chondroitin,[277] which 
have a similar chain structure to HA.[265]  In addition to attachment to surface 
receptors of some cells, it has specific affinities for binding to proteins in the ECM. 
CD44 receptor uptake can be inhibited with certain sulphated glycosamino-glycans 
such as chondroitin sulphate [281] [257]. Attachment acts as a stabilizing force 
creating a loose fabric of connection [255] ).  The composition of matrices vary with 
amount of HA on a tissue-specific basis, but generally the ECM contain HA binding 
proteoglycans [versican, aggrecan, and link proteins] [250]. Binding of HA by 
specific cell types has been reported, and particularly in the liver, endothelial cells 
bind the HA as it passes in the plasma.  Elimination in the liver by these cells is 
regulated primarily through receptor-mediated uptake (via LYVE-1), and the rate of 
elimination is due to a characteristic affinity.  The affinity for the molecule is 
proportional to the molecular weight of the HA polysaccharide.[265]  The underlying 
reason for this is that larger polysaccharides provide a greater number of attachment 
sites to interact with the receptors.  As another bi-modality of the relationship of 
molecular weight/size of HA and cellular attachment, large concentrations of HA in 
the extracellular space decrease the number of cell surface receptors for multiple 
interactions. 
1.4.2 Hyaluronans and Embryonic Development 
       Defining the relationship between clonal expansion, differentiation, and 
HA depends largely on the work done with the effects of HA in embryonic 
development.  Concentrations of resident HA increase with rapid repair and 
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regeneration [266].  Reasoned to be crucial in this role by provision of highly 
hydrated locals allowing uninhibited cellular migration, and decreased density, HA is 
a key regulator of embryogenesis [277]. Studies have indicated upregulation in 
specific variants of HA synthesis.  HAS2 is thought to stimulate motility in 
embryonic development.  Further studies indicate that the production of each HAS is 
differentially scheduled during the embryonic development.  Furthermore, their 
expression is tissue and cell specific.  Mouse models in which the HAS synthesis 
genes have been deleted show that only the HAS2 is vital in development.  Without 
it, the mice never develop hearts [248].  In fact, HA is a major component of the 
extracellular matrix during embryogenesis. [257]  The turn over rate of endogenous 
HA is equal to at least a 12-fold difference between fetus and adults depending on 
species.[265]  As a scaffolding component, HA has been linked to neural crest cell 
migration, cardiac development and prostate duct formation [250].  Rapidly dividing 
epithelial cells show increased binding activity towards HA, and it is plausible that 
transformation from epithelial to mesenchymal phenotypes take place via 
interactions mediated by HA binding [250, 277].  Under such conditions, 
delamination of cells in the embryo go from a tightly bound sheet into an 
unconnected operational cell unit. Lannace et al, report HA-CD44 interactions 
enhance matrix dependent locomotion by establishing phosphoinositide 3-kinase, 
(PI3-kinase) activity [264].  In addition to the transition from a tight to loose tissue 
connective type, digestion of HA can drive cells to change phenotype.  As HA within 
the extracellular matrix disappears, cells become more tightly bound in a smaller 
area triggering differentiation.[282] 
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Recreating a similar environment for stem cells/progenitors to proliferate 
within a HA matrix is feasible.   As concentrations of HA decrease towards the end of 
embryogenesis by hyaluronidase activity, cells produce a differentiated type matrix 
containing more stable forms of collagens and more highly sulfated GAGs and 
proteoglycans [259]. 
1.4.3 Prevalence in the Body, General Forms, and Structure of HA 
    HA is produced continuously in the peripheral tissues of vertebrate 
animals, and every tissue analyzed shows traces of the GAG.[265]  There are several 
different isoforms of the polysaccharide-producing proteins defined by coding of the 
hyaluronic synthases.  They are classified by numeric nomenclature as HAS1, HAS2, 
and HAS3; are transcribed from 3 different chromosomes; and share a 50 to 70 
percent homology.[283]  Eukaryotic HA-synthase is located in the extracellular 
membrane, and has activity correlated with a number of cellular actions (growth, 
transformation, differentiation, metastasis, and mitosis).[284]  Elevation of HA 
synthase activity and matrix deposition correlates with cellular proliferation and 
migration.[264]  Once produced and exuded into the extracellular space, 
hyaluronans can still maintain associations with specific ions such as sodium.[285] 
HA is produced continuously in the peripheral tissues of vertebrate animals, 
and every tissue analyzed shows traces of the GAG.[265]  Mammals however 
produce relatively longer chains of HA and also express the ability to degrade the 
oligosaccharide with hyaluronidases [226].  The extracellular polysaccharide is 
found throughout the ECM and especially in connective tissues  [257].  There are 
several different isoforms of the polysaccharide-producing proteins defined by 
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coding of the hyaluronic synthases and resulting in variants within the HA 
oligomers.   
In addition, there are splice variants within HA receptors.  Kikuchi and 
associates described such variants in their studies of CD44 expression by hepatic 
stellate cells in normal and injured rat liver.[258]  The polysaccharide-producing 
proteins are classified by numeric nomenclature as HAS1, HAS2, and HAS3; are 
transcribed from 3 different chromosomes; and share a 50 to 70 percent homology 
[250]  The isoenzymes, all homologous to the original streptococcal enzyme isolated 
and to invertebrate chitin synthases, have been identified in xenopus, chicken, mice, 
and humans [248].  Eukaryotic HA-synthase is located in the extracellular 
membrane, and has activity correlated with a number of cellular actions including 
growth, transformation, differentiation, metastasis, and mitosis.[284, 286]  
Elevation of HA synthase activity and matrix deposition correlates with cellular 
proliferation and migration [264]. Once produced and exuded into the extracellular 
space, physiological associations can persist such as a close relationship between 
sodium and the hyaluronan GAG [285].   
 
1.4.4 Clinical and Investigational Uses of HA 
         HAs have been a economically valuable and powerful reagent used 
clinically.  they are readily available and FDA approved.  No matter what the source, 
the polysaccharide is conserved across all species and is biocompatible, eliciting no 
pyrogenic, inflammatory, immunologic or toxic response [254]. Immuno-neutrality 
and high water saturation make it a great building block for biomaterials [262].  In 
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the interest of looking at possible expansion apparatus, it is obtainable, and allowing 
for advances in chemistry more cost effective to modify as compared to other ECM 
components like collagen III.  Recent research has been furthered because five 
hyaluronidase genes, and 1 pseudo gene have been recently cloned [248].  
Independent of creating the HA oligomer for synthesis, the field of study is using it’s 
important remnants to further Tissue Engineering.   Most research and medical 
forms of HA, both cheap and relatively pure, are obtained from bacteria 
(Streptococcus Equi) [287].  Improved methods of production along with chemical 
advances in modification increased general use of HA in fields from cosmetics to 
surgery.   In clinical settings, HA has been used for drug delivery [255], hydrophilic 
coatings of catheters, sensors and guide wires [260, 266]  surgical adhesion reducing 
agents [287], lubrication agents [251], treatment for arthritis [287],cataract, 
ophthalmic surgery [251, 260, 285] and have been suggested as a sensitive 
biomarker for tracking liver cirrhosis.[265]  Each of these uses proclaims various 
benefits of the GAG.  Lubrication depends on HAs water homeostasis ability, 
whereas reduction of surgical adhesions can make use of its steric exclusion 
phenomena.[251]  Surfaces coated with HA show reduction of cellular attachment, 
fouling and bacterial growth.[266] 
 
1.4.5 Cancer 
     Developmental mechanisms tend to occur both in simple and more 
complex systems with evidence of the conservativeness of evolution in these 
processes.  In fact, conservation of essential gene sequences is shown in the 
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homologies of the molecules between many species within and outside of a specific 
phyla.  The role of HA to cancers is implicated by the long-known phenomena that 
cancers are somehow related to stem cells and early progenitors.  In the 1960s, Van 
Potter proposed that cancers are cells blocked in ontogeny [288] Later, Stewart Sell 
and Barry Pierce also focused on cancers as transformants of stem cells and early 
progenitors [289, 290]  they hypothesized that known oncogenic insults somehow 
targeted the stem cells.  More recently, it has been realized that tissues are organized 
as maturational lineages with the most mature cells producing signals that inhibit 
the growth of the stem cells, constituting a feedback loop of regulation.[23, 37, 38, 
152] Oncogenic insults actually kill the most mature cells in the lineage(s) 
eliminating the feedback loop and resulting in expansion of stem cells and early 
progenitors.  If the insults are chronic, then there is an increased risk of one or more 
mutational events in the expanding stem cells and leading to loss of ability to 
undergo apoptosis and then to malignant transformation.[23, 38]  Thus, tumors are 
enriched in transformed stem cells and/or progenitors with phenotypes overlapping 
extensively with that of normal stem cells and/or progenitors[23, 291] This 
background provides an explanation for some of the findings of HA’s roles in 
regulating tumor cells.  Several studies have shown that there is a marked increase in 
HA accumulation in growth, survival and invasion of carcinomas.[250]  Up-
regulation of HA in embryos leads to cell migration, and it is assumed that some 
cancers may mobilize in a similar fashion.[264]  One postulated role of the CD44 
integral glycoprotein receptor is lymphatic homing used by HA-binding cells.[277]  
Tumors and proliferating cells are often surrounded by heavily enriched 
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environment of HA, and that can “enhance anchorage-independent growth.”[264, 
277]  In addition to cellular metastasis, cancers that spread through HA-regulated 
pathways may also be affected by HA’s known roles in angiogenesis.  This pathway 
isn’t exactly clear but there is an association between HA rich matrices and newly 
forming blood vessels in tumors.[250] 
 
1.4.6 Inhibitory Characteristics 
      The presence of high levels of HA is assumed to be associated with known 
functions of HA such as cell attachment, migration, and creating water tunnels.  
However, there is a bi-modality to HAs, and it can truly be thought of as a matrix 
component that is biphasic functionally.  In addition to the achievements allowed 
through interactions, HA can be inhibitory.  High concentrations of HA around cells 
can inhibit migration (e.g. peritoneal macrophages)[277] by filling pathways.  High 
concentrations can limit phagocytosis and immune response[282, 292] including 
mitogen-induced proliferation of cultured lymphocytes[277].  Responses of the cell 
types are dependent on intercellular communications. Migration of the cells dropped 
by 50% when cells were contact with specific splice variants of the HAs.[293] 
 
1.4.7 Characteristics Defined by the Molecule 
     Interactions between HAs and other biological components are controlled 
by the chemical structure of the GAG.  Many of the polar groups of HAs form 
interactions within the protein leaving limited availability for reactions outside the 
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individual structure[267].  As a result, fewer reactive groups offer fewer points of 
attachment for multipoint functional adhesions.  The twist is that the molecule 
experiences lower non-specific interactions with the environment.   The adage of 
form follows function is easily applied to HA.  The biophysical [mechanical strength 
and flexibility], and biochemical [polar group interactions] characteristics of the 
GAG underlie its functional properties as a matrix component.  Many of the clinical 
applications, discussed later, are not possible without modifications. Naturally 
occurring HA has a quick turn over rate in vivo and has poor biomechanical 
properties[255].  When in its natural molecular form, unbranched[294] and 
unmodified, HA is hydrophilic[250] and water soluble at room temperature.[295]  
Mo, et al reported that the hydration of HA is 0.77 cm3/g.”[296] This hydration is 
due to the large negative charge carried by the molecule and the positioning of acidic 
groups, generating great water binding capacity.[254]  NMR studies show that five 
hydrogen bonds can exist over as little space as four sugar units.[247]  As a result of 
its water binding capacity, HA tends to become less flexible.  The positive attribute of 
having a greater stiffness is the ability to resist compressive forces [253]. The pitfall 
of giving up flexibility in turn generates a stiff matrix component which is susceptible 
to shear forces in any fluidic or motion system.  As applicable to tissue, it is highly 
likely that a stiff spring like component of HA can function to keep other matrix 
components separated and thus form fairly large water tunnels through which 
soluble molecules can diffuse.[267]  
Although linear in molecular form as shown by electron microscopy,[259] HA 
exists as a collapsed coil in secondary structure.[273]  The coiled structure can be 
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linked to viscosity through charge related changes in the physical dynamics 
demonstrated by expansions in low ionic strength buffers and high pH[294].  This 
viscosity effect is primarily dependent on the degree of ionization of the carboxyl 
groups.  HA expands at low ionic strength due to repulsion effects of the molecular 
charges whereas at physiological pH, the carboxyl group on each disaccharide unit is 
dissociated negating this effect.[254, 259] Changes in the concentration of HA 
present in solution can greatly change the values for viscosity and shear due to 
entanglement of the coiled chains.[294] 
 HA has rheological properties based on the tendency towards self association.  
Individual chains become entangled at low concentrations.[273]  The entanglement 
is comparable to placing a number of “slinky – toys” in a box and jostling it around.  
A few individual chains can form a contiguous network.  Mo, etal[296] have found 
the critical concentration of coil-induced entanglement to be 1 milligram/cm for 
extracted HA with an average molecular weight of 3.9E5.  The characteristic 
structure of the GAG that allows for nonpolar interactions is a number of 
hydrophobic patches repeated in intervals on alternating sides by CH groups.  
Although broad in coverage [over eight or nine units] and relatively weak, they allow 
for self-association as well as interactions with membranes and hydrophobic 
proteins.[247, 267]  As expressed by Tammi et al “Hyaluronan exhibits unusual 
physicochemical properties in concentrated solutions due to a combination of its 
random-coil structure, its large size, which results in molecular entanglement, and 
its capacity to interact with water molecules. A molecule of hyaluronan, therefore, 
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has a large hydrodynamic volume and forms solutions with high viscosity and 
elasticity that provide space filling, lubricating, and filtering functions.”[248] 
 
1.5 Nuclear Magnetic Resonance Spectroscopy (NMR) 
Nuclear magnetic resonance is based on the same technologies used for 
magnetic resonance imaging.  The key feature presented by the technologies is based 
around the known fact that when materials are placed within a magnetic field, they 
align their magnetic angular axis in parallel with the field, and spins of nuclei are 
able to be identified according to their resonance frequencies.  Within the system, an 
atom is surrounded by a magnetic field. Then a radio frequency pulse is used to 
knock the alignment of that molecule out of the field of which it is parallel.  
Subsequently, the electrons precess around an axis to realign to the field and 
resonate the frequency at which they move, where the spin is the angular momentum 
created by the precession of the unpaired nuclear particles.   
 The best commonly found biological elements for NMR detection are ones 
with non-zero spins such as 1H, 13C, 15N, and 32P.[297]  A transceiver to the radio 
frequencies can then detect the free induction decay described as the relaxation 
signal.  These decays are recorded and are available for mathematical manipulation 
to facilitate analyses of characteristics of the molecules of interest.    
NMR is used in chemistry, biology, medicine, materials science and 
geology.[298]  Biological investigators find that it is useful given that it is non-
invasive, and it does not destroy the sample as other methods do, in a trade for 
sensitivity.   Probably even more important is the fact that the complex mixtures 
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offered by biological samples do not have to be pure to discern molecular structures 
of interest, and NMR is a perfect mining tool advantageous to creating usable 
data.[299]  As technology proceeds with engineering stronger magnetic fields, NMR 
resolution becomes better.   
 
1.5.1 Use  of NMR for Phenotyping and Metabolomics 
1.5.1.1 Metabolomics Historical Perspective 
 
Taking a step upward from clinical chemistry metabolomics does not look to 
define one metabolite or even just two for that manner.  It’s power comes in the 
resolution of literally hundreds of metabolites simultaneously [300], making it 
“ultrahigh-throughput.”[301] Furthermore, historically, one perceives the cell as a 
unit, but the observation of metabolites can be subdivided into extracellular and 
intracellular aspects both following nomenclature that is developing as techniques 
and methods develop around phenotyping methodologies.  Each type of cell can have 
an appreciated phenotype based on the capacity to metabolize given compounds.  In 
fact, the hundreds of specialized human cell types interact differently with 
environmental factors to influence day to day functions, and furthermore play a role 
in development, pathophysiological processes, and certainly homeostatic 
maintenance through daily metabolic processes [302] 
Metabolites by definition are the end products as effect by cellular process on 
present compounds.  Metabolites fall into defined classes of compounds such as 
polar lipids and carbohydrates [303].  Endogenous metabolism follows all energy 
  62 
 
generating and biosynthetic pathways by which host cells modify their environment 
from a proteomics and genetic point of view [302].  It is well known that every 
organism from microorganisms to humans excretes metabolites into their external 
environment.  An analysis of distribution of the metabolome of several species 
suggests that the molecular weights of interest by any detection method pursued 
generally falls with a capped range of under 300 Daltons  [304].  As a discrete 
method of discriminating the difference between what occurs within the cell 
(internally detectable metabolites) and outside of the cell (extracellular metabolites 
excreted by the cell) Kell and others proposed the nomenclature of “footprinting and 
fingerprinting,” where footprinting specifically monitors metabolites consumed and 
secreted into the extracellular compartment.  Furthermore, environmental 
provocations of the metabolic pathways of any system can be analyzed by the 
excretion of metabolites into the extracellular space.  These profiles are highly 
specific to species and genetic backgrounds [305].  This method was and is 
particularly useful in describing microorganisms at the metabolic level based on its 
genome, and was forwarded as a technology for high throughput analysis even 
without identification of particular metabolites.  Remarkably, single gene knockouts 
were distinguished from wild type organisms in subsequent studies [305].  
Furthermore, the discrimination between seemingly similar phenotypes has been 
applied to transgenic yeast, plants and mice [300] Fingerprinting looks at both 
inside and outside the cells/tissues of interest.  In respect, only looking at the 
footprint offers advantages over total metabolic analysis (looking at both 
intracellular and extracellular).  It potentially pares down the number of pathways of 
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the system and thus the complexity added by the intracellular metabolites.  Those 
metabolites excreted into the environment are usually long lived as compared to that 
of turnover rates of intracellular metabolites, which doesn’t require a stabilization 
and fast quenching method for isolation, which most of the time are time consuming 
and impede reproducibility because of added complexity [305]. 
As to what can be learned by looking at the metabolites of a closed system, it 
starts with a mass balance and a careful look at fluxomics, where metabolites are 
used to report the end response of the given biological system to environment and 
genetic changes. In this way, a scientist can trace the perturbations of a system and 
the concurrent changes within the cells (ie stem cell differentiation).  Prediction of 
cellular order and control is strongly stressed by the methodologies of metabolytic 
pathways, which when diagrammed represent cell capacity and interchange within 
the environment.  In such a manner, mapping of metabolites can be used as an 
insight into the cells biotransformation capabilities [302].  Reflections of the 
metabolome response are caught in the rippled effects of system perturbations 
throughout the transcriptome, proteome and metabolome.  Often the result of small 
changes in each upstream event cause greater changes in the downstream event.  
Consequently, the metabolome exemplifies conditions where perturbations become 
more responsive extending through mechanisms of both the transcriptome and the 
proteome. [304]  These events, are helpful in inferring genetic functionality by 
metabolome inspection, where changes in the levels of enzymatic activity have 
occurred.  Much of the early work revolved around finding a single metabolite and 
then correlating it to other known expressions of cell activity [306]  As with the other 
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“omics” the study of the metabolites lend to the accomplishment of understanding 
systems biology better.[307, 308]   
Conditionally, many different devices have been used to look at the 
metabolome of various cell types and organs, producing signatures of the 
biomaterial.  Listed as various methods inclusive of NMR, are infrared spectroscopy, 
thin layer chromatography, high performance liquid chromatography with 
ultraviolet and photodiode array detection, capillary electrophoresis coupled to 
ultraviolet absorbance detection, capillary electrophoresis coupled to laser induced 
fluorescence detection, capillary electrophoresis coupled to mass spectrometry, gas 
chromatography-mass spectrometry, liquid chromatography-mass spectrometry, 
liquid chromatography tandem mass spectrometry, Fourier transform ion cyclotron 
mass spectrometry, high performance liquid chromatography coupled with both 
mass spectrometry and nuclear magnetic resonance detection [299, 306]. No matter 
what the technique, the method chosen must maintain sensitivity, selectivity, and 
universal applicability.   Early metabolic profiling is often credited to Devaux, 
Horning and Horning of the Baylor College of Medicine [306].  The metabolome is 
described as the full set of metabolites within or secreted by a specific cell type or 
[302].  Applications of various methodologies have led to the systematic methods of 
identifying and quantifying those recognized metabolites within a given system.[303, 
308]  Robertson describes metabolomics as being ‘‘the quantitative measurement of 
the time related multi-parametric metabolic response of living systems to 
pathophysiological stimuli or genetic modification.’’[308]  Jeremy Nicholson further 
demarks the difference between metabolomics and metabonomics, where 
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“Metabolomics is the measurement of metabolite concentrations, fluxes and 
secretions in cells and tissues in which there is a direct connection between the gene 
expression, protein activity and the metabolic activity itself and metabonomics is the 
quantitative measurement of the multivariate metabolic responses of multicellular 
systems to pathophysiological stimuli or genetic modification, [302]” and that 
continues to be on ongoing debate.  Terminally the debate ends where one is the 
study of and the second is the application of the technology of phenotyping to 
specific physiological process.  And as follows the metabolome is the set of 
metabolites that an organism can synthesize[303, 309] and generally falls within a 
low molecular weight.[304] 
 
1.5.1.2 Metabolite Profiling 
 
As with the proteome, metabolites can be tagged as belonging to the simplest 
systems of cellular compartments or all the way to tissue and even to organismal 
level.[303]  As mentioned before, Devaux et al, and Horning and Horning in the 
early 1970s are credited with metabolite profiling of steroids and acid urinary 
metabolites by gas chromatography and mass spectroscopy methodologies [306].  In 
the last 30 years, metabolomics has been become a growing field. With the use of 
computer-aided analyses, scientists are able to handle copious amounts of data that 
are produced.  In this regard, metabolomics parallels proteomics and genomics.[310]  
The potential of studying the metabolic biomarkers is underscored by methodologies 
introduced into various facets of study including toxicology.  To this effect, it has 
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evolved as a critical process to measure timed responses in toxic processes, drug 
efficacy and safety when dealing with metabolic studies [300, 311]  Applications to 
toxicology are an ideal use because of the need to identify time dependent changes in 
metabolites as they change, furthermore exhaustive characterization of activity is 
pursued along with drug metabolic stability, profiles, and enzymatic inhibition and 
induction.[312] 
Using the metabolome as a study tool is prevalent from plant to animal.  
Functional genomics and systems biology based on phytochemical reactions in 
plants are analyzed using metabolomics [306].  Allen et al. has used metabolic 
footprinting, the original paper discussing the methodology, to classify yeast 
mutants.[313]  Metabolic profiling has been used to identifying biomarkers in renal 
and hepatic toxicity [308]. Pharmaceutical companies have adopted metabonomics 
techniques for evaluation of drug-candidates [299].  Others have used it as an organ 
monitoring tool after transplantation.  However the evaluation is done ex vivo on 
biofluids, and those that are in vivo often only model a few metabolites based on 
inorganic phosphates.[301] 
     Furthermore, functional genomics can make use of metabonomics to 
classify variant species or variants within the same species.  Examples of this have 
been done with mice and rats, simply based on metabolite patterns.  As a means of 
diagnosis, metabolitic profiles in biomedical applications other than toxicology have 
been used to differentiate tumor progression and development.[300, 308] 
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1.5.1.3 Metabolomics in NMR 
 
Use of NMR to study biofluids (urine, blood plasma, and cerebrospinal fluid) 
has been around for about as long as the instrumentation  [308].  Its speed and 
selective uses have been successful in investigation of disease and toxic processes, 
despite it’s low sensitivity[299, 306].  However, it was not until the early 1980s that 
the application of NMR metabolite profiling started to be published.[306, 314, 315]  
Each biofluid yields a characteristic 1H-NMR spectra dependant upon the 
distribution and concentration of metabolites within the sample.    As the frequency 
of the NMR climbs higher, resolution of metabolite peaks increases and potentially 
hundreds to thousands of individual peaks can be isolated from a 1H-NMR spectra 
[299].  Specific metabolites can be masked by co-resolution around the same peak or 
by specific interactions with other metabolites present within the system, and as the 
power of the spectroscopy is decreased the resolution of fine peaks becomes spread 
and interpretable. Unfortunately, the strongest peak within samples containing 
mostly water is that of the water itself, which denies the ability to correctly identify 
metabolites with spectral peaks within that region without refined methods of water 
suppression.  The large interfering peak is eliminated from many samples in this 
manner.[299]  
 
1.5.1.4 Advantages of Metabolomics 
 
The noninvasive techniques of proton NMR give a large chunk of information 
about the processes of the subject with no harm.[300, 316]  In fact the technique 
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produces large amounts of data, with little sample preparation, about multiple 
metabolic pathways without destroying the sample as other methods do.[317]  Those 
metabolites are associated with generic cellular process present in every cell.  Insight 
into glycolysis, gluconogenesis, lipid metabolism is all reflected and indicative of cell 
viability, apoptosis, anoxia, local pH, and homeostatsis maintained within the 
system of interest [301].  Quantification of the substances can be performed in a 
straightforward manner.[318, 319]  For this reason, it is a preeminent tool for 
biofluid and tissue extraction analysis,[320-322] with high reproducibility [300] 
 
1.5.1.5 Applications of NMR to Metabolite Profiling 
 
Applications of NMR to metabolite profiling is far reaching, from 
differentiating cell lines to tumor types [300]  Groups have made quantitative and 
qualitative analyses applied to disease state and genetic modifications of model 
systems [323].    In addition, varied methods of NMR (one and two dimensional, 
gradient-selected heteronuclear NMR techniques) lends itself to more in depth 
investigations of the metabolome.[324, 325]  Hundreds of low molecular weight 
metabolites result in the generation of an endogenous profile responsive to 
physiological states.[326]  NMR spectroscopy is useful in the analysis biological 
mixtures of mammalian biofuids, cell cultures, and microbial cultures.[324, 327-
332]  Toxicology is a large component of current NMR application which has been 
used to show time related changes of urine exposed to various mouse and rat models 
of liver and kidney toxic injury, including exposure to hydrazine and HgCl2.[317, 
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326]  Warne and others investigated the metabolic effects of toxins in 
earthworms.[303]  The majority of research with metabolic profiling is done on 
biofluids and not tissues [301], and certainly not organisms. 
Dealing with organismal work, E Holmes and others demonstrated the 
biochemical differences between Han Wistar and Sprague-Dawley rats using NMR, 
which was supplemental to work showing that even similar strains of mice could be 
differentiated by coat color by acquisition and analysis of its metabolic profile.[317] 
This is functional genomics by means of metabolic assays.  Although the animals are 
phenotypically the same, silent genes function to influence metabolic pathways.[299]  
The NMR analysis was used to differentiate biomarkers of phenotypical normal 
mice.[303, 308, 333]  The metabolic fingerprints of mutated yeast strains were 
investigated by Raamsdonk et al. [303]  Supernatants from cryptococcal cultures 
indentified more than 30 individual metabolites, including many amino acids, 
alditols, nucleosides, acetate, and ethanol.[325]  Metabolites from both supernatants 
and cell containing solutions have been characterized including investigations on 
microbial cultures.[324] 
On a cellular level 1H-NMR is used to provide information of cultured 
primary cells, [318] including differentiating cancer cell types and monitoring 
cellular events such as apoptosis [300]  It has been used to profile neuronal 
cell,[316] and the current underlying suggestion is that each individual cell type has 
its own unique metabolic pattern which can be discerned by NMR patterning.  
Spectroscopy, can potentially identify these markers and allow examination of 
systems differentiation in the cellular metabolism pathways, as is projected Nesti 
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etal in looking at the metabolic properties of mitochondrial specific metabolic 
pathways as a sign of  “stemness.”[334, 335]  In fact, Grayson et al. recently released 
a publication on the effects of low physiological oxygen conditions on the human 
mesenchymal stem cell population, drawing implications that tissue development 
can be effected by the oxygen level and significantly characterized using 
metabolomics.[336]  Other metabolic stem cell studies have been performed 
including distinguishing neural cell types inclusive of adult differentiated cells and 
progenitors[337] classification of murine embryonic stem cells and neural stem cell 
derivatives based on metabolic profiles.[335] 
Generating data that applies to specific pathways of metabolism is key in 
identifying metabolic disfunction in disease state[317].  As forwarded in the 
methodologies, 1H NMR can be used to access many known pathways of 
metabolism.  Systems pathways able to be investigated by NMR include glycolysis, 
the Krebs cycle, acetate production, urea synthesis, transamination events.[318]  The 
disadvantage of the NMR identification system is substances identification depends 
on spectral comparisons to like identified samples.  Thus there is a need for a 
database for the computational evaluation of peaks under various conditions.  
Samples undergo chemical shifts and couplings due to their environment which can 
often obscure those patterns which readily identify the metabolite.[325, 338, 339] 
 
1.5.1.6 Applications of Mathematics to NMR spectroscopy 
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Robust studies can produce thousands of samples, and even the simplest 
studies can produce hundreds, compounded by exponential data derivation by NMR, 
biofluids offer a niche in which individual characterization of one spectra at a time is 
nearly impossible to deal with mass metabolite comparisons across a data set [308]  
Application of statistical analysis methods allow for reduction of the mass data set 
and in fact reduces the complexity hidden within the dynamic range of the metabolic 
profile allowing for classification methods based on a few simple rules or 
observations.  The value of the methodology allows data mining and in fact is useful 
for bioinformatics.[326, 340-342]  Methods in which mathematics allows 
quantitative modeling of constrained systems prove to be informative, and leads to 
analysis and qualitative predictions and assessments of the systems of interest.[310] 
NMR spectroscopy data used in metabolomics is dependent on the use of 
multivariant statistics.  Application of  Fourier transformations to data analysis to 
produce the spectra have greatly facilitated data analyses.[343]  Techniques have 
been derived mathematically and instrumentally to simplify spectra and to identify 
the components of mixtures including the biofluids.[325]  Many different 
mathematical tools are used in the analysis of current spectra.  Principle component 
analysis (PCA) is a popular method to investigate the individual components of a 
system to observe which gives the most variance within the system based on 
combinatorial linear relations.  It is unsupervised method,[300] meaning that the 
data points are able to organize themselves without any predetermined 
classifications.  It is one of the oldest and most widely used methods [344]  for 
dealing with multivariate systems.   PCA reduces the variables into a system of 
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uncorrelated components.  As the data is scored upon a plot in which each variable is 
represented as a different dimension of the plot, the relationships are indicated, and 
related by their variability.[308]  Sumner et al [306] summarize the method as: 
 
“The concept behind PCA is to describe the variance in a set of multivariate 
data in terms of a set of underlying orthogonal variables (principal 
components). The original variables (metabolite concentrations) can be 
expressed as a particular linear combination of the principal components. 
PCA is a linear additive model, in the sense that each principal component 
(PC) accounts for a portion of the total variance of the data set. Often, a small 
set of principal components (2 or 3) account for over 90% of the total 
variance, and in such circumstances, one can resynthesize the data from those 
few PCs and thus reduce the dimension of the data set. Plotting the data in the 
space defined by the two or three largest PCs provides a rapid means of 
visualizing similarities or differences in the data set, perhaps allowing for 
improved discrimination of samples.”  
 
Other techniques in addition, applied to data sets are pattern recognition 
hierarchies and cluster analysis, as applied in studies differentiating hydrazine 
treated rats from control.[300, 326]  Groups have used discriminate partial least 
squares as part of algorithms to distinguish coronary heart disease, and to observe 
changes in the normal human serum due to dietary changes. Yet others have 
combined NMR spectra with neural networks in success.[310]  Many applications, 
such as studying drug effects on whole organisms can not be accomplished without 
multiparametric measurement and analysis.[299] 
 
1.5.1.7 NMR Analyses of Liver Tissue and Cells 
 
The field of characterization of the metabolic profiles of liver and 
nonparenchymal hepatic cells is in its infancy.   As the largest internal organ, the 
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liver is approximately 2 percent of the body’s mass, of which only 65 percent of the 
adult liver cells are hepatocytes, but these displace 80 percent of the volume of the 
liver.[345] As reported previously, toxicology is a major focus for the use of NMR. 
Isolated hepatocytes are a key model system for drug metabolism interactions[312]  
Measured effects of hepatic metabolism is important in order to access the full 
complement of enzymes in primary cultures.  Drug testing in liver, the major cite for 
xenobiotic metabolism, is assessed at this first pass encounters, but the down side is 
recognized that monolayered cultures of hepatocytes tend to quickly lose gene 
expression and thus utility as a model system.[346] 
However, there are many studies that show the uses of NMR as a tool 
including the investigations of cryopreservations of primary hepatocytes derived 
from pig livers, most similar to human in many cases.[318]  Dabose and all, used 
simple 1H NMR to evaluate the metabolic function of hepatocytes frozen under 
various protocols and compared to freshly isolated cells.   
Zonation of the metabolomic profiles with respect to the zones of the liver 
acinus has been shown.[347]  Oxidative energy, carbohydrate, lipid, nitrogen, bile 
conjugation, and xenobiotic metabolisms have been identified as compartmentalized 
within zones of the liver acinus.[346]  1H NMR can be effective in identifying small 
concentration of metabolite changes in conditioned media supernates taken from 
cultures.  As applied to cultures of hepatocytes and nonparenchymal cells in order to 
understand metabolism, cycles such as glycolysis, the Krebs cycle, acetate 
production, glucose metabolism, transamination, glutamine synthesis and succinate 
synthesis, urea and albumin production have been examined.[318]  The various 
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methods work in combinations of known pathways where the observation of one 
metabolite decreasing leads to the generation of other metabolites as seen in 
glycolysis, based on anaerobic respiration and production of lactate.  Liver metabolic 
pathways of cultures subjected to various treatments show differences in the manner 
of respiration.  Wishart etal [301] describes the injury response for metabolites in the 
liver in terms of net increase and decrease of normal levels, where lactate, pyruvate, 
glycerol, alanine, glutamate, GABA, taurine, and arininine all increase after 19 hours 
post injury and only arginine was reported as decreasing prior to that time However 
under other conditions, ischemia, grafting, and post transplantation, a different set 
of biomarkers can be observed as key metabolites including methylated arginine, 
glutamine, urea, and phosphatidylcholine.[301] 
There have been few studies regarding mammalian primary hepatic cells and 
monitoring perturbations of identified metabolites such as those found in 
mitochondrial pathways or glucose production and metabolism, but it is feasible to 
do this with NMR spectroscopy.[318]  One such study characterized the specific 
metabolite pathway (induced by hypoxia-inducible factor 1) as applied to tumor 
growth and angiogenesis in hepatomas, of glucose metabolism, [300]  Applications 
derived from metabolic characterization can easily be applied towards the ongoing 
bioartificial organ programs for cell culture and production of cell therapy methods.   
 
1.5.2 Technical Issues.  
Metabolic profiling surpasses proteomics and transcriptomics, in the ability to 
be high through-put, cheap, reliable and precise [300, 303, 304]However, it is not 
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without its faults.  A major liability is the identification of metabolites without the 
use of a standard library. The daunting task of creating a library for such biomarkers 
has already begun with groups in North America and world wide 
(http://www.hmdb.ca)[301] and there are general, non-species specific databases 
already in existence like the Kyoto encyclopedia of genes and genomes (KEGG, 
http://www.genome.ad.jp/kegg). Those spectra which teeter towards being 
ambiguous often lead to a challenge in the identification of the characteristic peaks, 
and in complicate predicting/modeling the complex behaviors of even the most basic 
cellular systems.  
NMR has rapid time analysis, but this advantage is paralleled by less 
sensitivity.   Other methods like mass spectroscopy are more sensitive but that 
becomes part of weighing out what is needed as compared to costs [299]  This can be 
modulated to increase sensitivity by letting samples resolve for longer periods of 
time within the magnet.  Recent publications show value to the claim that high-
resolution 1H NMR spectra can identify metabolites at far lower concentrations than 
standard clinical systems of different natures.[337]  Griffin et al in 2004 reported 
current detection levels for proton NMR on the order of 100 uM in biofluids and 
tissue extracts, with acquisition times of 10 minutes or longer [300]  Low sensitivity 
only allows interpretable spectra from more concentrated metabolites, which show 
as higher peaks [306].  Compounding the situation is the problem of co-resonation.  
In the end, the complexity of signals given off by the compounds range through such 
an array of substances that no single analytical technique can provide all the 
information about them in one single sweep.  Being able to do that would give a 
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perspective on the overall physiology of the cell and tissues for comprehension [301] 
Different facets of NMR have been developed such as magic angle spinning to 
address how to identify variable moieties.  However, as any spectroscopist will point 
out, being able to quantitate and qualitate a system of metabolites for the very 
simplest of cells is not a reality for various reasons, but it doesn’t mean that we can’t 
identify key metabolites which show us a picture of what is going on within the 
metabolic and genetic world.  The technical challenges make a thourough analysis of 
a complete system a dream at this juncture in time and not a reality [300] 
For use in endogenous detections it has been shown that simple variations in 
diet can change the metabolic signature of a system.[311]  This in turn can have the 
value of giving a very strong control as to where cultured cells can be given the exact 
same external stimuli with the variation of one component for computational 
interpretation.  The data that is produced from the metabolic profile is very different 
in terms of other -omics in that it is modified by outside sources and by self, and that 
by chance alone makes the data complex and hard to integrate with other functional 
genomic data.[305]  Even though the generated data is highly reproducible, the 
number of metabolites is deemed to be smaller than the number of transcripts that 
gives rise to them, and thus in a response situation, a given metabolic pattern may 
reflect multiple changes in the genome transcription and translation process.[300] 
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1.5.3 Summary 
As Sumner, et al noted  “The comprehensive quantitative and qualitative 
analysis of all metabolites within a cell, tissue or organism is a very ambitious goal 
and is still far from a reality for any system, although substantial progress is being 
made.”[306]  By using defined metabolic phenotypes of cells, tissues and organisms 
we can still assess various natures indicative of disease, stem-ness, and physiological 
state.  Limited headway has been made in each of these categories, Jansen et al.[335] 
has established that classifying ES and adult stem cells along with their progeny is 
limited, and as a direct abuttal to conflicting gene array results, NMR metabolite 
analysis should be seriously considered as a path to pursue.  Wishart, et al.[301] 
notes that metabolomics will not be the miracle answer for solid organ transplant 
monitoring, but it has its usefulness already showing itself in clinical applications. 
The ease of metabolomics may make it an ideal screening technique for common 
metabolic disorders. It’s systematic approach is informative in drug assessment, 
disease process and diagnosis, genetic functioning, and developmental 
discovery.[299]  Metabolomics ties genomics and transcriptomics together by 
analytical computations.  
  
 
2 Chapter II. Identification, Isolation and 
Characterization of Human Hepatic Stem Cells and 
Hepatoblasts  
Hepatic stem cells and maturational lineage biology of the liver are central 
themes in my studies.  The pluripotent hepatic populations in human livers were 
found by us to be two:  hepatic stem cells (hHpSCs), multipotent stem cells (that are 
possibly endodermal stem cells), and hepatoblasts (hHBs), bipotent progenitors, the 
probable transit amplifying cell of the liver.   These give rise to unipotent, committed 
biliary and hepatocytic progenitors.  The antigenic, biochemical and morphological 
characteristics of hHpSCs and hHBs were defined enabling the cells to be identified 
in vivo and by flow cytometry and isolated by immunoselection technologies.  
Methods for their ex vivo culture were also established.  The paper is in press in the 
Journal of Experimental Medicine (due to come out this summer).  The findings of 
the paper undermine a number of dearly held dogmas: 1) that hepatic stem cells 
must express α-fetoprotein (AFP)---they do not; 2) that there are no hHpSCs in adult 
tissues---there are but they have an antigenic/biochemical profile distinct from the 
one  used in the past to identify hHpSCs; 3) that the liver’s stem cell niche is the bulk 
of the parenchyma in fetal liver---it is, in fact, the ductal plates (also called limiting 
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plates) in fetal and neonatal livers and the canals of Hering in pediatric and adult 
livers.  
IDENTIFICATION, ISOLATION AND CHARACTERIZTION OF HHPSCS AND 
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2.1 Abstract 
Human hepatic stem cells (hHpSCs), pluripotent precursors of hepatoblasts 
and thence of hepatocytic and biliary epithelia, are located in ductal plates in fetal 
livers and in Canals of Hering in adult livers.  They can be isolated by 
immunoselection for EpCAM+ cells and constitute ~ 0.5-2.5% of liver parenchyma of 
all donor ages.  Self-renewal capacity of hHpSCs is indicated by phenotypic stability 
after expansion for more than 150 population doublings in a serum-free, defined 
medium and with a doubling time of ~36 hours.  Survival and proliferation of 
hHpSCs require paracrine signaling by hepatic stellate cells and/or angioblasts that 
co-isolate with them.  The hHpSCs are ~9 µm in diameter, express cytokeratins 8, 18 
and 19, CD133/1, telomerase, CD44H, claudin 3, and albumin (weakly). They are 
negative for α-fetoprotein, ICAM1, and for markers of adult liver cells (e.g. 
cytochrome P450s), hemopoietic cells (e.g. CD45), and mesenchymal cells (e.g. 
VEGFr, desmin).  If transferred to STO feeders, hHpSCs give rise to hepatoblasts, 
recognizable by cord-like colony morphology and up-regulation of α-fetoprotein, 
P450A7 and ICAM1.  Transplantation of freshly isolated EpCAM+ cells or of hHpSCs 
expanded in culture into NOD/SCID mice results in mature liver tissue expressing 
human-specific proteins.  The hHpSCs are candidates for liver cell therapies. 
 
2.2 Introduction 
The role of hepatic stem cells (hHpSCs), particularly in the maintenance and 
regeneration of the adult liver, has been a subject of debate without clear consensus 
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[22, 348-351].  During embryonic development, endodermal cells in the mid-region 
of the embryo bulge into the cardiac mesenchyme, are affected by critical signaling 
from endothelia forming vasculature, and form the liver bud [1, 352].  The cells 
within the liver bud are recognized as hepatoblasts due to expression of a signature 
marker, α-fetoprotein (AFP) and are bipotent giving rise to  hepatocytes and bile 
duct epithelial cells, cholangiocytes (11).  We and others have described the isolation 
and expansion in culture of AFP+ cells from fetal and adult livers of  several species 
[43, 117, 353].  Clonogenic expansion assays of rodent hepatoblasts under wholly 
defined conditions have demonstrated that hepatoblasts are capable of  extensive 
expansion ex vivo as well as differentiation to both hepatocytic and biliary lineages 
[43].  The findings from investigations of liver organogenesis as well as the ex vivo 
studies of hepatoblasts have led to a long-standing assumption that hHpSCs 
correspond to hepatoblasts, and that hHpSCs would express AFP.  However,  AFP+ 
cells are rare in normal adult livers (<0.01%) except in livers with severe injury or 
disease [116, 354, 355].  In addition, the renowned replicative capacity of hepatocytes 
in vivo [107] has led to the opinion that adult livers do not have hHpScs and that all 
regenerative responses are from mature parenchymal cells except in certain disease 
states [348].   
Here we define a novel class of AFP-negative cells in fetal and adult human 
livers, that are precursors to hepatoblasts, and have properties consistent with 
hHpSCs.  The hHpSCs are negative for AFP but positive for epithelial cell adhesion 
molecule, EpCAM (CD326, C017-1A antigen, GA733-2).  This protein, encoded by 
the tumor –associated calcium signal transducer 1 gene, is expressed by many 
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carcinomas and serves a regulatory function in certain normal epithelia, including all 
of those derived from endoderm (e.g. liver, lung, pancreas, intestine) [356, 357].  By 
immunohistochemistry, deBoer and colleagues observed that hepatoblasts in 
embryonic human liver are EpCAM+, whereas mature hepatocytes are EpCAM- 
[356]  In adult livers, most (but not all) bile duct epithelia are EpCAM+.  Also, 
expanded ductular structures, seen in cases of focal nodular hyperplasia or biliary 
cirrhosis, contain numerous EpCAM+ cells [356].   
We have reported previously that EpCAM+ , AFP-negative cells from human 
livers are hHpSCs and have compared their pattern of gene expression with that of 
hepatoblasts and mature liver parenchyma [46].  We now show that the hHpSCs are 
located in ductal plates in fetal and neonatal livers and in the proximal branches of 
the intrahepatic biliary tree, the Canals of Hering, in pediatric and adult livers of all 
donor ages, with the frequency of  hHpSCs remaining relatively constant throughout 
life.  We further document the immunoselection of these cells using monoclonal 
antibodies to EpCAM and test whether they meet the defining criteria for stem cells, 
namely, self-renewal and pluripotency.  
2.3 Results 
2.3.1 In Vivo Localization of EpCAM+  Hepatic Stem Cells 
 Sections of fetal and adult livers were stained  for EpCAM and for liver-
specific markers (albumin, AFP, and CK19) (Fig. 1).  We found that ductal plates, a 
band of tissue encircling each of the portal triads in fetal and neonatal livers, have 
small cells (7-10 µm) with a paucity of cytoplasm, and stained intensely both 
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cytoplasmically and at the surface for CK19, EpCAM, and weakly for albumin but are 
negative for AFP.  In non-diseased, postnatal (pediatric and adult) livers, cells 
staining positively for EpCAM by immunohistochemistry appear exclusively in the 
Canals of Hering in the vicinity of the portal triads of acini.  Theise and colleagues 
[358] reported that cells lining these ductules express cytokeratin (CK) 19, present in 
biliary epithelia but not hepatocytes.  Our data confirm their report and demonstrate 
that the CK19+ cells within the Canals of Hering express EpCAM and that 
subpopulations of them also express albumin (Fig. 1; yellow color is due to overlap 
of CK19 and albumin expression).  The co-expression of CK19 and albumin is 
consistent with hHpSCs and corroborates the hypothesis of others that the Canals of 
Hering comprise a niche for hHpSCs [359].  Below are data from ex vivo studies of  
EpCAM+ cells supportive of the interpretation that they include hHpSCs.  
Most parenchymal cells of fetal and neonatal livers consisted of hepatoblasts, 
slightly larger cells (10-12 µm in diameter) that stained positively for albumin, AFP, 
and CK19.  In hepatoblasts the distribution of CK19 is more particulate and less 
intense than that in ductal plate cells.  EpCAM expression in AFP+ cells, both in fetal 
and postnatal livers, occurred at the membrane only.  In pediatric and adult livers, 
hepatoblasts were found as individual cells or small clusters of cells tethered to the 
ends of the Canals of Hering (Fig. 1).  The hepatoblasts in non-diseased, postnatal 
livers constitute fewer than 0.01% of cells and express AFP weakly. 
 Figure 2-1 Immunohistochemical Studies on Human Fetal and Adult Livers 
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2.3.2 Flow Cytometry of EpCAM+ Cells 
 By flow cytometry we observed EpCAM+ cells in human liver cell 
suspensions of all donor ages (Fig. 2A).  Suspensions from fetal livers from which 
hemopoietic cells had been purged contained, on average, 12% EpCAM+ cells.  
However, the percentage could be as high as 20% depending on the gestational age 
of the fetus.  Most of the EpCAM- cells in fetal livers were of non-hepatic lineage and 
were predominantly hemopoietic.  The vast majority (>90%) of the EpCAM+ cells in 
fetal livers co-express AFP, albumin (ALB), and CK19 (Fig. 2).  They could be 
subdivided into two subpopulations: 1) Hepatoblasts showed expression of ICAM1, 
AFP, ALB, CK19, CD133/1, P450A7 and CD44H (hyaluronan receptor);  2) hHpSCs, 
constituting ~5% of EpCAM+ cells from fetal livers, had an overlapping but distinct 
profile: they were positive for ALB (weak), CK19, CD44H, CD133/1+, NCAM+, and 
claudin 3, but negative for AFP and for P450A7.   
 
Figure 2-2 Flow Cytometric Characterization of EpCAM+ Cells 
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Cell suspensions from adult human livers averaged 1.3% EpCAM+ cells, and 
those from neonatal and pediatric donors two to three-fold higher.  Preparations 
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having EpCAM+ cell populations at levels above 1.5% were obtained typically from 
livers subjected to ischemia (cold or warm) prior to organ procurement and/or 
during transportation.  This suggests that the EpCAM+ liver cells are more resistant 
to ischemia than mature liver cells.  The postnatal EpCAM+ liver cells also co-
express CK19 and ALB (data not shown) but have no detectable AFP+ cells (by flow 
cytometry), except in rare cases of overt hepatic disease (e.g. cirrhosis; data not 
shown).  Neonatal livers, including some from premature births, showed rapidly 
decreasing levels of AFP+ cells as a function of age, falling below detection level by a 
few months after birth.  Based on considerations detailed below and from our 
previously published work [46], we identify the EpCAM+ cells from pediatric and 
adult livers as almost exclusively hHpSCs, not hepatoblasts.  
 
2.3.3 Culture Selection on Plastic and in Serum-free KM  
 Suspensions of liver cells plated in Kubota’s Medium (KM), a serum-
free medium optimized for ex vivo expansion of hepatic progenitors [43], either on 
tissue culture plastic or on embryonic stromal cell feeders, yielded parenchymal cell 
colonies with two distinct morphologies.  Type I colonies consisted of cells forming a 
cord-like morphology interspersed with clear channels and expressing EpCAM, 
albumin, CK19, ICAM, and AFP but not NCAM (Supplement Figs. 1-4).  Type 2 
colonies consisted of densely packed, morphologically uniform cells, strongly 
expressing EpCAM, NCAM, CD44H, claudin 3, weakly expressing or negative for 
ALB, and negative for AFP and ICAM-1 (Fig. 3 and Supplement Fig. 3).  We interpret 
the type I colonies as corresponding to hepatoblasts and the type 2 colonies as 
corresponding to hHpSCs (Table 1).  
 
Figure 2-3 hhHpSCs in culture 
 
 In cultures on plastic, by 5-7 days (mean 5.2 ± 1.6; maximum of days), 
the hepatoblast colonies disappeared.  However, if cultured on STO feeders, 
hepatoblasts survived for up to two months, continuing to show co-expression of 
ALB, AFP and CK19 (Supplement Figs. 1, 2).  The hepatoblast colonies typically 
contained fewer than ~100 cells.   
 By contrast to hepatoblasts, hhHpSC colonies on plastic continued to 
expand.  A time lapse sequence of a growing hhHpSC colony is shown in Fig 3A-E 
and in movies, given in the Supplement, in which the expansion of hHpScs seeded at 
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very low density is shown on day 1, day 3 and day 8.  The hHpSCs can be subcultured 
after mechanical disaggregation and continue to multiply extensively.  Their 
doubling time on plastic is ~36 hours.  That doubling time decreased to less than 24 
hours if they are plated on specific extracellular matrix substrata (R McClelland et 
al., submitted).  By 2-3 weeks, hhHpSC colonies typically contained many thousands 
of cells.   
 The hhHpSC Colonies were assessed for expression of lineage markers 
by immunofluorescent staining.  The expression pattern closely resembled that of 
ductal plate cells in vivo.  They were positive for CK19, NCAM, EpCAM, and CD44H 
(Figs. 3F-L).  In addition, they were positive for ALB (weak), E-Cadherin, N-
Cadherin, CK8 and 18, CD133/1, integrin β-1 (CD29), claudin 3, and telomerase 
(data not shown).  They were negative for AFP, any form of cytochrome P450, 
hemopoietic markers (CD34, CD45, CD38, CD14, CD90, and glycophorin A), 
endothelial cell markers (VEGFr, Von Willebrand Factor, and PECAM or CD31), and 
mesenchymal markers such as those for hepatic stellate cells (CD146, desmin, and α-
smooth muscle actin).  The expression of NCAM by the hHpSCs is significant, since 
previous studies have shown that this marker is present on the ductal plate in fetal 
livers and evident on liver cell populations proliferating under various disease states 
[166, 360-362].  
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2.3.4 Immunoselection using EpCAM Isolates Hepatoblasts from Fetal 
and Neonatal Livers; Immunoselection Using EpCAM or NCAM 
Isolates hHpSCs from Livers of All Donor Ages 
 To enrich for hepatic progenitors from liver cell suspensions, we 
explored a number of fractionation strategies, including separation by buoyant 
density on Ficoll gradients (see Supplement Table 1) and by immunoselection.  The 
most satisfactory results were obtained using magnetic immunoselection.  While 
fluorescence activated cell sorting (FACS) was able to yield highly purified cellular 
subpopulations, the shear forces and the use of buffers (e.g. phosphate buffered 
saline) that are not optimal resulted in low yields of viable cells. We used magnetic 
microspheres conjugated with monoclonal antibody to EpCAM (Miltenyi Biotec, 
Auburn, CA) to immunoselect EpCAM+ cells from liver cell suspensions and 
obtained robust, highly viable sorted cells that survived and expanded well when 
cultured (Fig. 4 and Supplement).  From postnatal livers up to 10 billion viable 
cells were processed in a single pass using the CliniMACS apparatus (Miltenyi 
Biotec) and yielded over 100 million EpCAM+ cells.  Purity of the enriched EpCAM+ 
cells was typically 75 to 90% and recovery usually exceeded 90%.  Representative 
fractionation of a fetal liver and of a postnatal liver are depicted in Fig. 4.  A cell 
suspension from the liver of a two year-old donor was found to contain 0.7% 
EpCAM+ cells.  The immunoselected population contained 81% EpCAM+ cells, while 
the flow-through fraction was almost entirely depleted of EpCAM+ cells.  The 
majority of hepatic EpCAM+ cells were of 8-10 µm diameter, as judged by Coulter 
Counter analysis, in contrast to 18-20 µm for diploid hepatocytes, the predominant 
population in the initial liver cell suspension.  A small peak of presumptive tetraploid 
cells also is evident, measuring ~25 µm in diameter.  Light scatter (“Side Scatter”) 
profiles indicate that the EpCAM+ liver cells are considerably smaller and less 
granular than the bulk of the parenchymal cell population.  
 
Figure 2-4 Magnetic immunoselection 
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Magnetic immunoselection for NCAM+ cells from fetal livers enriched for 
cells capable of forming only hhHpSC colonies (Fig. 4).  The majority of EpCAM+ 
cells from fetal liver co-expressed NCAM, whereas only ~40% of those from adult 
liver were also NCAM+.  Therefore, sorting for NCAM+ cells proved useful for 
isolation of hHpSCs from fetal livers but less so from adult livers.  It is unknown at 
this time whether NCAM and EpCAM co-expression is a definitive property of  
hHpSCs.  An alternative hypothesis, now being tested, is that NCAM is present on 
angioblasts or other mesenchymal companion cells tightly bound to the hHpSCs 
such that immunoselection for it results in co-selection of the two cell types (see 
below for more on this theme).  Sorts for KDR (VEGFr) resulted mostly in 
angioblasts (Fig. 4).  However, these sorts also yielded an increase in hhHpSC 
colonies due, we assume, to co-selection of hHpSCs and angioblasts.   
 
2.3.5 Proteins and Genes Expressed by EpCAM+ Cells 
 Immunoselected EpCAM+ cells from fetal and postnatal livers were 
examined by flow cytometry for expression of lineage markers characteristic of 
various cell types that reside in the liver (Figs 2, 4 and Supplement).  As judged 
by double label flow cytometry, about 95% of the immunoselected EpCAM+ cells 
expressed CK19, and comparable percentages expressed ALB and CD133.  
Evaluations of many preparations indicated that over 90% of the EpCAM+ cells are 
positive for CD133, detected with monoclonal antibodies to two distinct epitopes 
(CD133-1 with monoclonal antibody AC133; CD133-2 with monoclonal antibody 
AC141).  Virtually all CD133-1+ cells in adult liver cell suspensions were found in the 
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EpCAM+ selected fraction, and mature hepatocytes were clearly negative.  However, 
it appeared that ~40% of  liver cells with light scatter profiles consistent with mature 
hepatocytes were positive for CD133-2.  Examination by immunofluorescent 
microscopy showed that staining for CD133-1 clearly outlines cell membranes, 
whereas that for CD133-2 shows a more diffuse pattern (data not shown).  It is likely 
that the staining of many more liver cells by CD133-2 results from a known cross-
reactivity with CK18 [363] which is expressed by hepatocytes and reportedly can be 
found on the cell surface [364].  Based on the more specific CD133-1 antibody, we 
conclude that EpCAM and CD133 (prominin) are co-expressed by the vast majority 
of hHpSCs.  
 Neural cell adhesion molecule, NCAM (CD56), shown previously to be 
expressed by glia, muscle cells and by neurons [365], was found on the majority of 
hHpSCs derived from fetal and neonatal livers, but only ~40% of the EpCAM+ cells 
from adult livers.  In our prior studies NCAM mRNA was enriched strongly in 
EpCAM+ cells from both fetal and postnatal livers, but expression at the protein 
level was variable [46].  NCAM staining was most evident at the borders of the 
hhHpSC colonies (Fig 3).   
 Less than 1% of the enriched EpCAM+ cells stained for the hemopoietic  
marker CD45 (leucocyte common antigen), which is found on Kupffer cells (tissue 
macrophages) and lymphocytes in the liver.  The EpCAM+ cells were negative for 
expression of other hemopoietic markers assayed (CD34, CD14, CD38, CD4, CD90, 
and glycophorin A), for endothelial cell markers (CD34, VEGFr or KDR, Von 
Willebrand factor, and CD31), and for mesenchymal markers, especially those 
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associated with hepatic stellate cells (CD146, also called Mel-CAM, desmin, α-
smooth muscle actin) (data not shown).  Finally, we found AFP expression at RNA 
and protein levels in EpCAM+ cells from fetal and neonatal livers, but not from 
pediatric or adult livers.  As noted above, small numbers of cells weakly positive for 
AFP, as judged by immunohistochemistry, were observed tethered to the ends of the 
Canals of Hering in sections from pediatric and adult livers (Fig 1E).  From our 
experience, these cells are too few and express AFP too weakly to permit recognition 
as a defined subpopulation by flow cytometry.  
Assessment by RT-PCR of RNA expression in the EpCAM+ liver cells (Fig 2) 
gave results consistent with the flow cytometry data.  Further details of these 
findings are reported elsewhere [46].  In brief, EpCAM+ selection from fetal livers 
more than doubled the expression levels of albumin, AFP and CK19.  
Immunoselection for  EpCAM+ cells from postnatal livers strongly enriched for 
transcripts encoding EpCAM, CK19, CD133 and CD117 (c-Kit); these transcripts were 
barely detectable in the EpCAM-negative cells.  AFP transcripts were not detectable 
in EpCAM+ or EpCAM-negative cells from postnatal livers.   
Although immunoselected cells are enriched for relative expression of CD117 
mRNA, we have not observed the corresponding protein by immunostaining of 
freshly isolated cells from fetal or postnatal livers nor on cultured cells from 
postnatal livers.  However, we occasionally have observed low levels of CD117 
staining on cells at the periphery of hhHpSC colonies from fetal livers, located in 
regions where hHpSCs overlap with mesenchymal companion cells. 
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Cytochrome P450 3A4 (CYP3A4), a protein expressed by mature hepatocytes, 
was not found at all in parenchymal cells, either EpCAM+ or EpCAM-, from fetal 
livers in terms of both mRNA and protein level of it.  The level of mRNA for 
cytochrome P450 in EpCAM+ cells was twenty-fold lower relative to EpCAM-
negative cells from postnatal livers.  The small amount of CYP3A4 RNA in the 
EpCAM+ cell fraction from postnatal livers could be accounted for by residual 
hepatocyte contaminants.  By contrast, the hepatoblasts, but not the hHpSCs, were 
found to express P450A7, a protein found in fetal livers (data not shown). EpCAM+ 
cells from postnatal livers also showed eight-fold lower relative expression of 
albumin RNA than the flow-through (EpCAM-negative) population.  Again, some 
transcripts can be attributed to incomplete removal of hepatocytes.  However, the 
detection of albumin protein in EpCAM+ cells by flow cytometry, taken together with 
the transcript data, demonstrates that these progenitor cells express the albumin 
gene, albeit at a significantly lower level than differentiated hepatocytes. 
Assays for telomerase activity indicate significant levels in freshly isolated 
EpCAM+ cells from livers of all donor ages and in cultures of colonies of both 
hHpSCs and hepatoblasts.  Full characterization of telomerase activity and its 
regulation in various fractions of human liver cells from fetal and postnatal donors is 
presented elsewhere (Schmelzer E and Reid L, submitted) as are studies on the 
effects of purified matrix substrata on telomerase activity in cultures of hHpSCs 
(McClelland et al, submitted).  
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2.3.6 Ex Vivo Clonogenic Expansion—Evidence for Self Renewal 
Colony formation by committed hepatic progenitors or diploid adult 
parenchyma involves a limited number of divisions (typically 5-7 divisions) over a 
relatively short period of time (e.g.  2 to 3 weeks)[43].  By contrast, self-renewal 
involves clonogenic expansion that can go on for more than 100 population 
doublings with phenotypic stability, properties associated with stem cells.  We found 
previously that rat hepatoblasts multiply far more extensively in KM with STO feeder 
cells than on tissue culture plastic [43].  However, STO feeders and KM were not 
permissive for clonogenic expansion of human hepatoblasts.  Under these conditions 
the hepatoblasts survived for a few months but demonstrated limited growth.  By 
contrast, hHpSCs from livers of all donor ages could undergo clonogenic expansion 
for more than 6 months (>150 population doublings) in culture on tissue culture 
plastic and in KM with only the native feeders (the companion cells) (Table 2).  The 
cells maintained phenotypic stability as assessed by morphology and by antigenic 
and biochemical profiles (Tables 1 and 2).  hhHpSC colonies starting from 1-3 cells 
(visual observation -Supplement-Movies) grew to cover 4.9+0.3 mm2 in area and 
contained an average of 1400 + 520 cells (three independent counts of total cells 
from 50 dispersed colonies).  Thus, the cells in this representative experiment had 
gone through 10-11 population doublings in 2 weeks corresponding to an average 
doubling time of 31-34 hours (Supplement; Table 2). 
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2.3.7 Mesenchymal Companion Cells Provide Critical Paracrine 
Signaling for hHpSCs  
The tightly packed colonies of hHpSCs have a prominent ridge at the 
perimeter (see Figs 3, 4 and 6) at which we have identified mesenchymal 
companion cells (Fig 5).  As the colonies grow, the companion cells penetrate the 
colonies and become found throughout them.  Time lapse movies (Supplement: 
Movies) reveal a boundary zone between the companion cells and the hhHpSCS in 
which the companion cells fluctuate back and forth, touching the edge of the 
hhHpSC colony, or traversing it and moving below the colony.  When removed from 
a culture dish, the attachment to the plastic surface is evident only at the edge of the 
colonies, not in the center.  This suggests that attachment to the plastic is mediated 
either by mesenchymal cells or by cooperative interactions between the hHpSCs and 
the mesenchymal cells.  
 Figure 2-5 Companion cells to the hHpSC Colonies comprise Hepatic Stellate cells and 
Angioblasts 
 
Phenotypic analyses of the companion cells indicates at least two distinct 
populations: angioblasts (VEGFr+ or KDR, CD133/1+, CD117+, Von Willebrand 
factor, CD31weak); and hepatic stellate cells (desmin+, α-smooth muscle actin+, 
CD146+) (Fig 5).  A comparison of their morphological and antigenic phenotypes is 
given in Fig 5.  Cells rigorously purified away from the companion cells (e.g. by 
repeated immunoselection for EpCAM+ cells) did not survive on culture plastic but 
only on STO feeders (data not shown).  Immunoselection of CD117+ cells yielded 
angioblasts but neither hepatic stellate cells nor hHpSCs (data not shown). 
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Immunoselection for other markers found on the companion cells (e.g. VEGFr) 
resulted mostly in selection of the companion cells alone, though we did find co-
selection for hHpSCs to occur at low and variable frequency (Fig. 4).  We still cannot 
rule out that the consistent enrichment of hHpSCs from fetal liver by 
immunoselection for NCAM could actually result from co-selection of the stem cells 
via tight association with NCAM+ companion cells.  
 
2.3.8 Proof of Pluripotency of hHpSCs 
Passaging (transfer) of colonies of hHpSCs (whether derived from fetal or 
adult livers) from culture plastic onto feeder layers of STO cells resulted within hours 
in eruption of hepatoblasts from the periphery of hhHpSC colonies (Figs. 6 and 7; 
Table 1).  After the transfer, the morphology and antigenic profile of the cells within 
the hhHpSC colonies proper did not change in most of the cells, though there were 
occasional cells with distinct gene expression within the colony (Fig. 7).  Rather the 
colonies of hHpSCs gave rise to cord-like eruptions from their edges, yielding cells 
with morphology, antigenic and biochemical profiles identical to that of 
hepatoblasts.  The cells in these erupted areas strongly expressed AFP, ICAM-1, ALB, 
and were positive for cytochrome P450-A7 (data not shown), but were negative for 
NCAM (Fig  7).  In addition, committed progenitors biliary progenitors were 
sometimes observed erupting from a colony of hHpSCs, as shown by staining for 
CK19 but not albumin (Fig. 7).   
 
 
  
Figure 2-6 hhHpSCs shifted to STO Feeders Erupt Hepatoblasts 
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 Figure 2-7 Shift in Antigenic Profile from hhHpSCs to Hepatoblasts when on STO 
Feeders 
 
In cultures of cells from postnatal livers, in colonies stained by double label 
immunofluorescence for CK19 and ALB, we have observed distinct sectors positive 
for one or the other marker but not both (Supplement Fig 4).  This was found 
most frequently in colonies of hepatoblast morphology.  We interpret such sectors as 
deriving from unipotent cells, corresponding to committed progenitors for biliary 
and hepatocytic lineages, respectively.  The sectoring could occur if at division a 
bipotent cell gives rise to a daughter cell restricted to the biliary or to the hepatocytic 
lineage.  Occasional small colonies showed expression of only one of the lineage 
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markers (CK19 or ALB) and are assumed to have arisen from committed progenitors 
for the corresponding cell type.  
  
2.3.9 EpCAM+ Cells and Colonies of hHpSCs Give Rise to Human Liver 
Tissue in vivo 
 Transplantation of freshly isolated EpCAM+ cells or of hhHpSC 
colonies, from either fetal or postnatal livers, into livers of NOD/SCID mice resulted 
in engraftment and the formation of human liver tissue (Fig 8).  Islands of cells 
staining positive for human ALB, CK19 and AFP were found within 2 days of 
transplantation (Fig. 8A, C, and E) and persisted within the livers for  weeks (Fig. 
8F).  The extent of engraftment and expansion of human liver cells in vivo was 
enhanced by treatment of the mice with carbon tetrachloride, CCL4, a poison for the 
pericentral zone of the liver acinus, often used to create a cellular vacuum in 
transplanted hosts (8B, D, G).  Human-specific DNA sequences were found in the 
liver of animals that received the human cell transplants, but not in other tissues, nor 
in control animals that did not receive human cells (data not shown).  Prior to 
transplantation, as expected, the cells were shown to express EpCAM and CK19 
strongly and ALB weakly, but were negative for AFP at both RNA and protein levels.  
The liver sections from mice transplanted with hHpSCs contained cells strongly 
expressing human-specific forms of ALB, CK19, and AFP but were negative for 
EpCAM.  However, human cytochrome P450 3A was not detectable.  Therefore, it 
appears that after transplantation and expansion in recipient livers, the human cells 
lost expression of a marker (EpCAM) found only on stem and progenitor cells, and, 
acquired some, but not yet all, of the functions specific to mature hepatocytes.  We 
think it logical that transferrin is expressed by not yet P450 3A in transplanted cells 
given that in mature liver,  transferrin is expressed by zone 2 parenchymal cells, 
whereas P450 3A by zone 3 parenchymal cells within the acinus.  Thus, P450 3A is a 
late gene produced by cells at the end of the liver’s maturational lineage.  
 
Figure 2-8 Transplantation of EpCAM+ Cells (or Colonies of Stem Cells in culture) 
results in Engrafted Liver Tissue in NOD/scid mice 
 
As an independent test of engraftment, we assessed expression of the human 
transferrin gene, encoding a protein characteristic of mature hepatocytes.  We found 
by quantitative RT-PCR analysis with human-specific primers that the livers of mice 
sampled one week after injection of the EpCAM+ cells derived from postnatal human 
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livers contained significant levels (2100 ± 1140 strands per 100 ng) of human 
transferrin RNA.  Such sequences were undetectable in RNA from livers of control 
mice (<100 strands per 100 ng RNA).  Although prior to transplantation over 80% of 
cells in the test cell population expressed EpCAM and CK19, cells in recipient 
animals were positive for human ALB and were negative for both of the progenitor 
cell markers.  Taken together, the data suggest that within seven days in vivo, the 
engrafted hHpSCs gave rise to mature human liver cells.  
2.4 Discussion 
Cells in the ductal plates in fetal and neonatal livers and in the Canals of 
Hering in pediatric and adult livers are hHpSCs.  They can be isolated efficiently by 
selective culture conditions and by immunoselection for EpCAM (CD326) and/or 
NCAM (CD56).  The hHpSCs have features typical of stem cells including Sonic and 
Indian Hedgehog signaling [28] and high telomerase activity (Schmelzer E and Reid 
L, submitted)..  They are capable of self-renewal, as shown by clonogenic expansion 
for over 150 population doublings, and are pluripotent, with the ability to give rise 
directly to committed biliary progenitors and to hepatoblasts and thence to 
hepatocytic and biliary lineages, as well as to other endodermal cell types (our 
unpublished data).  The hHpSCs express certain markers of both hepatocytic and the 
biliary lineages but lack expression of mature liver functions [46].  They yield human 
liver tissue when transplanted intrahepatically in immune deficient mice.  
Hepatoblasts, expressing AFP, ALB and CK19, and emerging in newly forming liver 
tissue, have long been considered hepatic stem cells [366].  However, AFP-negative 
hHpSCs are actually precursors to hepatoblasts.   
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Recognition of the ductal plate as the liver’s stem cell niche provides a new 
insight into organogenesis,  The specification of foregut cells to an hepatic fate is 
associated with expansion of endoderm into the surrounding cardiac mesenchyme, a 
process leading to ductal plate formation [28].  Our data suggests that ductal plates 
are directly antecedent to the Canals of Hering, which have been identified as the 
reservoir of stem cells in postnatal livers.[358, 367]  
The liver at all ages displays a remarkable capacity to regenerate after physical 
or toxic injury [348].  Two forms of regenerative response are known. The first is a 
hypertrophic cellular response by mature hepatocytes that undergo DNA synthesis 
with minimal cytokinesis, the predominant mechanism of regeneration after partial 
hepatectomy in postnatal livers [42, 368].  The other is a hyperplastic response by 
both progenitor cells and diploid hepatocytes following significant loss of liver cells 
in zones 2 and 3, as detailed in a number of review articles [349, 369, 370].  
Contributions of progenitors to regeneration after partial hepatectomy have been 
presumed negligible based on assumptions that they should be AFP+ [348]  Since 
hHpSCs are AFP-, their role in liver regeneration in adults requires re-evaluation by 
tracking the involvement of EpCAM+ and NCAM+ cells.  The frequency of EpCAM+ 
cells in suspensions prepared from postnatal human livers is consistent at all ages 
beyond a few months, in the range of 0.5 to 2.5%.  We infer that a substantial pool of 
hHpSCs is maintained throughout life.  The number of hHpSCs is much higher than 
estimates based on the frequency of AFP+ cells (<0.01%).  Some authors have 
argued that the mature liver contains only “facultative” stem cells, activated in 
response to pathological states and injuries that invoke a hyperplastic response [350, 
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358, 370, 371].  We have previously raised the alternative hypothesis that hHpSCs 
function routinely to replenish the liver as mature cells are lost slowly through 
terminal differentiation [38, 42, 46].  The presence of a much larger pool of hHpSCs 
than previously suspected in normal adult livers provides a further rationale to 
examine this possibility more carefully. 
During development a limited number of hHpSCs are associated with 
developing portal tracts and steadily give rise to hepatoblasts that we hypothesize are 
the liver’s transit amplifying cells.  The hepatoblasts, in turn, are precursors to 
committed hepatocytic and biliary progenitors.  Further evidence for hepatoblasts in 
normal adult livers is given elsewhere.[128]  In the findings reported here, we show 
the generation of hepatoblasts and unipotent progenitors from hhHpSC colonies in 
culture.  This occurs spontaneously from discrete regions at the periphery of 
hhHpSC colonies and may correspond to a localized signal that triggers a rapid burst 
of expansion from one or more cells.  As noted below, cell-cell interactions are key to 
both maintenance and differentiation of hHpSCs.  STO feeder cells promote 
differentiation of hHpSCs, whereas they contribute primarily to survival and 
expansion of rodent hepatoblasts,  and may offer a tool to identify some of the 
differentiation-promoting signals for hHsPCs. 
 
2.4.1 Functions of Cell Surface Markers of hHpSCs 
Characteristic cell surface antigens of hHpSCs and hepatoblasts overlap 
extensively, with both populations expressing EpCAM, E-Cadherin, integrin β-1 
(CD29), and CD133.  The hHpSCs and hepatoblasts are negative for markers of 
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hematopoietic (CD34, CD45, CD38, CD14, CD90, glycophorin A), endothelial 
(VEGFr, Von Willebrand’s factor, CD31) and mesenchymal (CD146, desmin, and α-
smooth muscle actin) cell lineages.   
EpCAM is present on proliferating epithelial cells in most, if not all, organs 
derived from endoderm (e.g. liver, lung, pancreas, intestine). The extracellular 
domain of EpCAM is thought to generate a relatively weak homotypic bond between 
adjacent cells [356].  Conversely, the cytosolic domain of EpCAM is believed to 
diminish the effectiveness of E-cadherin binding through impairment of the 
interaction between beta-catenin and the actin cytoskeleton [357].  This role may be 
physiologically relevant for hHpSCs and hepatoblasts, as E-cadherin was expressed 
with the same distribution as EpCAM.   
The role of NCAM in the biology of hHpSCs requires further elucidation.  We 
found that the hHpSCs from fetal and neonatal liver consistently show strong NCAM 
expression and that immunoselection for NCAM enriches for hHpSCs.  However, 
only ~40% of hHpSCs from adult livers are positive for this antigen.  In cultures of 
hHpSCs, NCAM expression is observed in a characteristic scalloped pattern located 
most prominently at the borders of the colonies. Thus far we have not been able to 
ascertain unequivocally whether NCAM is expressed by hHpSCs, by tightly 
associated mesenchymal companion cells, or both.  Ultrastructural studies by 
electron microscopy are needed to resolve this point.  NCAM is a member of the Ig 
superfamily, with more than 20 alternatively spliced mRNAs encoding multiple 
protein isoforms [166, 372].  It is the only sialated cell adhesion molecule and forms 
homotypic cell/cell attachments that are inversely proportional to the degree of 
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sialation; an increase in sialation results in muted cell-cell adhesion and consequent 
increase in migration and invasion [166].  Several groups have reported that NCAM 
is expressed by ductal plate cells within the fetal liver and, interestingly, also by 
proliferative ductular cells that characterize pathologies collectively termed ductal 
plate malformations, such as primary biliary atresia [94, 360, 362, 373, 374].  Thus, 
positive staining for NCAM, in addition to ALB, CK19 and CK8/18, supports the 
interpretation of these cells as ones derived from the ductal plate.   
We found consistent expression of CD133 (prominin-1) by hHpSCs cultured 
on both plastic and on STO substrata, and by >90% of EpCAM+ cells 
immunoselected from adult livers.  Although angioblasts also are CD133+, the 
staining in hhHpSC colonies was associated with most or all cells, indicating that 
CD133 is expressed by the hHpSCs and not only by companion cells.  This pentaspan 
transmembrane glycoprotein was first identified on hematopoietic stem cells, and its 
expression also has been observed on stem/progenitor cells of a variety of lineages, 
including endothelia, muscle, neural, prostatic, epidermal, and others [375, 376].  
The role, if any, of CD133 in the self-renewal and differentiative capacity of hHpSCs 
is not yet understood.  However, it may be significant that an isoform of CD133 
specifically associated with stem cells was found in cells of the basal layer of human 
neonatal epidermis, and co-expressed there with integrin β-1, which also is 
expressed by hHpSCs and hepatoblasts.  Furthermore, CD133 expression was lost as 
the epidermal cells stopped proliferating and acquired a differentiated phenotype in 
culture [377].   
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2.4.2 Association of Mesenchymal “Companion” Cells with hHpSCs 
The specific association of multiple adhesion molecules with hHpSCs and 
hepatoblasts suggests that they play important regulatory functions in modulating 
interactions with cells that comprise local inductive environments and/or stem cell 
niches.  A critical, enabling event, required for formation of the liver, is that 
angioblasts from the septum transversum induce the hepatic bud to form.[352]  Such 
key interactions are now amenable to study in vitro using hHpSCs.  We observed 
that colony expansion and cell outgrowth of hHpSCs depends on mesenchymal 
companion cells prominent at the periphery of hhHpSC colonies and identified by 
antigenic profiles as angioblasts (positive for VEGFr , CD31 or PECAM, CD117, CD 
133) or hepatic stellate cell precursors (positive for CD146 (MEL-CAM, MCAM), 
desmin and α-smooth muscle actin). These findings parallel our prior work defining 
hepatic stellate cell precursors supportive of rodent hepatic progenitors and in which 
we find that they express vitamin A, desmin, and alpha-smooth muscle actin but also 
various markers associated with endothelia such as VCAM.[26] 
CD146 forms homotypic cell-cell connections that were first localized on 
melanoma cells and subsequently at cell junctions within endothelial cell layers 
[378].  CD146 has now been identified on many different cell types including 
keratinocytes and hair follicle epithelia, stromal cells in adipose tissue and bone 
marrow, and most cell types in the thymus [379, 380].  The expression of CD146 on 
cells at the periphery of colonies of hHpSCs, and extending to the innermost cells of 
aging colonies on plastic, is consistent with the known anti-cohesive activity of 
CD146.  In this capacity CD146 functions as an outside-in transducer that suppresses 
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gap junction connections, inhibits β-1-mediated integrin binding, and disturbs E-
cadherin-based adherens junctions [378, 381].  Furthermore, the strong expression 
of ICAM-1 by more differentiated cells emerging from hhHpSC colonies may also 
reflect modulation of cell-cell interactions.  ICAM has been shown to act in 
conjunction with CD146 to disturb E-cadherin-based cell junctions [382].  The 
dramatic increase in expression of CD146 in association with differentiation of the 
hHpSCs into hepatoblasts is assumed to model angiogenesis in the forming liver, an 
interpretation supported by the findings of Sonic and Indian Hedgehog signaling 
and the Patched receptor in the ridge formed by the angioblasts and the hepatic 
stellate cells [28].   
The possibility of co-isolation of  hHpSCs with mesenchymal cells may 
account for some apparent differences between the hHpSCs described here and 
candidate hHpSCs reported by others.[383]  For example, liver-derived, stem-like 
cells have been reported to express markers shared with hematopoietic progenitors, 
including CD45 (leucocyte common antigen), CD34, and CD117 , and/or to be 
capable of giving rise to both hepatic and endothelial cells [384].  Another report 
describes candidate hepatic stem cells found in regeneration after massive hepatic 
necrosis as “lymphoid blastlike” cells that express CD133 and CD117 but not 
CD45.[385]  We suspect that the multipotent stem cells found in fetal liver and 
reported to give rise to liver and also mesenchymal lineages (e.g. cartilage) and that 
co-express EpCAM and various mesenchymal cell markers are also an example of co-
selection (51).  
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The hhHpSC populations from both fetal and adult livers appear essentially 
negative for CD45, CD34 and CD117.  However, CD34 and CD117 are expressed by 
angioblasts, which we have found in companion cells associated with hHpSCs.  
Based on immunofluorescent staining CD117 was variably present in the border zone 
between the companion cells and some (but not all) hhHpSC colonies cultured on 
plastic.  Also, transcript analysis revealed a slight enrichment in CD117 mRNA in 
EpCAM+ cell populations from fetal livers and a significantly greater enrichment in 
EpCAM+ cells from postnatal liver.[46]  Nonetheless, immunoselection for CD117 or 
CD34 yielded angioblasts, not hHpSCs.  In summary, our data remain inconclusive; 
we cannot rule out that a minor subpopulation of hHpSCs cells express CD117. 
It is conceivable that phenotypic differences between hHpSCs obtained by 
different isolation procedures reflect varying stages within a common lineage and/or 
subtle effects of in vitro selection protocols.  However, it is clearly important to be 
aware of the physical and functional interaction of hepatic (endodermal lineage) and 
mesenchymal lineage cells both in the developing liver and the adult organ, and the 
possibility of ascribing properties to a single cell type that actually correspond to a 
mixed population.  In any case we argue that the relative frequency and anatomical 
location of EpCAM+, CD133+. CD34-negative cells, and the growth and 
differentiation capacity of these cells, provide strong evidence that the hHpSCs 
described here are authentic stem cells in fetal and postnatal livers. 
Purified EpCAM+ cells, from fetal or postnatal livers, are able to engraft the 
livers of immunodeficient adult mice, with or without prior injury, yielding mature 
human liver tissue. The engrafted cells lose expression of stem cell markers  (e.g., 
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EpCAM, CD133, and CK19) and show enhanced expression of mature human 
proteins and mRNAs characteristic of hepatocytes (e.g. ALB and transferrin).  The 
use of human-specific antibodies and sequence probes confirmed that these were 
made by donor-origin cells.  The extent of humanization of the murine livers was 
greatly enhanced by treatment of mice with CCl4, known to selectively kill mature 
parenchymal cells and, thereby, to create a cellular vacuum in the host. 
The efficiency with which EpCAM+ cells can be isolated from human livers, 
their ability to clonogenically expand ex vivo, their pluripotency, and the evidence 
that they yield mature liver tissue after transplantation encourage consideration of 
their clinical utility.  Potential applications include cell-based therapies of liver 
disease and generation of cells for bioartificial livers. 
2.5 Materials and Methods 
(Details are provided in the supplement available online) 
Human Liver Sourcing.  
Fetal Livers. Liver tissue was provided by an accredited agency (Advanced 
Biological Resources, San Francisco, CA) from fetuses between 18-22 weeks 
gestational age obtained by elective terminations of pregnancy. The research 
protocol was reviewed and approved by the IRB for Human Research Studies at the 
UNC.   
Postnatal Livers. Intact livers from cadaveric neonatal, pediatric and adult 
donors were obtained through organ donation programs via UNOS.  Those used for 
these studies were considered normal with no evidence of disease processes. 
Informed consent was obtained from next of kin for use of the livers for research 
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purposes, protocols received Institutional Review Board approval, and processing 
was compliant with Good Manufacturing Practice.  
 
Liver Processing.  
Fetal livers.  All processing and cell enrichment procedures were conducted 
in a cell wash buffer composed of a basal medium (RPMI 1640) supplemented with 
0.1% bovine serum albumin  (BSA Fraction V, 0.1%, Sigma, St. Louis, Mo.), insulin 
and iron saturated transferrin both at 5 ug/ml (Sigma St Louis MO ) trace elements 
(selenious acid ,300 pM and  ZnSO4, 50 pM), and antibiotics ( AAS, Gibco 
BRL/Invitrogen Corporation, Carlsbad, California).   Liver tissue was subdivided into 
3 mL fragments (total volume ranged from 2-12 mL) for digestion in 25 mL of cell 
wash buffer containing type IV collagenase and deoxyribonuclease (Sigma Chemical 
Co. St Louis, both at 6 mg per mL) at 32 EC with frequent agitation for 15 – 20 
minutes.   This resulted in a homogeneous suspension of cell aggregates that were 
passed through a 40 gauge mesh and spun at 1200 RPM for five minutes before 
resuspension in cell wash solution.  Erythrocytes were eliminated by either slow 
speed centrifugation [386, 387] or by treating suspensions with anti-human red 
blood cell (RBC) antibodies (Rockland, #109-4139)  (1:5000 dilution) for 15 min 
followed by LowTox Guinea Pig complement (Cedarlane Labs, # CL4051) (1:3000 
dilution) for 10 min both at 37°C. Estimated cell viability by trypan blue exclusion 
was routinely higher than 95%. See supplemental data for further details.  
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Postnatal livers. The livers were perfused through the portal vein and 
hepatic artery for 15 min with EGTA-containing buffer and then with 600 mg/L 
collagenase (Sigma) for 30 min at 34oC. The organ was then mechanical dissociated 
in either collection buffer; the cell suspension passed through filters of pore size 
1,000, 500, and 150 microns; the single cells collected and then live cells 
fractionated from dead cells and debris using density gradient centrifugation (500 x 
g for 15 min at room temperature) in Optiprep-supplemented buffer in a Cobe 2991 
cell washer. The resulting hepatic cell band residing at the interface between the 
OptiPrep/cell solution and the RPMI-1640 without phenol red was collected. 
 
Magnetic Immunoselection.  Isolation of cells expressing EpCAM from 
human liver cell suspensions was carried out using monoclonal antibody HEA-125 
coupled to magnetic microbeads, and separated using a miniMACS™ ,  a midiMACS 
TM , an autoMACS™ or CliniMACS® magnetic column separation system from 
Miltenyi Biotec (Bergisch Gladbach, Germany), following the manufacturer’s 
recommended procedures.  Similar protocols were used for sorts for NCAM+, 
CD117+, VEGFr (KDR)+,  CD34+. and CD146+ cells.  
 
Colony Formation.  Cells were plated in serum-free, hormonally defined 
medium, “Kubota’s Medium (KM),  in 6-well tissue culture dishes seeded with 
monolayers of Mitomycin-treated STO feeder cells, as described by Kubota and Reid 
[43, 212]. Medium was changed every 2 to 4 days. Colonies were observed within a 7-
10 days and were followed for up to six months using an inverted microscope.  
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Additional results (tables and figures) are given in the supplement available 
online. 
 
Abbreviations: EpCAM: Epithelial Cell Adhesion Molecule; hHpSCs: 
HhHpSCs;  AFP:α-Fetoprotein; ALB: albumin; CK: cytokeratin; NCAM: Neuronal 
Cell Adhesion Molecule; ICAM: Intercellular Adhesion Molecule; CD: common 
determinant; KM: Kubota’s Medium; PBS: phosphate buffered saline; CCL4= carbon 
tetrachloride 
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Figure Legends 
Fig 1.  Immunohistochemical Studies on Human Fetal Livers.  
Confocal microscopic images  on 5 µm liver sections.  The antigenic profiles are given 
in the Table. Sections were stained for: 
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 Human Fetal Livers: A. EpCAM (green) and CK19 (red); B. EpCAM 
(green) and AFP (red); C. CK19 (green) and albumin (red); D. CK19 (green) and AFP 
(red) 
Adult Livers: E. EpCAM.  Black arrows denote probable hepatoblasts at the 
end of a canal of Hering; F. Canals of Hering around portal triad with EpCAM 
(green) and CK19 (red); G. A Canal of Hering showing EpCAM+ cells (green) some 
of which also express albumin (red).   
 
Fig 2. Flow Cytometric Characterization of EpCAM+ Cells.  A. The % 
of EpCAM+ cells in livers of  varying donor ages.  *The numbers for fetal livers have 
been reported previously (28)   but are presented here for comparison to findings in 
livers from older donors. B. Analyses of EpCAM+ cells from fetal livers (similar 
findings occur with EpCAM+ cells from adult livers except that few cells express 
AFP).  C. Quantitative RT-PCR Assays on freshly isolated EpCAM+ versus EpCAM- 
cells from fetal versus postnatal livers.   These data are compared to the findings 
from colonies of hhHpSC grown on plastic and in serum-free KM for 30-60 days.  
 
Fig 3. hHpSCs in culture.  A-E show a stem cell colony forming at 2 days 
(A),  4 days (B), 7 days (C), 10 days (D), and 14 days (14) in culture  on plastic and in 
KM.  Scale bar: 20 um.   Phase contrast coupled with image of cells with staining for  
NCAM (E and F), CK19 (G and H), EpCAM (I and J ), and CD44H (L).   
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Fig 4. Magnetic immunoselection.  A-F.  Flow cytometry on human fetal 
liver cells stained for EpCAM (Panel D; Panel A is the isotype control for D used for 
setting the gate shown in pink) indicated 20.7 % of the cell suspension were positive 
for EpCAM. The cells were subjected to  magnetic bead sorting and yielded a 
suspension enriched for EpCAM to 54.6% of the cells (Panel B is the isotype control 
used for the data in panel E).  The flow-through cells (Panel F; Panel C is the isotype 
control for Panel F) were depleted in EpCAM yielding 7.15% of the cells. G-I. Flow 
cytometry on cells from adult livers.  EpCAM expression (Y axis ) vs side scatter (X 
axis) .  In the original, unfractionated cell suspension were found 0.73% EpCAM+ 
cells.  H. a single pass through Miltenyi microbead sorting resulted in enrichment for 
EpCAM+ cells to 80.9%. I. In the flow through were found only 0.06% EpCAM+ 
cells.  J. The EpCAM+ cells were ~9-10 µm in diameter vs 18-22 µm for mature 
parenchyma and had low side scatter (K) relative to that found for mature cells in the 
unfractionated mixture (UMIX) of liver cells (L).  Table: summary of  profiles of 
cells immunoselected for EpCAM, NCAM, KDR (VEGFr) or for KDR-/EpCAM- cells. 
Phase micrograph images are of an hhHpSC colony from an EpCAM+ sort and 
one from an NCAM+ sort.  
 
Fig 5. Companion cells to the hHpSC Colonies comprise Hepatic 
Stellate cells and Angioblasts. hHpSCs are associated with mesenchymal 
companion cells with distinct antigenic profiles.  See movies in the Supplement. Two 
types of companion cells are evident: angioblasts (positive for VEGF-R, CD133/1, 
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CD117, weakly positive for CD31 and von Willebrand’s factor) and hepatic stellate 
cells (positive for desmin and α-smooth muscle actin—ASMA).    
 
Fig 6. hHpSCs shifted to STO Feeders Erupt Hepatoblasts. Passage of 
hHpSCs from plastic to STO feeders results in cord-like eruptions that 
morphologically and antigenically are identical to hepatoblasts.  A.  An hhHpSC 
colony shortly after passaging.  B-E. A small group of passaged stem cells appears as 
a tightly compacted group of cells that erupts cords of hepatoblasts at the periphery 
of the colonies.  Shown is a colony and the steady eruption of hepatoblasts by the end 
of day 1 (B),  day 3 (C), day 5 (D) and day 7 (E) after passaging.   
 
Fig 7. Shift in Antigenic Profile from hHpSCs to Hepatoblasts when on STO 
Feeders  
The border between the hhHpSC colony and hepatoblast outgrowths is 
marked by arrowheads. A and B. The antigenic profile of the cords of cells erupting 
from the parent colony is identical to that of hepatoblasts and includes a shift from 
expression of NCAM (green) to ICAM (red)  
C and D. Lineage restriction to committed biliary progenitors (CBPs) 
indicated by staining for CK19 (green) and albumin (red). E and F expression of AFP 
(green) and albumin (red) indicates that erupting cells are hepatoblasts. 
 
Fig 8. Transplantation of EpCAM+ Cells (or Colonies of Stem Cells in culture) 
results in Engrafted Liver Tissue in NOD/scid mice.   
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 NOD/scid mice were transplanted with 106 cells of either freshly 
isolated and immunoselected EpCAM+ cells or colonies of  hHpSCs from culture on 
plastic for 30-60 days (>~40 population doublings).   Similar results were obtained 
with both populations.  After transplantation, half the mice were treated with carbon 
tetrachloride (CCL4) (representative results shown in Fig. 8B, D, and F; 
representative results from transplanted mice not treated with CCL4 are shown in 
Fig. 8A, C, E and F).  In Fig 8A, C, and E are shown sections of murine livers stained 
for human-specific proteins two days (Fig. A, C, and E), 8 days (Fig 8F) or 8 days 
after transplantation and 7 days after CCL4 treatment (Fig. B, D, G).  Controls 
included sections of mice not transplanted  (H) or sections stained with only the 
secondary antibody (I).  All antibodies but that to albumin gave little no background; 
shown is the control for albumin  
Online Supplemental Materials 
I. Details on Materials and Methods 
Optiprep Fractionation of liver cells from postnatal donors 
OptiPrep (60% solution of Iodixanol, Accurate Chemicals, Westbury, NY) was 
diluted with RPMI-1640, without phenol red, to give a 25% solution of OptiPrep 
having a density of 1.12. After calculating the volume of cells based on weight, 
enough RPMI-1640 without phenol red was added to bring the final volume of cell 
suspension to 250 ml, with a total cell number not to exceed 10 x 109 (40 x 106 
cells/ml). 250 ml of 25% OptiPrep will then was added to the cell suspension and 
mixed gently. The resulting OptiPrep/cell solution was then gravity fed into a COBE 
2991 cell washer-processing bag. 100 ml of RPMI-1640 without phenol red will be 
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layered on top of the OptiPrep/cell solution using a peristaltic pump at a rate of 20 
ml/min while the bag is spinning. 
 
Purging of Contaminant Cells (e.g. Erythrocytes) Requires Gentle 
Procedures to Avoid Damaging the Hepatic Stem Cells. Cell suspensions 
from fetal livers are replete with erthryoid cells and other hemopoietic cells such that 
the parenchymal cells constitute only 8-9% of the cells by flow cytometric analyses of 
cells expressing albumin and  a- fetoprotein (see supplemental data).  The standard 
lysing buffer used for elimination of red blood cells from hemopoietic cell 
suspensions was found to damage the hepatic progenitors and could not be used 
(data not shown).  Therefore, alternative methods for purging the cell suspensions of 
such hemopoietic cells were identified.  One method found effective is a modification 
of that of Lilja and associates [386, 387] in which red blood cells are eliminated from 
pellets of parenchymal cells by slow speed centrifugation.  The adaptation 
introduced in these studies was to use the slow speed centrifugation steps on 
partially enzymatically digested liver containing clumped parenchymal cells enabling 
ready separation from erythrocytes and other hemopoietic cells that are present as 
single cells.  After debulking of the erythrocytes and other hemopoietic cells, the 
clumps of parenchymal cells are prepared as single cell suspensions by an additional 
collagenase step yielding cell suspensions that are more than 80% parenchymal cells 
as evidenced by percentage  of cells expressing albumin and  a- fetoprotein, 
approximately a ten fold enrichment. An alternative method, complement-mediated 
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cytotoxicity to erythrocytes (or to other hemopoietic cell populations) also proved 
successful.  
Ficoll fractionation was tried initially and found to be ideal for isolating 
hepatoblasts that constituted >95% of the cells in the Ficoll pellets. The hepatic stem 
cells were found as a minor constitutent (~0.1%-0.5%) of the cells of the Ficoll 
interface (Supplement:Table 2).  They were isolated far more efficiently by 
immunoselection technologies (Fig. 4).  
 
Histology.  Human or mouse liver specimens were fixed in 4% buffered 
paraformaldehyde for 12 hours and subjected to immunohistochemical staining by 
the methods noted in supplemental data. 
 
Flow Cytometry.  For cell surface markers 1 x 106 cells were labeled, 
following standard procedures, with 1 µg of each monoclonal antibody directly 
conjugated with fluorescein (FITC) or phycoerythrin (PE). For intracellular markers, 
cells first were fixed with 2% paraformaldehyde in PBS for 10 min at room 
temperature and then incubated in permeabilization/blocking buffer (2% Triton X-
100, 10% goat serum, 2% teleostean fish gel in PBS) for an additional 30 to 60 min, 
prior to incubation with a monoclonal antibody, washing, and incubation for 30 min 
with a fluorescent-labeled secondary antibody. Analysis was performed using a 
FACSCalibur flow cytometer (BD Biosciences, San Jose, CA) and FlowJo software 
(Tree Star, Inc., Palo Alto, CA). Nonspecific binding with isotype-matched control 
antibodies (BD Pharmingen, San Jose, CA) was used to establish gating. Monoclonal 
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antibodies, labeled with fluorescein (F) or R-phycoerythrin (PE), were: EpCAM-F 
(clone Ber-EP4, DakoCytomation); CD133/1-PE (clone AC133, Miltenyi Biotec); 
CD34-PE (BD Pharmingen); CD45-PE (BD Pharmingen); CD14-PE (BD 
Pharmingen); CD38-PE (BD Pharmingen); CD4-PE (BD Pharmingen). For detection 
of intracellular antigens, primary mouse monoclonal antibodies of IgG2a isotype to 
human serum albumin (clone HAS-11, Sigma Aldrich),  a- fetoprotein (clone 4A3, 
Biodesign), or cytokeratin 19 (CK19, clone A53B/A2, Zymed) were utilized and 
detected using secondary Alexa Fluor® 647-goat anti-mouse IgG2a (InVitrogen, 
Carlsbad, CA), which does not react with the IgG1 EpCAM-F monoclonal antibody. 
 
Fluorescent Staining of Cultured Cells. Cells were fixed with 
acetone/methanol (1:1) for 2 hrs at ambient temperature, rinsed with Hank’s 
Balanced Salt Solution (HBSS), incubated with 20% goat serum in HBSS for 4 – 6 
hours, and rinsed. Fixed cells were incubated with monoclonal antibodies to albumin 
and CK19 for 6 – 12 hrs, washed, incubated for 4 – 6 hrs with labeled isotype-specific 
secondary antibodies, and washed, always at 4º C. Stained cells were preserved with 
2% formaldehyde in HBSS and viewed using an inverted fluorescence microscope. 
 
Immunhistochemistry ⎯ Fetal livers (16 – 20 weeks of gestation) were 
fixed in 4% para-formaldehyde over night and stored in 70% ethanol. Tissues were 
embedded in paraffin and cut into 5 µm sections. Sections were de-paraffinized with 
xylene and re-hydrated with decreasing alcohol series. Antigens were retrieved by 
boiling sections for 25 min in a pressure cooker in Retrieval Buffer (Dako, 
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Carpinteria, CA). Endogeneous peroxidases were blocked by incubation for 30 min 
in 0.3% H2O2 solution. Sections were blocked in Serum Block (Dako); primary 
antibody was applied in Diluent (Dako), using rabbit anti-human telomerase reverse 
transcriptase (Calbiochem/EMD Biosciences, San Diego, CA). Secondary antibody 
and ABC-staining were performed using the RTU Vectastain Kit (Vector 
Laboratories, Burlingame, CA). DAB (Dako) was used as substrate and sections were 
counterstained with hematoxylin QS for nuclei staining (Vector Laboratories). 
Sections were de-hydrated with increasing alcohol series, fixed in xylene and 
embedded in Eukitt Mounting Media (Electron Microscopy Sciences, Hatfield, PA). 
Sections were analyzed using a Leica DMIRB inverted microscope and pictures were 
taken with a MicroPublisher camera (Q-Imaging, Burnaby, BC, Canada) controlled 
by SimplePCI (Compix Imaging Systems) software. 
Antibodies used for Liver Sections, for freshly isolated cells and for cultures  
Markers Markers (sources) 
Hemopoietic Markers Glycophorin A (Caltag #MHGLA04); CD14-FITC (Pharmingen 
#555397), CD34-FITC (Caltag #CD3458101); CD38-PE (Pharmingen 
#M030098); CD45-FITC (BD #347463) 
Mesenchymal Cell 
Markers 
CD146, CD31 (PECAM), alpha-smooth muscle actin, VEGFr, (KDR), 
desmin 
Cell Surface Proteins EpCAM, 1:800 (Neomarkers; # MS-144-P1ABX); N-CAM (CD56), 
1:100 (Novocastra, #NCL-CD56-1B6;  also NCAM 16.2 –PE (BD# 
340363); I-CAM-1 (CD54), 1:200 (Pharmingen; # 664970 or Bender 
MedSystems;#BMS108); c-kit or CD117 (Dako #R7145); CD133/1 
(Myltenyi Biotec # 130-080-801);  Epithelial Antigen (Dako # 
F0860);  CD54 or I-CAM 1 (BD #347977). 
Intracellular Proteins Albumin, 1:800 (Sigma, # A6684); α- fetoprotein ( a- fetoprotein), 
1:500 (Sigma, # 8452); CK19, 1:200 ( NovaCastra;  #NCL-CK19), 
CK8 and CK18 
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Goat anti-mouse 
Isotype-specific 
antibodies 
Alexa Fluor 568 conjugated goat anti-mouse IgG2a ,1:200 
(Molecular probe, A21124), Cy5 conjugated goat anti-mouse IgG1, 
1:200 (Southern Biotec;#1070-15) 
Conjugated Isotype 
Controls 
Mouse IgG FITC and PE (BD #’s 349041 and 349043). 
 
 
Livers samples were fixed in buffered paraformaldehyde 4% over night at  
4° C, followed by incubation with 30% sucrose at 4° C for 18-24 hours, washed with 
PBS and placed in optimal cutting temperature (O.C.T) compound (Sakura finetek , 
CA, USA), frozen in cold 2-Mythelbutane (Fisher scientific), and stored at -80° C. 
The tissue was sectioned at 5-10 µm thick frozen sections, in serial sections of 50 
sections for each liver. Routine examinations were made in four sections stained 
with hematoxylin-eosin (H&E) and with the others for immunohistochemistry 
staining. 
 
Confocal Microscopy. Immunofluorescence was observed using a Zeiss 
510 Meta Laser Scanning Confocal Microscope (Zeiss; Jena, Germany) or Leica SP2 
Laser Scanning Confocal Microscope (Leica; Wetzlar, Germany).  
 
Cell Culture. The culture medium, “Kubota’s Medium” (KM),  is serum-free 
and its preparations are described in detail in  prior publications [43].  
 
Stromal feeders.  Murine embryonic stromal feeder cells, STO cells, were 
prepared as described previously [43].  
  
Gene Gene Bank 
Acc. No. 
Forward 
Primer  
(5’ → 3’) 
Reverse 
Primer  
(5’ → 3’) 
Tm  
Forward/ 
Reverse 
Primer (°C) 
Product 
length 
(bp) 
 
AFP 
NM_001134 accatgaag 
tgggtggaatc 
Tggtagccaggtca
gctaaa 
59.64/58.53 148 
ALB NM_000477 gtgggcagc 
aaatgttgtaa 
tcatcgacttccaga
gctga 
59.59/59.66 188 
C3A4 NM_017460 gcctggtgc 
tcctctatcta 
ggctgttgaccatca
taaaagc 
57.11/60.86 187 
CK19 NM_002276 ccgcgacta 
cagccactact 
gagcctgttccgtctc
aaac 
60.47/59.85 152 
c-kit NM_000222 gatgacgagttggccct
aga 
caggtagtcgagcgt
ttcct 
60.22/59.50 233 
EpCAM NM_002354 ctggccgtaaactgcttt
gt 
agcccatcattgttct
ggag 
60.30/60.07 182 
G
APD 
NM_002046 atgttcgtcatgggtgtg
aa 
gtcttctgggtggca
gtgat 
59.81/60.12 173 
Quantitative RT-PCR:  The assays were done as described previously [46]. 
Gene specific primers used included the following:  
 
Telomerase Activity Measurement ⎯ Measurement of telomerase 
activity was done using a modified, real-time PCR Telomeric Repeat Amplification 
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Protocol (TRAP) adapted for the use in the Roche LightCycler and Roche SYBR 
Green DNA kits (Roche). Collected cell pellets were resuspended in 20 µl ice cold 
CHAPS buffer (Chemicon, Temecula, CA) containing 20 U RNase out (Invitrogen), 
tissue was homogenized in 150 µl ice cold buffer using glass potter and pestle. 
Extracts were incubated for 30 min on ice. After centrifugation (20 min, 4°C, 20,000 
g) supernatants were frozen on dry ice immediately and kept at -80°C. Total protein 
measurement was done using the DC-protein assay (Bio-Rad Laboratories, Hercules, 
CA). Extracts from cultured HeLa cells (American Type Culture Collection, 
Manassas, VA) were used as positive controls, CHAPS buffer with RNase out served 
as negative control, and heart tissue was used as reference. HeLa extracts were used 
to create standard curves in quantitative real time PCR, using the LightCycler 
(Roche) and SYBR Green Fast Start Master DNA kit (Roche). Extracts containing 0.2 
µg total protein were incubated with SYBR green mix and oligonucleotide sequences 
(primer TS: 5’ AAT CCG TCG AGC AGA GTT 3’; ACX: 5’ GCG CGG CTT ACC CTT 
ACC CTT ACC CTA ACC-3’) and incubated for 20 min at 25°C in the dark. Two step 
PCR was performed with 10 min denaturation at 95°C, and 35 cycles at 95°C for 20s 
and at 60°C for 90s. Standard curves were linear applying extracts from 1, 10, 100, 
1,000 and 10,000 HeLa cells. 
 
Mice.  C57Bl/6 SCID/nod mice were purchased from Jackson Laboratories 
(Bar Harbor, Maine) and were housed in a barrier facility on the campus of the 
University of North Carolina-Chapel Hill (UNC-CH), NC . Animals received care 
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according to the Division of Laboratory Animal Medicine, UNC-CH guidelines, ones 
approved by AALAC.  
 
In vivo Engraftment. C57Bl/6 NOD/scid mice were purchased from 
Jackson Laboratories (Bar Harbor, Maine) and used at 5 weeks of age. Mice were 
anesthetized with Ketamine-HCl (Vedco Inc, St. Joseph, Mo) and Xylazine-HCl 
(ProLab LTD., St. Joseph, Mo) and injected intrasplenically with 8 x 105 cells. The 
spleen was exteriorized through a small left flank incision (5 – 10 mm), and 70 µl of 
cell suspension was injected slowly into it using a 26-gauge needle on a Hamilton 
syringe. The spleen was returned to the abdominal cavity and the incision site was 
closed.  Seven  days following transplantation animals were euthanized under 
sedation and the livers were recovered.  In parallel, half the animals were treated 
with carbon tetrachloride at 0.6 ul/gm body weight.  In some experiments the cells 
were injected after CCL4 treatment, and in others were injected prior to CCL4 
treatment.  A portion of tissue was frozen in liquid N2 and stored at -80° C for 
isolation of RNA. The remainder was fixed for histological analysis. 
 
II. Tables 
Table 1. Antigenic Profiles of Human Hepatic Stem Cell (hHpSC) and 
Hepatoblasts 
Markers hHpSC on 
Plastic and 
in KM1
hHpSC on 
STO feeders 
and in KM1
Hepatoblasts  
α- fetoprotein2 Negative 
 
+++ in those from fetal liver; ± 
in those from postnatal livers 
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Albumin2 Negative or ± ++ 
P450-3A42 Negative 
P450-A72 Negative Positive 
CK 8/18, CD29, CAM 5.2 +++ 
CK192  +++ + found as particular staining 
in cytoplasm 
EpCAM2 +++ cytoplasmically and at 
membrane 
++ at membrane surface but 
not cytoplasm 
NCAM2 Strongly positive especially at 
edge of colonies 
Negative 
Indian and Sonic 
Hedgehog and Patch3
+++; Sonic is at periphery and 
Indian in center of cells  
++ 
ICAM-12 Negative Positive (see Figure 6 ) 
Claudin 32 +++ Negative 
CD44H 4 +++ 
CD133/12 +++ 
Telomerase5 +++ 
CD1172 Debatable**  Negative 
Mesenchymal6 Cell 
Markers  
Negative 
Endothelial Cell Markers7 Negative 
Hemopoietic Markers8 Negative  
**It is not detected on freshly isolated EpCAM+ cells from fetal or postnatal livers; RNA for it is  enriched in 
EpCAM+ cells [356]; it is variably found in HpSC colonies from fetal but not adult livers and when found, is always near or 
overlapping with the companion cells; immunoselection for it does not yield hHpSCs .  We suspect it is on angioblasts but not 
the hHpSCs (and for certain is not on hepatoblasts). 
1Kubota’s Medium.  See reference for original description of it’s development [117]and a review for its details of its 
preparation. [43]  
2Phenotypic characterization of more than 20 genes by RT-PCR and Western blot analyses was done on hHpSCs, 
hepatoblasts and hepatocytes from livers from varying donor ages [356]. 
3More extensive studies on hedgehog signaling are presented elsewhere  
4More extensive studies on hyaluronan receptors and their relevance to use of[362] hyaluronan hydrogels for ex vivo 
maintenance of hHpSCs are given elsewhere [45] 
5Telomerase activity has been measured in hHpSCs, hepatoblasts versus in mature liver cells  
6Mesenchymal markers: CD146, desmin, α-smooth muscle actin 
7Endothelial cell markers: VEGFr (also called KDR), Von Willebrand factor, CD31 
8Hemopoietic cell markers: CD45, CD34, CD14, CD38, Thy 1 (CD90), Glycophorin A 
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Table 2. Evidence for Self-Renewal 
 hHpSCs Hepatoblasts 
Minimum 
Conditions for 
survival  
KM1 + Culture plastic 
 
KM1 + STO Feeders  
Life-span of cells Culture plastic:>6 months 
STO Feeders: indefinite 
Plastic: No survival after ~5-8 days 
STO Feeders: ~2 months 
Doubling Time on 
Plastic or feeders2
Plastic : 1.5-2 days   
STO Feeders: 12-24 days 
(<24 hours on certain 
matrix substrata4) 
Plastic: No survival  
STO Feeders: essentially no growth 
2Cell 
number/colony 
after 2 weeks 
(“clonogenic” 
expansion)  
Plastic: 1.4X103 + 5.2 X 102 
(derived from a single 
hHpSC partnered with a 
single companion cell—see 
movies) 
 
Plastic: No survival 
Phenotype of  
hHpSCs after > 150 
divisions (>6 
months in culture) 
Identical to that of cells 
after initial plating; 
characterization 
summarized in Table 1 
 
Within the ~ 2 months of survival time 
on STO feeders, cells retained 
expression of albumin,  a- fetoprotein 
and CK19  
 
Ability to form liver 
tissue after 
transplantation 3
Capable after 1-2 months in 
culture on plastic and in 
KM1
Only if transplanted within ~7 days of 
culture on plastic (not tested with cells 
on STO feeders) 
1KM =Kubota’s Medium,  serum-free RPMI 1640 with no copper, low calcium (0.3 mM) and supplemented with zinc, 
selenium, insulin, transferrin, HDL and lipids[388].    
 
2See movies (Supplement) of day 1-day 8 colonies of hHpSCs.  Clonogenic 
expansion occurs but requires each hHpSC to be partnered with at least one 
companion cell; the companion cells proved to be angioblasts or hepatic stellate cell 
precursors (see Fig 5; see also the movies in supplemental data for colony formation 
at low seeding densities and on days 1-8).  
3In Fig 8 are shown images from liver sections from animals transplanted 
with human hepatic stem cells.  
4Elsewhere we report that plating the stem cells onto specific forms of 
extracellular matrix, found in abundance in embryonic or fetal tissues enables them 
to go for months through  rapid divisions with doubling times of <24 hours for 
months (McClelland R,et al.  submitted).  
Supplement Table 1. Antigenic profile of freshly isolated cells in the Ficoll 
interface fraction versus Ficoll pellet fraction derived from suspensions of human 
fetal liver cells 
Mean + SEM.  N=3 
Marker* Interface cell 
fraction 
Pellet cell fraction 
α- fetoprotein  26.0 + 7.6 72.3 + 3.9 
Albumin  33.7 + 5.4  79.8 + 9.2 
CD117 (c-kit) 5.4 + 3.0  2.2 + 1.7 
E-Cadherin 57.9 + 6.2 70.8 + 1.5 
NCAM 5.7 + 1.8  2.0 + 0.9 
EpCAM 63.9 + 9.4 61.2 + 9.5 
CD146  7.5 + 1.5 0.6 + 0.2 
CD133 4.9 + 1.3 3.0 + 1.9 
CD31  11.0 + 1.9 3.7 + 2.0 
ICAM-1 33.2 ± 15.3 22.6 ± 7.5 
N-Cadherin 0.9 +  0.4   1.0+0.3 
CD45 10.5 + 1.8 2.2 + 1.2 
CD14 3.0 + 2.6 0.3 + 0.2 
CD34  12.2 + 0.8 2.6 + 0.8 
HLA  28.4 + 8.1 6.4 + 3.9 
*All  data are calculated for the glycophorin A-negative population (gated out by flow cytometric analyses). 
Glycophorin A was present at 57.5 + 7.6% in the interface fraction and at 39.5 + 7.0% in the pellet.  The pellet fraction was 
found to be predominantly hepatoblasts.   
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Donor Age 
(yr) 
Samples Analyzed EpCAM+ 
Cells (%) 
Hepatoblast 
Colonies 
hHpSC 
Colonies 
 
0.75 
1Unfractionated 
2EpCAM+
3Flow-Through 
1.8 
84.7 
< 0.05 
1209 
18 
1293 
2 
199 
0 
 
3 
Unfractionated 
EpCAM+ 
Flow-Through 
0.5 
75.0 
< 0.05 
339 
237 
308 
0.5 
76.2 
0 
 
9 
Unfractionated 
EpCAM+ 
Flow-Through 
0.73 
80.9 
< 0.05 
169 
1.3 
101 
1.3 
52.3 
0.3 
 
36 
Unfractionated 
EpCAM+ 
Flow-Through 
3.9 
93.2 
< 0.05 
> 500 
1.7 
> 500 
11 
27.7 
3.3 
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Supplement Table 2. Colony forming Cells in Postnatal Human Livers 
1 Unfractionated: starting cell suspension after cell isolation 
2 EpCAM+ cells: positive fraction from immunoselection 
3 Flow-Through: cells not retained during magnetic selection for EpCAM 
Data are means of triplicate wells seeded with 20,000 live cells. 
 
Supplement Figures  
Supplement-Figs 1 and 2. Hepatoblasts cultured on tissue culture plastic 
and in Kubota’s Medium.  The cells form cords and intensely co- express alpha- 
fetoprotein, albumin and cytokeratin 19.  The cells survive only for 7-10 days. 
Hepatoblasts colonies do not survive on culture plastic  but only on embryonic 
stromal feeders (see Suppl. Fig. 2). Cultures in Figs A-H are plated onto tissue 
culture plastic and those on I-N are on feeders of murine embryonic stromal cells, 
STO cells.   
Figs A, C. E and G are cells after 1 day in culture; those in B, D.F and H are 
after 5 days; all Figs on STO cells are after 14 days in culture. A, B, J, and N are phase 
micrographs. Those in C, D and I are stained for albumin; those in E, F and K are 
stained for  a- fetoprotein; those in G, H, and M are stained for CK 19. On day 1 the 
cells are tightly aggregated and show strong immunofluorescent staining for ALB,  a- 
fetoprotein and CK19. By day 5 the cells have disaggregated and died. 
Immunostaining for albumin and  a- fetoprotein is reduced to background levels; 
however residual cells still stain strongly for CK19. Scale bar = 20 µm.  
Hepatoblasts plated directly onto a STO feeder layer, fixed, immunostained 
and imaged at day 14. Upper panels Phase contrast images of three groups of 
hepatoblasts. Lower panels: Immunofluorescent staining of ALB, a- fetoprotein, and 
CK19. Note how morphology and immunogenic profile is sustained on STO feeders, 
unlike the cultures on plastic. The cells survived for more than 2 months and grew 
very slowly when on STO feeder cells. Table 3 in Supplement-Fig. 1. Survey of 
markers on the cells on culture plastic; Table 4 in Suppl. Fig. 2. Survey of the 
markers on the hepatoblasts on STO feeders.  
 
Figure 2-9 Details on Materials and Methods, Optiprep Fractionation of liver cells from 
postnatal donors 
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 Figure 2-10 Purging of Contaminant Cells (e.g. Erythrocytes) Requires Gentle 
Procedures to Avoid Damaging the Hepatic Stem Cells. 
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Supplement-Fig 3.  Phase microscopy shows the colonies of hepatic 
progenitors from postnatal livers that include hepatoblasts (A) and hHpSCs (B, C).  
Immunochemistry studies show expression in hHpSC colony of albumin (D), CK19 
(E), and merged image (F).      
 
Figure 2-11 Hepatic Stem Cell Colonies 
 
Supplement-Fig. 4. Hepatoblasts (A-F), sectored colonies (G, H, K, L) and 
unipotent progenitor colony (I, J) shown in phase microscopy (A, E, G, I, K) or for 
immunochemistry for albumin (green) and CK19 (red).   Note that CK19 in 
hepatoblasts are filamentous and in hHpSCs (Suppl. Fig. 3) are particulate; in 
parallel, albumin expression is also distinct in hHpSCs and hepatoblasts.  
implicating distinctions in processing of these proteins in these two lineage stages.   
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Figure 2-12 Characterization of Hepatic Stem Cell Colonies 
 
Supplement: Movie 1.  Day 1 after plating of hepatic stem cells on culture 
plastic and in Kubota’s medium.  Note the clonogenic expansion at cells at extremely 
low seeding densities.  (On line not submitted) 
 
Supplement: Movie 2. Day 3 after plating of hepatic stem cells on culture 
plastic and in Kubota’s Medium. Colony formation has continued over that observed 
on day 1.  (On line not submitted) 
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Supplement: Movie 3. Day 8 after plating of hepatic stem cells on culture 
plastic and in Kubota’s Medium.  The stem cell colony is expanding at the rate of ~ a 
division every 24-36 hours.  Note the “companion cells” that surround the colony 
and that were determined to contain subpopulations of hepatic stellate cells and 
angioblasts (see Fig 5 in the paper).  
 
  
3 Chapter III. Initial Explorations with Hyaluronan 
Hydrogels for Cultures of Hepatic Stem Cells and 
Hepatoblasts:  Hyaluronan Hydrogels with 
Aldehyde Linkages  
3.1 Prelude: 
Ex vivo maintenance of  stem cell and progenitor populations from any tissue 
has  been done almost always under monolayer conditions.  Our studies, especially 
those expected in the near future, require that we utilize 3-dimensional cultures and 
wholly defined, serum-free medium and extracellular matrix components.  We have 
already established the serum-free media needed for the hHpSCs, the hHpSTCss and 
are close to having one for the angioblasts (see Table 13), meaning that we are able to 
have the liver’s trinity of cells found in the stem cell niche in co-culture.  We now 
turned out attention to define the matrix components needed in scaffolds and that 
would allow the cells to grow, or distinct conditions that would allow them to 
differentiate.  We have focused on extracellular matrix components found in the 
liver’s stem cell niche: laminin, type III and IV collagen[25, 47] and in the studies 
here, hyaluronans, non-sulfated forms of glycosaminoglycans (GAGs).  Early tests 
were done to see if the GAGs had any negative effect on the cultures by adding them 
to hepatoblasts and hHpSCs seeded onto plastic.  The preliminary studies looked 
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promising.  So we began the efforts with collaborators who had found ways to cross-
link the HAs to increase their stability:  Dr. Weillem Chen of SUNY at Stony Brook, 
New York.  Dr. Chen made available an adipic dihydrazide-crosslinked sponge 
(Licensed through Clean Solutions Inc., Stony Brook, NY).  The results of our studies 
are summarized in the following paper electronically published in December of 2006 
and published in hard copy form in May, 2007.  We show that the 3-D environment 
provided by the HA sponges facilitates cell survival and slow growth for weeks and 
keeps the cells in a lineage state intermediate between that of hHpSCs and 
hepatoblasts.   The rate of growth of the cells was inhibited by the form of cross-
linking (aldehyde bridges) that prevented the cells from turning over the scaffold.  
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3.2 Abstract 
Human hepatoblasts and hepatic stem cells, pluripotent hepatic progenitors 
that give rise to hepatocytes and biliary cells, were isolated from fetal livers and 
found to express hyaluronan receptors (CD44) in both the freshly isolated cells and 
after culture.  This implicates an in vivo connection to hyaluronan (HA), an 
embryonic matrix component, as a candidate 3-dimensional scaffold for hepatic 
progenitor cell expansion and/or differentiation.  To assess HAs as scaffolds, 
hepatoblasts and hepatic stem cells were seeded into HA hydrogels with a serum-
free, hormonally defined medium tailored for expansion of hepatic progenitors.  Cell 
aggregates formed within the HA hydrogels and remained viable, proliferative, and 
demonstrated a stable phenotype intermediate between that of hepatic stem cells 
and hepatoblasts throughout more than 4 weeks of culturing, with little evidence of 
lineage restriction towards either hepatocytic or biliary pathways.  The phenotype 
consisted of stable co-expression of both hepatocytic and biliary markers such as 
biliary-specific cytokeratin, CK19, low levels of expression of albumin, and urea 
synthesis.  HA hydrogels are ideal as 3-dimensional scaffolds for pluripotent hepatic 
progenitors and should be useful for generating cells to be used in bioartificial livers 
or tissue engineered liver grafts.   
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3.3 Introduction 
In vivo, liver cells undergo interactions with both soluble signals (nutrients, 
gases, growth factors) and with insoluble ones found in the extracellular matrix 
[389].  All such interactions, especially cell-to-cell interactions, effects of soluble 
growth factors, and effects of extracellular matrix found in mature liver tissue, have 
been studied extensively [390-393].   However, less studied have been the effects of 
matrix chemistries found predominantly in embryonic and fetal tissues.   
Hyaluronans are glycosaminoglycans (GAGs) consisting of a disaccharide unit linked 
with β-1-4, β-1-3 bonds between N-acetyl-D-glucosamine and glucuronic acid 
moieties respectively [255].  HAs contribute to matrix structure stabilization and 
integrity, water and protein homeostasis, tissue protection, separation and 
lubrication, facilitation of cell movement/migration, transport regulation including 
steric exclusion, anchoring of hormones as a reservoir and integration of the immune 
inflammation response[249, 251, 252, 254, 255, 394, 395].   HA is evident in 
significant amounts in embryonic tissues[396] and in adult tissues undergoing 
cellular expansion and proliferation[249, 397-399], wound repair[252, 253] , and 
regeneration[253].  In the liver, HAs are present in the matrix of embryonic and fetal 
tissues and near the presumptive stem cell compartment, the Canals of Hering, 
located in zone 1 of adult livers[9], but are not in association with the mature 
parenchymal cells.  Therefore, HAs are candidate matrix components as 3-D 
scaffolds for ex vivo cultures of hepatic progenitors.  
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Human livers are comprised of a mixture of hemopoietic, mesenchymal, and 
hepatic progenitor cells[46].  The hepatic progenitor subpopulations in human fetal 
livers consist of two pluripotent cell populations, hepatic stem cells and 
hepatoblasts, and two unipotent populations, hepatocytic and biliary committed 
progenitors. Hepatic stem cells constitute approximately 1.0-3.0% of liver 
parenchymal cells in livers of all donor ages and are 7-9 um diameter, whereas their 
immediate descendents, hepatoblasts are larger, 10-12 um in diameter, and 
constitute 80-85% of fetal livers but less than 0.1% of adult livers. The hepatic stem 
cells and hepatoblasts have extensive overlap in their phenotype; expressing 
albumin, epithelial-specific cytokeratins (CK) 8 and 18, a biliary-specific cytokeratin 
CK19, epithelial cell adhesion molecule EpCAM (CD326 or HEA125), CD133/1 
(prominin), and being negative for hemopoietic (CD45, CD34) and mesenchymal 
(CD146, KDR) markers.  They are distinguishable in that hepatic stem cells express 
NCAM and claudin 3, whereas hepatoblasts express ICAM-1 (CD54), alpha-
fetoprotein (AFP), and fetal P450s (e.g. P450A7)[46] (see Table 1) In vivo, the 
pluripotent hepatic progenitor cells give rise to the hepatocytic and biliary lineages 
between the 11th and 13th weeks of gestation[400].   
Hepatic progenitors from diverse mammalian species (murine, rat, porcine, 
human) have been cultured under classic culture conditions (plastic dishes and a 
serum-supplemented medium) under which the cells survived for less than 7 days.  If 
serum is maintained, the stem cells and the hepatoblasts rapidly differentiate and 
lose their proliferative potential.  However, if rodent hepatic progenitors are plated 
onto embryonic stromal feeders, and in a hormonally defined medium known as  
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“Kubota’s Medium” (KM), which is a serum-free basal medium with no copper, low 
calcium (<0.5 mM), and supplemented with insulin, transferrin/fe, lipids (high 
density lipoprotein and free fatty acids), and certain trace elements (zinc, 
selenium)[43], they will undergo clonogenic expansion.   On culture plastic, and in 
this same medium, hHpSCs, but not human hepatoblasts, will survive and expand 
for more than 6 months. If transferred to embryonic stromal feeders these stem cells 
will slow in expansion and give rise to eruptions of hepatoblasts and committed 
progenitors.[22] We report here that seeding hepatic progenitors from human fetal 
livers into hyaluronan hydrogels with KM medium elicits long-term (more than 4 
weeks) survival and expansion of progenitors with maintenance of stable gene 
expression for a phenotype intermediate between that of stem cells and hepatoblasts.  
 
3.4 Materials and Methods 
3.4.1 Sourcing of Human Fetal Livers 
Liver tissue from human fetuses between 18-20 weeks gestational age was 
obtained from an accredited agency (Advanced Biological Resources, San Francisco, 
CA).  The research protocol was reviewed and approved by the Institutional Review 
Board for Human Research Studies at the University of North Carolina at Chapel 
Hill. 
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3.4.2 Cell Isolation 
The methods for processing human fetal liver tissues have been previously 
reported.[40, 46]  In brief, the livers were allowed to undergo partial digestion with 
an enzymatic buffer [60 mg collagenase (Sigma, catalog # C5138) plus 30 mg DNAse 
(Sigma, # DN-25) prepared in 100 ml of RPMI 1640 supplemented with 0.5 g of BSA 
(Sigma, # A8806-5G), selenium (10-8 M), antibiotics and antimycotics] to yield small 
clumps of tissue.  The clumps were then centrifuged at low speed spins (20 
revolutionary centrifugal force) to separate hemopoietic cells (largely red blood cells) 
from parenchymal cells.  The parenchymal cell clumps were then subjected to 
further mechanical and chemical digestion to yield single cell and small aggregate 
suspensions.  The majority of the parenchymal cells (hepatoblasts) were fully 
dispersed by filtration through a 75 µm nylon mesh (cat# 34-1800-02 PGC Scientific, 
Frederick Maryland).  The process generated suspensions of single cell and small cell 
aggregates of 3 to 8 hepatoblasts per group.  The viability of the cell suspension was 
greater than 95% on average and was assessed by Trypan Blue Exclusion assays. 
Viability was assessed in cultures using one of several vital dyes: Lysotracker 
Green, Mitotracker Red, and Lysotracker Red (Molecular Probes, Eugene Oregon). 
The dye was chosen for contrast to other fluoroprobes used in co-staining process.  
Addition of the vital dyes was for a 30 minute incubation time period in KM media 
and at the following concentrations: 75nM Lysotracker Green, 75nM Lysotracker 
Red, 250nM Mitotracker Red. 
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3.4.3 Cell Culture Media 
The suspensions of fetal human liver cells, highly enriched for hepatoblasts, 
were suspended into a serum-free medium tailored for hepatic progenitors[43] , 
referred to as “Kubota’s Medium” (KM), and consisting of a serum-free basal 
medium (RPMI 1640, Gibco – Invitrogen, Carlesbad, CA) containing no copper, low 
calcium (< 0.5mM) and supplemented with insulin (5 ug/ml), transferrin/fe (5 
ug/ml), high density lipoprotein (10 ug/ml), selenium (10-10 M), zinc (10-12 M) and 
7.6uE of a mixture of free fatty acids bound to purified albumin; the detailed 
methods for its preparation have been published elsewhere[43, 212].  Following 
isolation, the hepatic progenitors were suspended in KM, and supplemented further 
with low levels of fetal bovine serum, typically 2.5%, in order to inactivate the 
enzymes used in the processing of the tissue.  The plating medium was replaced after 
16 hours with serum-free KM, and the cultures were maintained for greater than 4 
weeks, with media changes every 2 to 3 days.      
 
3.4.4 Culture Plastic 
Suspensions of the human hepatic progenitors, enriched for hepatoblasts, 
were seeded onto plastic with a 2.5% Fetal Bovine Serum (FBS) addition to the KM 
medium.  After 16 hours of incubation at 37ºC with 5% CO2, the media was replaced 
with serum free KM media for the remainder of the study.  Cells on plastic were 
cultured with media changes every 3 days, until the end of the experiment.  Cells that 
did not attach within the first 16 hrs of culture were aspirated at times of media 
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change.  At the experiments end, the cells were fixed with 4% paraformaldehyde 
added to the plate after aspiration of the KM media.   
 
3.4.5 Hyaluronan Hydrogels 
Hyaluronan (average MW: 1,500,000) was obtained from Kraeber GMBH and 
Co. (Waldhofstr, Germany).  Adipic dihydrazide (ADH) and Ethyl-3-[3-dimethyl 
amino] propyl carbodiimide (EDCI) was purchased from Sigma-Aldrich (St. Louis, 
MO). Hyaluronan matrices configured for cell culture were prepared using a method 
modified from previously published protocol.[401, 402]  Briefly, a 1% aqueous 
Hyaluronan solution was prepared, aliquoted and deposited in aluminum molds of 
proper sizes, snap frozen on dry ice and lyophilized to form solid, spongy wafers. The 
wafers were incubated in a 0.1% ADH solution (90% isopropanol/10% water) for 30 
minutes to enable the complete penetration of the ADH solution. EDCI (120 mg) was 
added to the ADH solution and quickly dissolved upon agitation. Cross-linking of the 
partially hydrated HA spongy wafers was initiated by adding 1N HCl to the reagent 
mixture to adjust the pH to ~4.5. The reaction was terminated by decanting the 
reagent mixture and replacing it with 100 ml of 90% isopropanol. The crosslinked 
HA matrices recovered were subsequently extracted with 100 ml of 90% isopropanol 
at least 5 times by incubating overnight. The HA matrices were transferred to pure 
isopropanol to remove all residual water and then air dried. The diameters of the 
cross-linked HA matrices were 0.7 or 3.5 cm, respectively. Upon re-hydration of the 
HA matrices, they readily absorbed water and formed highly porous HA spongy 
hydrogels. 
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3.4.5.1 Sterilization of the Hyaluronan Hydrogels 
 
Sterilization of the HA hydrogels was performed by exposure to a Cesium 
source (JL Shepard Mark I Model 68 Cesium Irradiator - Department of Radiation 
Oncology, UNC) with a deliverable dosage of 40 Gray (40 Joule/kg), over a 10 
minute period 
 
3.4.5.2 Hepatoblast Cultures in Hyaluronan Hydrogels 
 
HA hydrogels were placed into culture wells, either 6-well culture treated 
polystyrene (Falcon – Beckton-Dickinson, Franklin Lakes, NJ), or for the smaller 
sized hydrogel matrices, chambered coverglass culturing slides (Lab-Tek - Nunc, 
Napersville, IL).  Smaller hydrogels required no manipulation (priming) prior to 
inoculation with freshly isolated cells other than a pre-soak with KM media.  The 
larger hydrogels required slight manipulation to insure the removal of air bubbles 
from the sponges.  In most cases, addition of 3mls of KM media onto the sponge 
would trap air bubbles; removal of air bubbles was mechanically accomplished by 
slight compression-relaxation of the sponge, forcing air from the lateral sides.  After 
priming, suspensions of human hepatic progenitors, enriched for hepatoblasts, were 
seeded onto large HA hydrogels at 2 x 10 6 cells/hydrogel in KM medium with 2.5% 
FBS and at 2 x105 cells per small hydrogel.   After 16 hours initial incubation at 37oC 
in a CO2 incubator (Forma Scientific, Baton Rouge, LA), the medium with FBS was 
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replaced with serum-free KM.  The working volume for a 6 well plate was 3ml and 
for the 2-chambered wells was 2ml.  Cells were cultured for 4 weeks under these 
same conditions, with changes of the media every 2-3 days.   
 
3.4.6 Cultures on Collagen and In Collagen Sandwiches 
 Collagen gels are utilized in this study, and in all cases rat tail collagen 
type I (Cohesion Technologies, Palo Alto, CA) is the extra-cellular matrix (ECM) 
material.  The Collagen ECM has a density concentration of 1.5 mg/ml, unless 
specified otherwise.  For flat plate cultures of this investigation, 0.4ml of Collagen-I 
is plated over the 35mm diameter culture surface and incubated for 1 hour at 37°C 
and 95% O2 - 5% CO2 to allow gelation.  Then 1E6 viable hepatocytes were seeded 
onto the gelled layer using media supplemented with 10% FBS.  Following 8 hours of 
cell incubation, the medium was removed and 0.5 ml of serum free culture media is 
added to the top of the culture, and changed daily.  Media samples were collected 
daily and stored at 4°C for later evaluation.  For sandwich culture studies of this 
investigation, the culture incorporates a 35mm tissue culture dish. Briefly, 1 million 
viable cells were plated on a Flat Plate Collagen ECM and allowed to attach for 8 
hours in media supplemented with 10% FBS at 37°C and 5% CO2.  The media is then 
removed and an additional 0.4ml of Collagen is applied to the top of the cells, 
followed by gelation for 1 hour at 37°C.  Next 0.5ml of serum free culture media was 
added to the top of the culture, and changed daily.  Media samples were collected 
daily and stored at 4°C for later evaluation.   
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3.4.7 Fixation and Sectioning of the Cells in the HA Hydrogels   
KM medium was removed from the cultures by aspiration, followed by 
addition of 3mls of 4% paraformaldehyde to each well.  After 1 hour incubation, the 
fixative was removed and replaced with serum-free RPMI 1640 and prepared for 
cryopreservation.  Prior to freezing, the RPMI 1640 was removed and the matrix was 
lifted using a flat edge spatula.  It was placed into Optimal Cutting Temperature 
Compound (OTC), (Tissue-Tek, Torrance, CA), in 2ml conical sample cups (Fischer 
Science, Pittsburgh, PA) and snap frozen using liquid nitrogen emersion.  Preserved 
specimens were kept at -80oC until sectioned.  Slides were made with 10 micron 
sections through the HA hydrogels.   
 
3.4.8 Cell Staining   
Cells were stained for immunofluorescence using primary antibodies directly 
labeled with the relevant fluoroprobe or two-step staining with  primary antibodies 
followed by secondary antibody coupled to the fluoroprobe (see Table 2). Prior to 
staining, approximately 1ml of Phosphate Buffer Solution (PBS) was placed on the 
site of interest to wash any debris away.  Goat serum (10% in PBS solution) was 
added for 1 hour to block non-specific binding sites within the tissue.  Blocking was 
removed and the site washed with 1x PBS.  Monoclonal antibody was added and 
incubated overnight.  After the overnight/18 hours incubation at 4oC, the primary 
monoclonal antibody solution was removed, and the sample was washed three times 
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with 1x PBS for 10 minutes each time. Secondary antibody (Alexa 488 or Alexa 594, 
Molecular Probes – Invitrogen, Carlsbad, CA) was added at a dilution of 1:750 or 
1:1000.  The sample was covered from light exposure and left for 1 hour incubation 
at room temperature. Samples were washed 3 times with 1x PBS  and prepared with 
cover slips using either DPX mounting media (Electron Microscopy Sciences, Fort 
Washington, PA) for microscopy  or Vector Shield containing DAPI mounting media 
(Vector Laboratories, Burlingame, CA).  The DAPI concentration was 1.5 ug/ml.  
Hepatic fetal stem cell colonies were fixed after 10 days in culture with 4% para-
formaldehyde in PBS, and blocked for 1 hour at RT with 10% goat serum in PBS 0.1% 
Triton-X100 (Sigma , Saint Louis, MO). Primary antibodies rabbit IgG anti desmin 
(Abcam, Cambridge, MA) and mouse IgG1 anti EpCAM (Labvision, Fremont, CA) 
were applied in blocking buffer for 1 hour at RT; secondary antibodies anti-rabbit 
AlexaFluor 568, anti-mouse IgG1 AlexaFluor 488 conjugated (Molecular 
Probes/Invitrogen, San Diego, CA), and DAPI (Sigma) for nuclei staining were 
applied in blocking buffer for 1 hour at RT. Fluorescence was analyzed using a Leica 
SP2 laser scanning confocal microscope controlled by Leica SP2 TCS software (Leica 
Microsystems, Bannockburn, IL). 
 
3.4.9 Confocal Microscopy 
For analysis of cytoplasmic antigens (e.g. albumin, AFP) coupled to a 
fluorochrome label, cells were imaged with a LeicaSP2 AOBS Upright Laser 
Scanning Confocal, a Zeiss 510 Meta Inverted Laser Scanning Confocal Microscope, 
  153 
 
and a Leica DMIRB Inverted Fluorescence/DIC Microscope - with B/W & Color 
digital cameras. 
 
3.4.10 Measurement of Albumin and Urea Production 
The media supernatant was collected from control (plastic) cultures and the 
HA smaller (0.7cm diameter) hydrogels once every day or every other day for the 
duration of a 4-week culture period.  Media from the culture were frozen and stored 
at -20ºC until analyzed. . 
 
3.4.10.1 Albumin Production  
 
Albumin production was measured by enzyme-linked immunosorbent assay 
(ELISA). Purified human albumin (Serologicals, Norcross, Georgia) was used as the 
standard, peroxidase-conjugated antibody (ICN Biomedicals/MP Biomedicals, 
Irvine, CA) was used as the fluoroprobe against albumin and measured with a 
Spectromax 250 multi-well plate reader (Molecular Devices, Sunnyvale, CA).  
3.4.10.2 Urea Production  
 
Urea Production was analyzed using the urea nitrogen sensitivity assays, 
based on direct interaction of urea with diacetyl monoxime (Sigma, St. Louis, MO). 
Urea concentration was measured spectrophotometrically at 515 - 540 nm with a 
cytofluor Spectromax 250 multi-well plate reader. 
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3.4.11 Isolation of RNA, DNA, and protein from cultured cells 
 Isolation of cultured cells in the HA hydrogels were accomplished using 
TRIzol isolation provided by Invitrogen (Carlsbad, CA).  Hydrogels were removed 
from the culture plates and placed into 2ml Eppendorf tubes, and spun at 12000 rcf 
(11,953.34g) on a microfuge (Brinkman, Westbury, NY) at 4˚C.  Supernatant was 
removed by aspiration and 1ml of TRIzol was added.  In comparative plastic control 
cultures, where cells were adherent to the culture plates, TRIzol was added directly 
to the plate and then collected into tubes without spinning, but after aspiration of the 
media.  Collection of RNA was done via phase separation with addition of 0.2ml 
chloroform (Cat # C-3422, Sigma).  After aqueous phase collection, RNA was 
precipitated via isopropyl alcohol, followed by a 70% ethanol wash.  Final 
preparations of RNA were air dried and resuspended in 100ul of RNase free water. 
Quantification was done with a DU7400 Spectrophotometer (Becker, Schaumberg, 
IL). 
 DNA isolation was performed by addition of 0.3ml of 100% ethanol to 
each tube of the remaining TRIzol.  Tubes were incubated for 2 minutes at room 
temperature, and then centrifuged at 1000g, 4˚C, for 5 minutes.  The phenol/ethanol 
aqueous phase was removed for further analysis of the protein.  The DNA pellet was 
washed twice with sodium citrate solution, then with 75% ethanol, and centrifuged 
each time at 5000g at 4˚C.  After a second ethanol spin, supernatant was removed by 
aspiration, and the sample was air dried for 15 minutes.  The pellet was re-dissolved 
in 100ul of 8mM NaOH and buffered with 3.2ul 1M Hepes (Mediatech, Herndon, 
VA) for a final pH of 7.0.  The samples were spun at 12000g for 10 minutes and the 
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supernatant was transferred to a new tube.  DNA quantification was done with the 
Beckman Photospectrometer (Fullerton, CA). 
 Protein isolation from the extracted phenol/ethanol aqueous phase was 
performed by precipitation with 1.5ml isopropanol and centrifugation for 10 minutes 
at 12000g and at 4˚C.  The protein extract was washed 3 times with 0.3M Guanidine 
HCl in 95% ethanol.  After the final wash and centrifugation at 7500g for 5 minutes 
at 4˚C, the protein pellet was vacuum dried for 15 minutes.  Resuspension of the 
protein was done in 1% SDS and incubation at 50˚C for 10 minutes.  
 
3.4.12 Quantitative real time RT-PCR Analyses 
Gene expression was analyzed by quantitative real time RT-PCR. Gene 
specific mRNAs were created as followed:  total RNA from livers was extracted using 
the RNeasy kit (Qiagen, Valencia, CA) and reverse transcribed by Superscript II 
reverse transcriptase (Invitrogen) and oligo-dT(12-18) primer.  cDNA was used as the 
template in conventional PCR with gene specific primers (for sequences see Table 
3) from which the forward primer possessed an 5’ overhang for T7-promotor 
sequence (5’gac tcg taa tac gac tca cta tag gg). This amplified gene specific DNA was 
used for in vitro transcription with T7-RNA polymerase (Promega, Madison, WI), 
generating gene specific RNA (with an additional 5’ggg included by T7-RNA 
polymerase) used as standards in quantitative RT-PCR using gene specific primers 
without 5’ overhang; standard ranges were linear from 1 to 108 templates. 
Quantitative RT-PCR was done in the LightCycler instrument (Roche) using the 
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LightCycler RNA Master SYBR Green I kit. RNA from samples was extracted using 
RNeasy mini kit (Qiagen). 
 
3.5 Results 
3.5.1 HhHpSCs and hepatoblasts have receptors for hyaluronans 
The hHpSCs and hepatoblasts are positive for hyaluronan receptors as 
evidenced by immunostaining of a tightly packed, 25 day-old colony of hHpSCs with 
fluorescent antibodies to CD44 as shown in Figure 1a.  Freshly isolated 
hepatoblasts, which are AFP positive are also shown to be positive for the CD44 
receptor in Figure 1b-d.  CD44, a cell surface glycoprotein, is indicated in green, 
which highlights a receptor for the HA attachment.  The receptors cover 100% of the 
cells in the stem cell colony in figure 1a, with individual cells containing varied 
amounts of the receptor seen as intense staining in some cells and lighter less 
intense staining of others.  Individual cells are contrasted by use of DAPI staining 
(blue) of their nuclei.  As shown, the stainings imply that each human hepatic 
progenitor cell has HA attachment capabilities. In Figure 1e, primary cultures of 
human hepatic progenitor cells, isolated from human fetal livers and cultured on 
plastic for 4 weeks, were imaged at 4x and are fluorescently stained for a HA-
BODIPY conjugate.  The hepatic progenitors express levels of receptors for HA at 
higher rates than other cells evident in the culture and that include stroma and 
endothelial cells. Hepatic progenitors, with heavy bodipy staining due to uptake of 
the conjugated HA are located in the lower left quadrant.  Comparatively, fibroblasts 
and non-parenchymal cells shown respectively in the lower right and upper 
quadrants are less active in their HA mediated binding and uptake. 
Immunohistochemical staining of the nonparenchymal cells has been done utilizing 
markers defined by others to identify specific subpopulations.   The mesenchymal 
cells comprise multiple subpopulations that include angioblasts (KDR+/CD133-1+ 
/CD117+) ; mature endothelia, (CD31+); hepatic Stellate Cells (desmin+, alpha-
smooth muscle actin+); hemopoietic cells (CD45+) including red blood cells  
(glycophorin A+).  Representative of these cellular subpopulations are those shown 
in Fig. 1f-i (hepatic stellate cells positive for desmin expression located adjacent to 
EpCAM positive stem cells)  
 
 
Figure 3-1:  Evidence of Hyaluronan Receptors on Hepatic Progenitors 
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 Figure 3-2 Evidence of Hyaluronan Receptors on Hepatic Progenitors (E thru I) 
 
 
3.5.2 Human hepatic progenitors are viable and expand 3-dimensionally 
in the HA hydrogels 
Cells isolated from freshly dissociated human fetal livers show an affinity for 
aggregation/expansion in the hydrogels.  Single cells and aggregates with up to four 
cells/aggregate were initially seeded within the HA hydrogels.  Cells aggregates, at 
the end of a 3 week culturing period, shown in Figures 2a, 2b, 2c and 2d show 
much larger cell aggregates.  Sampled aggregates of Figure 2b have cell counts  
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ranging between 63 and 2595 per aggregate. Figures 2a & 2b illustrate visible 
aggregate spheroids within the HA hydrogel.  Furthermore those aggregates, 
Figures 2c & 2d display cell viability with fluorescence capture of Mitotracker and 
Lysotracker activity, where the fluoroprobe is cleaved into a visible component after 
active uptake.  Figure 2d also represents a confocal plane that shows the aggregate 
spheroid is neither hollow nor necrotic within the interior (Mitotracker-red, stained) 
frames 2-5.  DNA measurement shows a complete reversal of quantifiable cell DNA 
collected from the death of cells on plastic versus their expansion in the HA sponge 
with an average daily increase of 2.28% over a 14 day incubation period (Data not 
shown).   
 
Figure 3-3 Viability of the Cells within Hyaluronan Hydrogels 
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 Figure 3-4 Viability of the Cells within Hyaluronan Hydrogels (C and D) 
 
3.5.3 Hepatoblasts survive longer in hyaluronan hydrogels in 
comparison to those on culture plastic 
Cells in the hydrogel sponges and in the KM medium maintained a stable 
phenotype intermediate between that for hepatic stem cells and hepatoblasts 
throughout more than 4 weeks of culture and did not lineage restrict towards either 
biliary or hepatocytic fates.  Representative data are shown by 
immunohistochemistry staining given in Figure 3.  The cells are hepatic 
parenchymal progenitors as evidenced by their co-expression of the biliary lineage 
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marker, CK19 with albumin (Figure 3a-f) and are epithelia as evidenced by their 
staining for CK8/18 (Figure 3g).  The I-CAM staining (Figure 3h), found in the 
majority of the cells and the low levels of expression of alpha-fetoprotein, indicates 
they are held in a differentiated state close to that of hepatoblasts (fully 
differentiated hepatoblasts would be expected to have very high levels of alpha-
fetoprotein), a conclusion corroborated by biochemical assays for functions (see 
below). Finally, hepatoblasts are marked by the co-expression of three markers: 
EpCAM, AFP, and Albumin (Figure 3i-l). 
 
Figure 3-5 Antigenic Expression in Human Hepatoblasts Cultured in Hyaluronan 
Hydrogels 
 
 
Figure 3-6 Antigenic Expression in Human Hepatoblasts Cultured in Hyaluronan 
Hydrogels (D through F) 
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Figure 3-7 Antigenic Expression in Human Hepatoblasts Cultured in Hyaluronan 
Hydrogels (I through L) 
 
 
Figure 3-8 Antigenic Expression in Human Hepatoblasts Cultured in Hyaluronan 
Hydrogels (G and H) 
 
3.5.4 Cells maintain phenotype of early stage hepatoblasts for longer 
than 4 weeks in HA hydrogels (Figures 4 and 5) 
Albumin production of the hepatic progenitors cultured in HA hydrogels was 
compared to that of hepatic progenitors cultured on plastic over the course of 30 
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days of culture.  The concentration of albumin (per volume) peaked between Days 7 
and 10 for all cultures.  Hepatoblasts lasted 7 to 10 days in cultures on plastic and 
reliably expressed significant levels of albumin.  By contrast, the hepatic progenitors 
lasted for more than 4 weeks in the cultures in HA hydrogels.   
Figure 4a is the normalized albumin production of hepatoblasts plated into 
HA sponges (Open Color Coded Circles).  The albumin levels spike and fall between 
days 8 and 10, similar to that of cells plated onto culture plastic and on type I 
collagen substrata.  The normalized amount of albumin is markedly higher 
modulating about a trend nearing 4.0 x 10-5 mg/ml, whereas hepatoblasts cultured 
on plastic are well below the 2.5 x 10-5 mg/ml baseline.  When the albumin 
 
Figure 3-9  Synthesis of Albumin by Hepatoblasts Cultured in Hyaluronan (HA) 
Hydrogels.    
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data for the cells on plastic (Closed-Filled Circles) is plotted relative to that for cells 
in the hydrogels, the normalized data is consistently lower than the same cells 
cultured in the HA hydrogels.   
Urea production, a common function for mature hepatocytes, is represented 
graphically in Figure 4b.  The concentration of urea is given in mg/dl for this assay.  
Normalized mg/dl urea production by hepatoblasts in hyaluronan hydrogel sponges 
(upside down-open triangle) are compared to that from cells on plastic (Closed 
Circles), on monolayer collagen I cultures (Open Circle), and when cultured between 
two layers of type I collagen (Hash filled triangles).  Again, there is a decrease in 
production in all cultures with the HA hydrogels performing slightly better than 
plastic, and forming a slower falling decay. [Exponential decay of the urea 
production in time without spiking the media with ammonia is an expected 
phenomenon, and low levels of urea would be expected for hepatoblasts as compared 
with mature parenchymal cells.] 
Figures 5a, 5b, 5c are graphical comparisons of CK19, albumin and AFP 
RNA levels normalized to that for the GAPDH housekeeping gene in hepatic 
progenitors cultured in HA hydrogel sponges, in hepatic stem cells in culture on 
plastic and in hepatoblasts freshly isolated from fetal liver cell suspensions.  For each 
30ng of total RNA from freshly isolated hepatoblasts, there were high levels of AFP 
(130 strands), albumin (7000 strands), and relatively low levels of CK19 (1.2 
strands).  By contrast, the RNA isolated from hepatic stem cells demonstrated no 
AFP at all, low levels of albumin (2.6 strands) and high levels of CK19 (100 strands).  
The hepatic progenitors seeded into the HA hydrogels showed low levels of CK19 
 
Figure 3-10 Synthesis of Urea by Hepatoblasts Cultured in Hyaluronan (HA) Hydrogels.    
 
 (1.66 strands), low but detectable levels of AFP (0.33 strands), and levels of albumin 
(5.77 strands) that are higher than that in the hepatic stem cells but dramatically 
lower than that observed in the freshly isolated hepatoblasts.  Cyp3A4, a P450 
cytochrome found in mature hepatocytes, could not be detected in either the hepatic 
stem cells or in the hepatic progenitors maintained in the HA hydrogels.  Thus, the 
hepatic progenitors in the HA hydrogels are not stem cells, since they express AFP 
and ICAM-1, but the quantitative levels of their functions are closer to the stem cells 
than to the freshly isolated hepatoblasts.  We conclude that they are early stage 
hepatoblasts.  
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 Figure 3-11 rt-PCR expression of CK19 
 
Figure 3-12 rt-PCR expression of Albumin 
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 Figure 3-13 rt-PCR expression of Alpha-fetoprotein 
 
3.6 Discussion 
  Hyaluronan hydrogels, in combination with a serum-free medium 
tailored for hepatic progenitors (KM medium), have proven suitable three-
dimensional scaffoldings for human hepatic progenitors, particularly for 
hepatoblasts.  They maintain the cells as early stage hepatoblasts in terms of 
viability, with proliferative capacity, with phenotypic stability through prolonged 
culture periods, and with minimal lineage restriction towards either biliary or 
hepatocytic fates.   
Hyaluronans in vivo have high turnover rates[265] and possess unique 
mechanical/chemical properties that are ideal for embryonic tissues but yield 
scaffolds that are fragile and unstable, affecting their ability  to be used in practical 
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ways needed for ex vivo cultures, for tissue engineering or in bioreactor systems[255, 
273, 282, 292].  Therefore, it was desired to stabilize the HA scaffold sufficiently to 
make its use in cell cultures more practical. When in its natural molecular form, 
unbranched[403, 404] and unmodified, HA is hydrophilic[250, 405] and water 
soluble at room temperature.[295] The biophysical (mechanical strength and 
flexibility), and biochemical (polar group interactions) characteristics of the GAG 
underlie its functionality as a matrix component.  Interactions between HA and 
other biological components are clearly controlled by the chemical structure of the 
GAG.  The polar groups interact within the interior of the folded protein structure 
leaving limited availability for reactivity with other molecules.[405]  As a result, 
fewer reactive groups offer a smaller quantity of points of attachment for multipoint 
functional adhesions, and thus the molecule experiences lower non-specific 
interactions with the environment.  Many of the clinical applications using HA are 
not possible without modifications such as attachment of linking groups or 
modifications to the COOH or OH functional groups.[262, 295, 406, 407]   
The random coiled structure of the HA GAG creates large areas for hydrogen 
bonding which can associate with up to 1000x the molecular weight in water[266, 
396]. This hydration is due to the large negative charge carried by the molecule and 
the positioning of acidic groups, generating great water binding capacity[254].  NMR 
studies show that five hydrogen bonds can exist over as little space as four sugar 
units[247].  As a result of its water binding capacity, HA tends to become less 
flexible.  The positive attribute of having a greater stiffness is the ability to resist 
compressive forces[253].   
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We tested the biological effects of hyaluronan chemically modified through 
cross-linking, which rendered the HA hydrogel scaffolds insoluble in water, and yet 
maintaining properties expected to be essential for their biological functions.   
Human hepatoblasts seeded into the HA hydrogels were found to retain their 
viability and their ability to divide for over 4 weeks, more than 3 times longer than 
those on plastic and the only 3-D scaffold found to sustain them for this length of 
time.  As important was the surprising discovery that the cells remained stable as 
very early stage hepatoblasts throughout the culture period.  Although other culture 
conditions are permissive for survival of hepatic stem cells (e.g. culture plastic or 
embryonic collagens or embryonic feeders)16, 17,35, hyaluronans have been the only 
culture condition identified that facilitate survival, proliferation and maintenance of 
hepatoblasts; hepatoblasts do survive on , STO embryonic stromal feeder cells but go 
essentially into growth arrest and undergo differentiation of the cells towards more 
mature fates.[46]   
The expansion potential of the cells in the HA hydrogels was low with only a 
2.28% increase/day of the cells.  Growth rate of hepatic progenitors in vivo is 
regulated by Hedgehog signaling pathways involving rapid expansion of endothelia 
that, in turn, enzymatically digest the HA GAG facilitating turnover of the 
extracellular matrix, a process essential for cell division.[28]  These particular HA 
hydrogels were extensively cross-linked via the carboxyl functionalities of HA and it 
is assumed were reduced in their ability to be digested by the endothelial progenitors 
typically found in association with the hepatic progenitors and evident in the HA 
cultures[46] The ability of the hydrogels to be dissolved was indicated by their 
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resistance to dissolution with hyaluronidase and harsh denaturants (data not 
shown).  The turnover of the extracellular matrix, most typically accomplished in 
vivo by enzymatic digestion by cells, is an intrinsic process in the establishment of a 
tissue or organ.[408, 409] The stiffness of the HA scaffold could affect the 
maturation of the cells as could the large fluidic volume contained by the hydrogel 
capacity.   Therefore, the physicochemical properties (such as flexibility and cross-
linking density) of the HA spongy hydrogel have to be modulated to reduce the 
limitation on cell expansion.   Other types of HA hydrogels, ones stabilized by 
alternative methods for crosslinking and complexed with other extracellular matrix 
components are now being tested for their efficacy as scaffolds for the hepatic 
progenitors.    
Many HA-based medical devices are already approved for clinical applications 
including injection and grafting within the body.  No matter what the source, the 
polysaccharide is conserved across all species and is biocompatible, eliciting no 
pyrogenic, inflammatory, immunologic or toxic responses[254].   HA hydrogels used 
to support human liver cells, including the several subpopulations of hepatic 
progenitors, will allow expansion of specific cell lineage states and provide a 
replenishing well for medical research and cell therapy.  
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Tables: 
Table 1:  Specific Markers of the Hepatic Cell Lineage: 
 Hepatic Stem Cell Hepatoblast Adult Hepatocyte 
EpCam +++ ++ --- 
AFP --- +++ -- 
Albumin + ++ +++ 
CK19 +++ ++ -- 
I-CAM --- +++ ++ 
N-Cam +++ --- --- 
C3A4 (rtPCR) --- --- +++ 
 
 
Table 2: Antibodies and Fluoroprobes 
Reagent Dilution Isotype Source 
Primary Antibodies 
Cytokeratin 19 (CK19)-biliary specific 
cytokeratin 
1:500 IgG  Amersham 
Cytokeratins 8/18 (CK 8/18)—epithelial-
specific cytokeratins 
1:800 IgG Zymed 
Hyaluronan receptor (CD44), a 
hyaladherins [410] 
1:300 IgG Molecular Probes 
 (Invitrogen) 
Albumin 1:800 IgG Sigma 
Alpha-fetoprotein 1:200 IgG Zymed 
ICAM-1 (CD54) 1:1000 IgG PharMingen 
Desmine 1:800 IgG AbCam 
EpCAM 1:800  IgG  Molecular Probes 
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(Invitrogen) 
Fluoroprobes 
Probe  Excitation/ 
Emission 
 
Alexa 647 (far red) 1:500  Sigma 
Alexa 594 (red) 1:750 590/617 Sigma 
Alexa 488 (Green) 1:1000 495/519 Molecular Probes 
DAPI (blue) 1:1000 358/461 Molecular Probes 
HA-Bodipy Conjugate 1:100 485/530 Invitrogen 
 
 
Table 3.  Primer Sequences used in the RT-PCR Assays 
Gene  Gene Bank Acc. 
No. 
Forward Primer  
(5’ → 3’) 
Reverse 
Primer  
(5’ → 3’) 
Tm 
Forward/Reverse 
Primer (°C) 
Product 
length 
(bp) 
ALB NM_000477 gtgggcagca 
aatgttgtaa 
tcatcgacttccag
agctga 
59.59/59.66 188 
AFP** NM_001134 accatgaagt 
gggtggaatc 
tggtagccaggtca
gctaaa 
59.64/58.53 148 
CK19 NM_002276 ccgcgactac 
agccactact 
gagcctgttccgtc
tcaaac 
60.47/59.85 152 
GAPD NM_002046 atgttcgtcat 
gggtgtgaa 
gtcttctgggtggc
agtgat 
59.81/60.12 173 
C3A4 NM_017460 gcctggtgctc 
ctctatcta 
ggctgttgaccatc
ataaaagc 
57.11/60.86 187 
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**Alpha-fetoprotein (AFP).  The AFP primers are ones to detect uniquely 
hepatic-specific AFP.  As reported previously, hepatic progenitor cells make a 
unique AFP isoform that was cloned and sequenced in the Reid lab. 
 
 Figure Legends 
 
Figure 1.  Evidence of Hyaluronan Receptors on Hepatic Progenitors  
A. Hyaluaronan receptors in hepatoblast cultures of human hepatic progenitors.  
Colony of hHpSCs in association with mesenchymal cells on culture plastic 
and stained for the hyaluronan receptors CD44 (Green) and Dapi (Blue). 
(10X) 
B – D.  Freshly isolated fetal hepatic hepatoblasts show receptors for CD44 
(Green) and AFP (Red). (60x) Panels represented by B. CD44 C. AFP D. 
Overlay. 
E.  Contrast of hyaluronan receptor expression in hepatic stem cell colony 
versus the associated mesenchymal cells.  Plate stained with Bodipy 
conjugated hyaluronan (4X) 
F – I. Composite showing varied cell types present on cultured plastic.  Colony of 
hHpSCs stained for DNA (Dapi-Blue), EpCAM (Green), and surrounded by 
hepatic stellate cells expressing Desmin (Red). (40x oil)  Panels represented 
by A. DAPI B. EpCAM C. Desmin D. overlay. 
 
Figure 2. Viability of the Cells within Hyaluronan Hydrogels.  
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A and B.  Phase contrast of hyaluronan hydrogels seeded with human 
hepatoblasts and cultured for 20 days (20X) 
C.  Aggregate (spheroid) of human hepatic progenitors cultured in hyaluronan 
hydrogels, cultured for 11 days, and then dyed with Lysotracker (green; 488 
nm) and Mitotracker (red; 543 nm) to indicate cell viability. Confocal section of 
the spheroid at 40x/1.3 Oil DIC; scaling .06 um x .06um. 
D.  Confocal sectioning through a spheroid showing viability of cells within the 
core of a spheroid within a hyaluronan sponge at day 11 of culture.  Starting 
in frame 1 and ending in frame 6, the images slice through the spheroid 
showing live cells within the center.  Stack Size 1024x1024x45 , 921.4um x 
921.4um x 132.0um.  Scaling .9um x .9um x 3.0 um.  Objective Plan-Neofluar 
10x/0.3 Wavelength: 543 nm.  (Zeiss 510) 
 
Figure 3. Antigenic Expression in Human Hepatoblasts Cultured in Hyaluronan 
Hydrogels  
Aggregates of human hepatoblasts cultured in hyaluronan hydrogels were 
stained for various  markers.  All photographs were taken on a Zeiss 510, the 
Leica and Olympus FlowView confocal microscopes.  
A.  Cytokeratin 19 (CK19) expression. Wavelength 488nm. A 40X objective/1.3 
Oil DIC Scaling 0.11 um x 0.11 um 
B. Phase micrograph of the spheroid of hepatic progenitors in the hyaluronan 
hydrogel using a 40X objective/1.3 Oil DIC 
C. Overlay image of A and B. 
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D. Albumin expression in the same culture of spheroids of cells as in B.  
Objective:  Plan-Neofluar 40x/1.3 Oil DIC.  Wavelength 543 nm.  Stack size:  
230.3um x 230.3um.  Scaling 0.22um X 0.22um. Albumin expression (red) in 
human hepatoblasts within a hyaluronan hydrogel.  
E. Phase micrograph of hepatoblasts within a hydrogel.   
F. Overlay image of D and E.  
G. Cytokeratin (CK) 8 and 18 expression (green; Alexa 488 ); nuclei stained with  
Dapi (Blue); the hyaluronan hydrogel does not stain and appears as wavy 
images in the background.   60x Oil Immersion (Leica).  
H. Expression of I-CAM/1 (Alexa 488; green) in cells within the spheroid of cells 
within a hyaluronan hydrogel.  The nuclei are stained with DAPI (Blue). 60x 
Oil Immersion (Leica).  
I-L.  Expression of EpCam, AFP, and Albumin in cells maintained in hydrogel 
cultures. 20x with 6x zoom.  (Olympus FV500) Panel I.  DIC (Black and 
White), Panel J.  EpCam (Green), Panel K.  AFP (Red), 20x with 6x zoom. 
Panel L.  Albumin (Yellow). 20x with 6x zoom.  
 
Figure 4. Synthesis of Albumin and Urea by Hepatoblasts Cultured in 
Hyaluronan (HA) Hydrogels.      
A. Albumin Production in cells in HA gels as compared to cells on plastic 
substrata over the course of a 30 day culture.  The Normalized Albumin 
production of hepatic progenitors cells plated into HA hydrogels (open color 
coded circles).  modulate in the collected culture and can be seen with the 
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peak Albumin production falling post days 8 and 9 (yellow color coded).  It is 
similar to that of the plastic.  The Normalized amount of Albumin is much 
higher, and at minimal 2.5x10-5. It is a baseline as opposed to being a 
maximum peak.  The albumin data for the plastic (closed-filled circles) is 
shown under the data for the hydrogel conditions with all points falling 
beneath the lowest concentration detected for the hydrogels.  No data line is 
fit for Albumin production. 
B. Urea production in cells in HA gels versus on other substrata. The normalized 
mg/dl urea produced by hepatic progenitors in the hyaluronan hydrogels 
(upside down-open triangle) as compared to plastic (closed circles), to cells 
plated on top of collagen I gels (open circles) or sandwiched in between 
collagen gels (filled triangles) cultures.  Point to point curves are added to 
make day to day following of the graphed points easier.  Fitted lines for the 
exponential decay of urea production over 6 days in HA hydrogels are not 
shown. 
 
Figure 5.  RNA expression of CK19, Albumin, Alpha-Fetoprotein (normalized to 
GAPDH) 
RNA encoding CK 19 (A), albumin (B), and alpha-fetorpotein (C)  isolated 
from cultures of freshly isolated hepatoblasts, hepatic stem cells and hepatic 
progenitors cultured in the HA hydrogels.  All values are normalized to the 
housekeeping gene, GAPDH, and are expressed as the number of strands 
present per 30ng of total RNA for the sample. 
  
4 CHAPTER IV. Human Hepatic Stem Cells and 
Hepatoblasts in Hyaluronan Hydrogels crosslinked 
with Disulfide Bridges 
The studies with dihydrazide-crosslinked hyaluronan sponges indicated that 
the cells survive long-term in the hydrogels, but the form of cross-linking was too 
robust and slowed turnover of the gels by the cells, resulting in very slow cell growth, 
and obviated experimental evaluations (e.g. cell counts), since the hydrogels did not 
dissolve even in strong denaturants (e.g. 6 M Guanidine HCL!).   Consequently, 
characterization of the cells in the dihydrazide-crosslinked hydrogels was done at 
great expense of time (e.g. manual counts of cells in sections of hydrogels).   
Subsequently, efforts were made to find hydrogels stabilized by other forms of cross-
linking.  An alternative cross-linking method has been developed by Dr. Glenn 
Prestwich and involves disulfide bridge crosslinking chemistry.  The HA hydrogels 
with disulfide cross-linking were assessed for their utility with respect to the cultures 
of the cells and found to be ideal for the cells and for experimental needs.   
Figure 1, contains images of cells in HA hydrogels with disulfide bonding to 
culture the hepatic stem cells and hepatoblasts.  Cell populations of mostly 
hepatoblasts were seeded into the hydrogel and cultured for more than one week.  A 
sample collected at week 1 was snap frozen and then treated with Dapi, that stains 
nuclei allowing for identification of cells within the hydrogel.  Individual cells are 
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blue from DAPI staining (image on the left).  The transmission image is given in the 
center of the trio of images, and then an overlay of the two is presented on the right.  
The hydrogel is clearly visable in the transmission and overlay images.  Cells, within 
the HA hydrogel are presented as an H&E stain at 20x.  These cells are located 
within a lacunae like area of the hydrogel.  Furthermore, images taken on the 
Olympus Flowview Confocal microscope at 20x indicates how cells aggregate in 
colonies within the scaffolding.  The FitC image was taken at the 488nm wavelength 
and is shows autofluorescencing hepatic cells in culture.  Within monolayers 
cultures,  the autoflourescence is not as bright as found here.  Additional images of 
smaller spheroids are shown in the set of 4 images in the lower right hand corner. 
The spheroids of cells maintained antigenic expression of EpCAM, AFP, and 
Albumin, indicative of hepatoblasts.  In cultures maintained on tissue culture plastic, 
the hepatoblasts disappear within a few days. By contrast, they persist for weeks in 
HA disulfide hydrogels.   
Since there was definitive proof that the cells remained  viable and 
phenotypically stable as progenitors, experiments were done to assess the effects of 
additional matrix molecules added to the hydrogels.   Matrix components, known to 
be in the stem cell niche or found in association with more mature parenchymal 
cells.  The additional matrix components were added to 100 percent pure hyaluronan 
hydrogel (Extracell).  Colonies of hepatoblasts were collected manually from plastic 
culture dishes and transferred to each test condition.  Overall effects of numbers of 
 
Figure 4-1 Characterization of Progenitors Populations in Disulfide Hydrogels 
 
attachments and growth of colonies were measured.  Figure 2 is a representative 
panel of all the conditions tried.  The bold red X marks where cells did not attach to 
the substrata used.  The cells showed poor attachment to 100 percent HA, tissue 
culture plastic, and collagen IV.  However, they showed better attachment to 
hydrogels mixed with fibronectin, Laminin, or Collagen III.  From the numbers of 
colonies attached and the amount of visible spreading of the colonies across the 
substrata, laminin performed the best giving the highest number of attachments for 
colonies and the most area covered by those that attached.  From this step, it was 
determined to carry on with the laminin into the next step which is inclusive of 
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metabolic profiling of the hepatic progenitor populations on various substrata.  
Furthermore, the addition of collagen I and laminin together caused a morphological 
change in the progenitors seeded.  Figure 3, represents colonies grown on this 
combination of substrata in which there are visible morphological changes within the 
cultured system such as cords and 3-dimensional structures indicating 
differentiation of the cells. .The following article submitted to Nature Biotechnology 
relates the findings via implementation of metabolomics on the characterization on 
the progenitor population in varied 3-D hydrogels.  
 
Figure 4-2 Matrix effects on hHpSCs attachment 
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 Figure 4-3 Morphology effects of Laminin, Collagen I and HA. 
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5.1 Abstract 
Metabolomic footprinting by nuclear magnetic resonance spectroscopy 
(NMR) has been used with cultures of human hepatic stem cells (hHpSCs) and 
hepatoblasts (hHBs) seeded into hyaluronan hydrogels mixed with other matrix 
components (specific collagens, laminin) and in a serum-free medium tailored for 
hepatic progenitors, “Kubota’s Medium” (KM).  NMR analyses were used to establish 
a metabolomic profile of the cells under each chemical version of the hydrogel 
scaffold.  The assays did not require destruction of the cells and allowed daily 
monitoring for the duration of the experiments (more than 4 weeks).   Metabolomic 
profiling was performed for numerous metabolites (glucose, lactate, glutamine, 
alanine, etc), and the data were utilized to assess cellular regulation of glycolysis, the 
Krebs cycle and other metabolic pathways. The cells were found to remain viable, 
expanding, and as stem cells.  Small changes in the extracellular matrix chemistry 
were found to influence the metabolism of the hHpSCs indicating the ability of these 
assays to discern even subtle effects by factors that influence changes in viability, 
growth and differentiation.  Such non-destructive analyses should be invaluable for 
projects in lineage restricting and differentiation of stem cells ex vivo to adult fates.  
 
  187 
 
5.2 Introduction 
Nuclear magnetic resonance (NMR) is used to analyze low molecular weight 
moieties, typically 10,000 Daltons or less, not detectable on large scale by standard 
biochemical assays[411],[412].  Based on detection of the absorption of 
electromagnetic radiation at specific frequency in a magnetic field, the chemical 
environment of a particular metabolite can be discerned[391].   In the past, it has 
been used as a tool for monitoring metabolic changes in biological systems including 
glycolysis, acetate production of hepatocytes, the Krebs cycle, urea synthesis and 
transamination.  The power in experimental strategies using NMR is in its ability to 
detect diverse metabolites non-invasively without extensive sample 
preparation[412].  An additional strength is that instead of looking at one particular 
metabolite or one class of metabolites such as amines, amino acids, carbohydrates, 
organic acids and their derivatives, NMR can be used to survey in parallel the entire 
spectrum of metabolites.  The subtleties of observing the metabolites to characterize 
a system may be overlooked as this system is potentially better than looking at the 
proteome to establish a defining phenotype based on amplification of next step 
reactions within the cell[413].  For example, the metabolome is the downstream 
result of the in vivo proteome, but ultimately, it is the small molecules acting on the 
proteome that act upstream on transcription.  
The cellular model systems to be subjected to metabolomic analyses are 
human hepatic stem cells (hHpSCs) and hepatoblasts (hHBs) placed under serum-
free, wholly defined culture conditions and with variations in the matrix substratum 
conditions.  The long-term goals are to determine precise sets of factors that alone or 
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in combination will lineage restrict and differentiate the stem cells to their mature 
fates while ex vivo.  The hHpSC, the first stage of the liver’s parenchymal lineages, 
are small cells (7-9 µm in diameter), with a unique antigenic profile  [EpCAM+, 
NCAM+, ICAM1-, Claudin 3+, cytokeratin (CK) 19+, albumin ±, α-fetoprotein (AFP)-
, sonic and Indian hedgehog proteins+, telomerase+] and located in vivo in the 
ductal plates in fetal and neonatal livers[128] and in the canals of Hering in pediatric 
and adult livers near to the portal triads of the liver acini[118].  The hHpSCs give rise 
to the second lineage stage, the hHBs, that are larger (10-12 µm in diameter), with an 
overlapping but distinct profile [EpCAM+, NCAM-, ICAM1+, Claudin 3-, CK19+, 
albumin ++, AFP++, sonic and Indian hedgehog proteins+, telomerase+] and 
located throughout the parenchyma of fetal and neonatal livers but limited to a 
handful of cells tethered to the ends of the canals of Hering in pediatric and adult 
livers[128].   The hHBs give rise to an additional 5-7 maturational lineage stages that 
include unipotent, committed progenitors (biliary and hepatocytic), diploid adult 
parenchyma (hepatocytes or cholangiocytes), multiple stages of mature parenchymal 
cells identifiable by ploidy and/or by gene expression, and ending with the final 
stage, apoptotic cells located near the central veins. 
The methods for identification, isolation and culture of the hHpSCs and hHBs 
under wholly defined culture conditions are also described in prior reports[22, 25, 
27, 28, 46, 47, 128].  The cells are cultured in a serum-free medium tailored for 
hepatic progenitors, called “Kubota’s Medium” (KM)[43] and on one or more 
purified extracellular matrix components.  Thus far, we have shown that self-
replication occurs  with KM and purified type III collagen[47]; lineage restriction to 
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hHBs occurs with cells on type IV collagen or on laminin and in KM[25]; more 
extensive differentiation occurs with type I collagen and with certain proteoglycans 
[25, 47].  The hHpSCs can be maintained also in a 3-dimensional (3-D) format on 
hyaluronan hydrogels[45].   Current efforts are towards identifying the conditions 
for lineage restriction of the hHpSCs through all of its maturational lineage stages to 
yield cells with mature liver cell fates.  We are using the studies reported here to 
begin to establish metabolomic data bases characteristic of the parenchymal cells at 
each lineage stage and that permit one to assess the effects of culture conditions on 
the progression of the cells through differentiation.  This report defines the database 
for the cells maintained as stem cells for weeks in 3-D hyaluronan hydrogel culture 
systems. 
 
5.3 Results 
5.3.1 Cultures 
 Human hepatic stem cells and hepatoblasts have been shown to have 
receptors for hyaluronans (CD44) and to survive and grow in hydrogels prepared 
from hyaluronans cross-linked by aldehyde bridges[45].  The ability of the cells to be 
maintained in hyaluronan hydrogels prepared with disulfide bridge cross-linking is 
equal to or better than that found previously with hydrogels cross-linked by aldehyde 
bridges.  Certainly, the ability to remove the cells from the hydrogels was enhanced 
dramatically given that one can dissolve the gels using reducing agents such as 
dithiothreitol along with hyaluronidase. Cell biological characterizations, such as 
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growth curves, morphology, and immunohistochemistry of markers in the cells in 
the matrix/hyaluronan hydrogels are given in a separate manuscript (Turner et al, in 
preparation). The focus for these studies has been the NMR analyses. Although data 
supports the conclusion that the amount of cross-linking does effect the cellular-
hydrogel dynamic, this study focuses upon the use of NMR (a known technology) to 
develop a new method/technique.   
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5.3.2 Identification and Quantification of Metabolites in Cultured 
Human Hepatic Stem Cells (hHpSCs)  and Hepatoblasts (hHBs) 
Areas of the spectra, Figure 1, that are of little interest due to the vicinity of 
water, the controls, or are beyond the range of the signal were not considered for 
principal component analysis PCA analysis and hence are represented as “dark” 
regions of the spectra. These dark regions specifically fall into three distinct ranges.  
The first is 0.2 ppm or less;  it conflicts with TSP and contains data out of range on 
the low end of the spectra.  The second dark region falls between 4.06 and 5.02 ppm, 
a region that captures the water peak, which is the strongest carrier frequency 
detected within the sample.  The last dark region falls between 8.24 and 8.48 and 
includes the known peak for formate, which is used as a standard to quantify the 
concentration [414]of metabolites present as a percentage of area under their 
respective spectral curve.  Many of the PCA determined significant metabolites fall 
within the region of 0.84 and 4.46 ppm, and include a vast majority of the amino 
acids and derivatives.  The box is expanded and metabolites assignments are shown 
in the upper left hand corner of the figure.   
 Figure 5-1 1H NMR spectra 
 
 The Principal Component Analysis was used to determine whether 
NMR spectra change systematically with time of incubation.  This analysis revealed 
that, indeed, the time of incubation is one of the most significant sources of 
variability among the samples.  The time-dependent variability was captured most 
prominently by the first two principal components, PC1 and PC2, which are shown in 
Figure 2.  The score plot in Figure 2A was generated by plotting the value (score) of 
each sample along PC1 vs. its value along PC2.  The samples are color-coded 
according to the day on which they were obtained, revealing substantial clustering of 
samples taken on different days in different regions of the plot.  From day 2 to day 8 
and then to day 12, samples tend to shift in the upper-leftward direction in the plot.  
Still, there is a major overlap among the three day-defined clusters.  Some of this 
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overlap happens to be due to systematic differences between liver 3 and livers 1 and 
2 used in this study.  To show these differences and also to remove this source of 
spectral variability, samples obtained from livers 1 and 2 are plotted in Figure 2B, 
while samples obtained from liver 3 are plotted separately in Figure 2C.  These two 
score plots clearly show that for each liver the day-2 samples are prominently 
displaced relative to the day-8 samples, which in turn are displaced – although to a 
lesser degree – relative to the day-12 samples. 
 
Figure 5-2 Scores plots from PCA 
 
To determine whether different treatments of the cell cultures had different 
effects on their temporal development, Figure 3 shows a score plot of group 
averages.  In this plot, each point is an average of scores of all the samples of a given 
day and a given treatment.  Different treatments are coded by different colors and 
different days of the same treatment are connected by lines, to make clear the paths 
traveled in the score plot by different treatments during the incubation period.  This 
plot fails to show any clearly evident differences in temporal trajectories that might 
be due to different treatments. 
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 Figure 5-3 Average scores plot 
 
To determine which metabolites were primarily responsible for the temporal 
changes in the NMR spectra, the contributions (loadings) of each spectral bin to PC1 
and PC2 are plotted in Figure 4.  In this loadings plot each bin is shown as a point.  
The bins that have little or no impact on PC1 and PC2 are placed at or near the plot 
origin.  The more significant the contribution of a bin to one or both principal 
components, the farther away from the origin is its position in the plot.  The bins 
responsible for the temporal shift of the spectra in the PC1 vs. PC2 score plots (i.e., 
the left-upward – or ~135° – shift of points in Figures 2 and 3) are the bins which in 
Figure 4 loadings plot are shifted in the same (~135°) or opposite (~215°) direction 
from the plot origin.  In other words, the spectral bins sensitive to incubation time 
are located in the upper-left and bottom-right corners of the loadings plot.  Among 
these bins we find, in particular, the bins containing the following metabolites: 
glucose, alanine, lactate, arginine, glutamine, and glutamate.  These bins are labeled 
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accordingly in the Figure 4 plot.  Thus, PCA suggests that concentrations of glucose, 
alanine, lactate, arginine, glutamine, and glutamate in the supernatant change 
systematically from day 2 to day 12. 
 
Figure 5-4 Principal component loadings plot 
 
 The concentrations derived from the spectral data are related as a 
percent area correlation to that of formate.  Representative samples are of glucose, 
alanine, lactate, arginine, and glutamine and are exhibited in Figure 5.  In each case 
the substrate is labeled as the X axis in the graph where the following seven different 
scaffolds for the cells are compared: Carbylan (C), Carbylan/Laminin (C+L), 
Carbylan/Gelatin (C+G), Carbylan/Gelatin/Laminin (C+G+L), Hyaluronan/Gelatin 
(H+G), Hyaluronan/Gelatin/Laminin (H+G+L), and Plastic (PL).  The last single 
column represents the endogenous amount of the metabolite found within the KM 
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media, also just labeled Media.  The sample days represented as 2, 8 and 12 are color 
coded and sequenced, thus giving a triplet of 2 (red), 8 (tan), 12 (blue) with day two 
on the left, and day 12 on the right for any given scaffold being assessed.  The height 
of the histogram is demarked by the y axis representing the percent formate peak.  
By setting the area under the formate peak in all spectra to be 100% of the 
concentration, then comparisons can be made between the spectra in regard to 
concentration of metabolite present.   
 
Figure 5-5  Formate Normalize Metabolites 
Figure 5a representing glucose shows that all cultures on all forms of matrix-
hydrogels are consumers of available glucose within the system.  Of the bins 
recognized as important in the PCA, three of them are representative of glucose.  
When peaks plotted for the three different glucose representative areas are 
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compared, they each show the same histogram differences (Data not shown for all 
three graphs).  The percentage then translates into a net amount for each known 
metabolite as is recorded as a net loss or production within the mass balance of the 
system.  Media Glucose is highest in the KM solution (the controls-no cells), whereas 
on other scaffolds, the net use of the glucose decreases from day 2 to day 12.  
Therefore, the cells are consuming glucose, not generating it as would occur in more 
differentiated liver cells capable of gluconeogenesis. 
Figure 5b is the histogram of alanine.  Again the x-axis represents the 
substratum, that is the type of matrix-hyaluronan scaffold, and the y-axis is the 
percent formate region under the curve of the spectra.  Alanine is produced in high 
quantity at day 2 of the culturing process and subsequently declines in production by 
day 12.  There is a shift between the first two graphed matrix-hyaluronan hydrogel 
scaffolds, carbylan and carbylan-laminin, in which production falls and consumption 
begins by day 12. 
Figure 5c represents the histogram for lactate.  The level of lactate within the 
medium, KM, is at a low level [0.0157 % Formate Peak].  However, cells by day 2 of 
culture show a minimum of an 8-fold increase in lactate in the media.  Tissue culture 
plastic is the substratum with the highest induction of lactate metabolites in the 
cells.  Over the course of the experiment, lactate production subsequently falls to 
close to the amount found in KM.  This suggests that the cells are recovering from 
the processing procedures that have injured them and have subsequently settled 
down to a more normal metabolism indicated by the restoration of lactate to low 
levels.  
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Figure 5d represents Arginine.  The amino acid metabolite is present in KM 
at low levels compared to that found by day 2.  Cells cultured on all forms of scaffolds 
or substrata demonstrate a high level of arginine which subsequently falls in 
concentration fairly quickly.  By day 12, arginine levels almost reached a 
concentration at which it is equivalent with the starting amount introduced by 
changes of culture media or that being consumed in the culture.   
Figure 5e represents Glutamine which has an overall consumption rate 
within the culture system on all substrates as recognized by the difference in height 
between the media and the cultures on days 2, 8 and 12.  However, net consumption 
of the Glutamine goes down over the course of time and appears to stabilize within a 
narrow range by day 8.  A common set of metabolites for this experiment are listed 
in Supplemental Table 1 for the basis of reference for phenotyping the footprint 
of the human progenitor metabolites. 
The statistical model employed (see methods), contains the predicted lines for 
each treatment over time with consideration of the substratum.  The model is 
constructed by using the actual values to predict or give an idea of what occurs after 
all factors are taken into account.  As with any of the metabolites, the model is 
considered individualized.  The overall p-values for this model are significant for 
time, but not for substratum or the day/substratum interactions, which considers all 
the factors at once.  The statistical model shows that the overall mean response of 
any metabolite is the combination of a fixed substratum effect, a fixed time effect, a 
random liver effect and the interaction of the substratum and time variables.  These 
effects are documented in pair-wise comparisons for significance found in Table 1. 
 5.3.3 Metabolomic Profiles 
 The metabolites identified by the PCA anaylsis Figure 1 
(supplemental Table 1) can be mapped into the cellular metabolism.  Figure 6 
(insert) illustrates the connection between many of the significantly identified 
metabolites including alanine, glucose, lactate, glutamine, and arginine.  Those 
metabolites can further be used to describe the metabolic pathways in which the cells 
produce proteins identified through ELISA assays.  During glycolysis, glucose is 
transformed through a chain of chemical modifications into Pyruvate and then 
Acetyl-CoA.  The Acetyl-CoA is located within the mitochondria and enters the Krebs 
Cycle, also known as the citric acid cycle; the cycle is denoted in the figure as a green 
sphere.   
 
Figure 5-6 Metabolomic Pathways 
 
Alpha-ketoglutarate in the Kreb cycle can be affected by aspartate to yield 
glutamate, which in turn is an intermediate towards the production of Glutamine 
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and/or Albumin.  Oxaloacetate from the TCA cycle is the by-product of the 
interaction of the alpha-ketoglutamate with the aspartate, as well as the conversion 
from malate, and in similar fashion, the combination of oxaloacetate and glutamate 
forms aspartate and alpha-ketoglutarate.  Aspartate is funneled into the urea cycle 
leading to the eventual production of arginine and eventually urea.  Pyruvate can be 
metabolized into alanine or lactate, with reversal of the process being plausible. 
 Measured end products, urea and albumin, are indicative of the 
metabolism of the cells.  As diagrammed in the previous figure, the relationship 
between arginine and urea production is indicated by the data in Figure 6a.  The 
double x axis represents the normalized arginine concentration as compared to the 
net urea analysis, where the y-axis represents the day.  Across all substrata tested, 
the trend from day 2 to day 12 is a decrease in production of both arginine and urea.  
The base amount of arginine in KM is 200 mg/L which correlates to the extracted 
value of 0.0066 concentration percentage of formate.  From day 2 through day 12 the 
amount of arginine productions falls from an average percent of formate of 
0.058988 to 0.010146, (178.7516 mg/dl to 30.7449 mg/dl arginine).  The paths of 
the arginine (blue) and the urea (red) are similar, because they are directly tied to a 
couple reaction in which arginine is used to make urea.  As the system slows and less 
arginine is produced, then less is available for the production of urea.   
Similarly, albumin production in Figure 6b can be tied to metabolites 
detected in the phenotype through glutamate.  Glutamate production like that of 
arginine is highest early in the culturing period (Figure 5f) on all substrata and 
decreases over the course of time.  However, net production is shown over all 
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substrata when removing the amount introduced by the KM media.  The net effect 
when paths are skewed according to culturing techniques shows that as time 
progresses throughout the experiment the amount of the cells, the conversion of 
glutamate to albumin or glutamine are opposite.  The albumin production of the 
system decreases as the glutamine production increases. 
 
5.4 Discussion 
Metabolite profiling through NMR analysis has been done with hHpSCs and 
hHBs cultured in wholly defined medium and on specific forms of matrix-
hyaluronan hydrogel scaffolds.  It has proven to an ideal strategy for phenotyping the 
cells given that it is non-invasive and provides a global survey of all the metabolic 
pathways operating in the cells.  To our knowledge, this is the first report of such a 
metabolic phenotyping of a stem cell population, the hHpSCs, via unbiased high 
through-put analytical methods utilizing computational mathematics to interpret the 
complex metabolic profiles. The novelty with respect to such an analysis being done 
on a stem cell population is furthered by the fact that there have been relatively few 
studies on metabolomics even of mature hepatocytes; most of the published reports 
are with respect to drug metabolism[312, 345, 412] or on a specific metabolic 
pathway, such as carbohydrates[415] or lipids[416].  These studies characterized 
transcription factors or signaling pathways but did not analyze the complement of 
small molecules produced by the cells.  It is possible, that the metabolomics was 
ignored in those studies due to the need for certain methods development for 
metabolomics of cell culture.  In this study, we carefully modified the extracellular 
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matrix composition of the hydrogels, insoluble components of the culture conditions, 
in order to identify their influence on metabolomic differences indicative of a stem 
cell versus differentiative phenotype. 
The extracellular matrix contains critical signals that along with various 
soluble signals (autocrine, paracrine, endocrine) regulating the phenotype of all 
metazoan cells.[389]-3.   Moreover, the chemistry of the matrix and of the soluble 
signals change in parallel with the maturation of the parenchyma [10, 38, 156, 214].    
The known matrix components in or near the liver’s stem cell niche include 
hyaluronans and their receptors, CD44H, fetal laminins and certain integrins (α4β6, 
β1)  that bind them,  type III and IV collagen, and chondroitin sulfate proteoglycans 
(CS-PGs) [10, 25, 47, 128, 156]; (Bruce Caterson, personal communication). The 
matrix chemistry transitions from that niche environment to that associated with the 
fully mature parenchymal cells located near the central vein.  The matrix 
components associated with the mature parenchyma are found in the Space of Disse 
and consist of collagen type I, some collagen type III, forms of heparan sulfate 
proteoglycans and heparin proteoglycans but not laminin, hyaluronans or type IV 
collagen3-8   The matrix components more distant from the parenchyma include also 
perlecan and tenascin.[6, 9, 10, 156, 417]    Due to matrix chemistry and 
positioning[25, 47], the hHpSCs are far less likely to come into contact with the shear 
stresses from blood flow or with the hormonal factors contained within the blood of 
the sinusoids  than their hepatocyte progeny, which are adjacent to fenestrated 
endothelial cells of the sinusoids[418].  The fenestrated endothelia offer cellular 
boundaries in some regions of the Space of Disse and only matrix chemistry at the 
  203 
 
sites of the fenestrae of the endothelia located near to the central vein.  The Kupffer 
cells are attached to the endothelium.  
   Applying metabolomics analytical methods, extensive multi-variate 
statistical analyses was performed on the NMR data, and it further illustrates that 
the changes in the matrix materials can give rise to significant changes in the 
production of certain metabolites and the consumption of specific compounds.  
Implications of the changes in the matrix chemistry and comparison to what occurs 
to the control (plastic) cultures are indicative as to what is going on within the cells 
on matrix scaffolds, especially those in 3-D cultures.  Table 1 is indicative of the 
comparison between plastic and Carbylan cultured hHpSCs.  Of the 560 paired 
comparisons, that between the Carbylan and the plastic show as being the most 
significant in metabolic divergence.  This is not to be confused as conclusions to the 
best culturing condition, because that is dependent upon the final desired result.  
However, using this method of analysis, Carbylan does exhibit properties which 
make it the preferred system, of those assayed, for the maintenance of hHpSCs as 
stem cells under a 3-D culture system, that is with minimal differentiation.  Cells that 
are engaged primarily in anaerobic, not aerobic metabolism are highly indicative or 
stem cells in the adult human liver[334].  Niche studies of the liver acinus show that 
cells derived from the periportal region experience lower levels of oxygen than do 
those of pericentral local[336]. The matrix chemistry used as substrata for hHpSCs 
and hHBs has been established by the known chemistry in the stem cell niche in 
vivo.[128] and components of it, such as type III collagen shown to elicit self-
replication of hHpSCs in culture[47].  Furthermore, isolated hepatocytes express 
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distinct gene expression, and thus metabolic phenotype, dependent on the matrix 
chemistry utilized [6, 146, 312, 419-421]. As the hHpSCs and hHBs have been 
characterized previously in serum-free KM and on plastic versus on matrix substrata 
in monolayer conditions[25, 27, 46, 47] this report offers studies on 3-dimensional 
cultures with evidence for significant changes in metabolic functionality with the 
pair-wise contrasts of each version of hydrogel (HA alone, HA with laminin, HA with 
collagen) versus plastic. As applied to this set of experiments, we have cultured the 
hHpSCs in KM and without the use of serum throughout the 4 weeks of the 
experiment.  Serum is known to result in lineage restriction and differentiation of the 
hepatic progenitors and to overgrowth of mesenchymal cell populations such as 
fibroblasts.  Others have reported that cultures that are serum free are least likely to 
have pronounced disparity in gene expression [312]. 
  The establishment of the proper matrix chemistry was launched with 
studies assessing hyaluronan hydrogels utilizing aldehyde cross-linking, and found 
to be quite supportive for cultures of human hepatic progenitors albeit with very 
slow growth of the cells and with difficulties in retrieval of the cells[45].    
Furthermore, methods of cell adaptation and mitochondrial energy supplementation 
implicate that levels of metabolites from aerobic metabolism of glucose are 
consuming available quantities rather than producing as seen in mature hepatocytes.  
Evidence has been presented in support of phenotyping via NMR of hepatic stem cell 
populations.  Metabolites are indicative of the processes in these cells and the 
influence of special configuration (3-D) and chemical scaffolding.  Metabolic 
functions related to reported metabolites (e.g. Figure 5 and Table 1) have been 
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reported by others and are reflective of changes in diverse functions from cell 
viability to general homeostasis.  Alanine and lactate are indicative of hypoxia[300], 
which can be due to cells being cultivated in 3-D as opposed to monolayer 
conditions.  Others have reported that low oxygen concentrations in mammalian 
embryonic tissues are natural, and if true, is a plausible strategy for maintenance of 
the hHpSCs in 3-D culturing conditions and under low oxygen tensions[336, 422, 
423] .  Indeed, corroborative data in support of the strategy has been found in that 
hHpSCs have proven very tolerant of ischemia enabling their isolation from livers 
from asystolic donors for some hours following cardiac arrest[27, 86]; thus, low 
oxygen tension is a selective culture condition for the hHpSCs.    
 Mammalian cells in general act in response to a hypoxic environment 
by increasing their carbohydrate consumption and switching to anaerobic 
respiration[336, 424]. Properties such as metabolic activity change with passage, 
and even mitochondrial placement and have been linked to differentiation[334]  For 
example, metabolic conversion from anaerobic pathways to aerobic mediates a 
change in condition recognized to indicate “stemness.”  Glycolytic enzymes are 
presnt in the cytosol, and do not require mitochondria, and is associated with 
dedifferentiated cancer cells. Therefore, lactate is an end product of anaerobic 
glycolysis, and indicative of low oxygen availability or a relatively undifferentiated 
state[300] or consumption by specific cell types.  Anaerobic utilization of glucose 
with low production of lactate has been reported within the hepatic culturing system.  
Gluconeogenic amino acids are alanine, threonine, tyrosine and phenylalanine[412].  
Profiles for these can be constructed using the NMR phenotyping method.  
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Reduction of these could be indicative of that metabolic pathway. Specific stem cell 
populations such as those related to the hemopoetic system are able to survive in this 
state by using glycolytic pathways[336, 425]. Grayson etal. report that human 
mesenchymal stem cells have increased glucose consumption and lactate production 
under such conditions.  Dependent on the type of cell, it may have the ability to 
survive under hypoxic conditions over extended periods of time, and stem cells may 
especially be able to do this as it is a reflection of there native 
microenvironment,[336]  tolerance for ischemia,[86] and relatively undifferentiated 
state.  Within the analyses of the data presented here, glucose consumption is high, 
and lactate production is high (Figure 4).  Each of these metabolites are reduced 
over time, which can be explained also as  a shift from one lineage stage (cellular 
subpopulation) to another during the culturing period.  Transamination of pyruvate, 
which leads to increased amounts of  alanine, occurs to help decrease systems of 
lactate.  .  
 In addition, the pathways activated during the production of both, albumin 
and urea, are equally important in evaluating how the system is working.  Liver is 
primary in the metabolism for the urea cycle producing biomarkers of arginine, 
glutamine, and urea[301].  Arginine is taken up from the system in order to produce 
urea[412].  As a direct player in production (Figure 5 insert), the log-log graph of 
arginine as compared to production of urea follows the same path.  Furthermore, the 
impact of this pathway and the albumin production pathway is complicated where 
the production of glutamine from glutamate is concerned.  Glutamate can be 
shuttled towards one pathway or another, and in the production of glutamine, it is 
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used as a cationic scavenger[412].  This is plausible for the graphic illustrated in 
Figure 5b in which glutamine and albumin follow opposing trends in production 
and consumption. 
 The work further lends itself to applications[426] and modification to 
bioreactors.  The advancement of functional bioreactors allows tissue engineers to 
better mimic the multifaceted complexity of in vivo situations[47, 412, 427].  
However, the short-comings of matching engineered constructs that are favorable for 
many applications call for either one of two design approaches.  Many groups are 
working to create bioreactors with particularly useful features, i.e. dissolvable 
boundaries, see-through portals, etc. Other groups seek to create a unique platform 
of analysis in which the tools for studying the device overcome the limitations of the 
device.  Here we have offered one such tool, which is a plausible alternative to years 
of bioreactor modifications.  In addition we have offered new information on the 
human hepatic cell progenitors.   
 The vision of this work was to set forth a means of declaring if a 
particular set of cells, namely hHpSCs or any maturational lineage stage within the 
tissue, can be identified by metabolomic analyses alone.  This application will be 
developed further for use in the fields of 3-Dimensional culture systems, especially 
the fields of bioartificial organs.  The data base being established permits non-
invasive assessment of a system by metabolomic analyses of the conditioned medium 
from the cultures, a data base that should prove ideal for rapid assessment of stem 
cells being lineage restricted to specific adult fates.   
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5.5 Methods 
5.5.1 Sourcing of Human Fetal Livers 
Liver tissue from human fetuses between 16-18 weeks gestational age was 
obtained from an accredited agency (Advanced Biological Resources, San Francisco, 
CA).  The research protocol was reviewed and approved by the Institutional Review 
Board for Human Research Studies at the University of North Carolina at Chapel 
Hill. 
 
5.5.2 Cell Isolation 
Methods for processing human fetal liver tissues have been previously 
reported.[46, 212]  In brief, the livers undergo partial digestion with an enzymatic 
buffer; [60 mg collagense (Sigma, catalog # C5138) plus 30 mg DNAse (Sigma, # 
DN-25) prepared in 100 ml of RPMI 1640 supplemented with 0.5 g of BSA (Sigma, # 
A8806-5G), selenium (10-8 M), antibiotics and antimycotics] to yield small clumps of 
tissue.  The small cellular aggregates were then centrifuged at low speed spins (20 
revolutionary centrifugal force) to separate hemopoietic cells (largely red blood cells) 
from parenchymal cells.  The parenchymal cell clumps were then subjected to 
further mechanical and chemical digestion to yield single cell and small aggregate 
suspensions of one to four cells in most cases.  The parenchymal cells were fully 
dispersed by filtration through a 75 µm nylon mesh (cat# 34-1800-02 PGC Scientific, 
Frederick Maryland).  The process generated suspensions of single cell and small cell 
aggregates.  The viability, determined by trypan blue exclusion assay,  was greater 
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than 95% .  In prior studies[27] we showed that freshly prepared suspensions of fetal 
liver cells are ~ 12% cells that are positive for epithelial cell adhesion molecule, 
EpCAM, a marker identifying hepatic stem cells, hepatoblasts, and unipotent 
parenchymal progenitors. The isolation protocol above strongly enriched for 
EpCAM+ parenchymal cells such that the suspensions were >80% hepatoblasts 
[EpCAM+, ICAM+, CK19+, albumin+, alpha-fetoprotein +) and ~ 10% hepatic stem 
cells [EpCAM+, NCAM+, CK19+, albumin ±, alpha-fetoprotein -).  The remainder of 
the cell types in the suspension included small percentages (2-5%) angioblasts 
(VEGFr+, CD117+, CD133/1+], hepatic stellate cells [CD146, desmin, alpha-smooth 
muscle actin], and hemopoietic cells [CD45+, CD34+].   
 
5.5.3 Cell Culture Medium 
The suspensions of hHpSCs and hepatoblasts were suspended in a serum-free 
medium tailored for hepatic progenitors[43] , called “Kubota’s Medium” (KM), 
consisting of a serum-free basal medium (RPMI 1640, Gibco – Invitrogen, 
Carlesbad, CA) containing no copper, low calcium (< 0.5mM) and supplemented 
with insulin (5 µg/ml), transferrin/fe (5 µg/ml), high density lipoprotein (10 µg/ml), 
selenium (10-10 M), zinc (10-12 M) and 7.6uE of a mixture of free fatty acids bound to 
purified albumin; the detailed methods for its preparation have been published 
elsewhere[43, 428].  Following isolation, the hepatic progenitors were suspended in 
freshly prepared, serum-free KM. There was no use of fetal bovine serum (FBS), used  
at any point in culturing or processing of the tissue.  The plating medium was 
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replaced every 24 hours with serum-free KM, and the cultures were maintained for 
greater than 4 weeks, with media changes every day.      
 
5.5.4 Culture Plastic 
Suspensions of human hepatic progenitors, enriched for hHpSCs and 
hepatoblasts, were seeded onto traditional polystyrene culture plastic with a 2.5% 
Fetal Bovine Serum (FBS) addition to KM medium.  After 16 hours of incubation at 
37ºC with 5% CO2, the medium was replaced with serum-free KM medium for the 
remainder of the study.  Cells on plastic were cultured with media changes every day, 
the same as the rest of the cultures, until the end of the experiment.  At the 
experiments end, the cells were lysed and collected for analyses with Trizol 
extraction buffer (Invitrogen, Carlsbad, CA).  
 
5.5.5 Hyaluronan Hydrogels/Extracellular Matrix Complexes 
The major components of the complexes were two forms of chemically-
modified hyaluronan (HA)[429]. First,  HA-DTPH is a  chemically modified HA 
possessing multiple thiols for cross-linking with disulfide bridges[255] or with a 
bivalent electrophile[430] Second, Carbylan-S (or, CMHA-S) is a carboxymethlated 
HA derivative that has been further modified with multiple thiols for 
crosslinking.[431] The cross-linking was triggered by a PEGDA crosslinker, enabling 
the hydrogels to be formed in desired containers,  to a variable but controllable level 
of cross-linking (affecting stiffness of the hydrogel), and permitting at the end of the 
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experiments for the hydrogels to be dissolved easily by reducing agents (e.g. 
dithiothreitol) together with hyaluronidase. The in situ crosslinkable hydrogel 
technology[432],[431],[433] has been extensively validated in vivo for tissue 
engineering and repair[434],[435],[436] and   all materials are commercially 
available as ExtracelTM from Glycosan Biosciences (Salt Lake City, Utah).  We 
prepared complexes of HA-DTPG or of Carbylan-S with a collagen , type I collagen 
(Sigma, St. Louis, MO) and/or a basal adhesion molecule, laminin (Sigma, St. Louis, 
MO ).  There were 7 variations on the matrix substrata tested: 1) culture plastic 
(PL)—the controls, 2) Hyaluronan+collagen in a gelatin form (H + G),  3) 
Hyaluronan-Gelatin-Laminin (H+G+L), 4) Carbylan (C),  5) Carbylan+Laminin 
(C+L), 6) Carbylan+Gelatin (C+G), and 7) Carbylan+Gelatin+Laminin (C+G+L).   
The hydrogel scaffolds or substrata were constructed as follows:  dry reagents 
were dissolved in serum-free KM to give a 2.0% solution (weight/volume) for the HA 
and the Carbylan-S gels.  The dry gelatin reagent was dissolved in the KM to yield a 
3.0% (weight/volume) solution.   The crosslinker (PEGDA) was dissolved in KM to 
give a 4.0% weight/volume solution.  Re-suspension of the gel based components in 
solution was accomplished more readily by allowing them to incubate in a 37o C 
water bath for 15-60 minutes depending on the final volume of solution desired.   All 
solutions used in preparing hydrogels were adjusted to a pH of 7.4 with 0.1N NaOH, 
after which they were ready to be mixed; they were stable as individual components 
for a few hours at room temperature.  Exposure to air increases the crosslinking of 
any individual component.  Therefore the solutions were kept under ceiled 
conditions avoiding air contact until ready for mixing with other matrix components.     
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The base ratios of crosslinker, medium (KM) and hyaluronan was based on a 
1:1:3 ratio. Blending of hyaluronans with other matrix components could be achieved 
by varying the ratios of hyaluronans to matrix components.  The hydrogels 
containing 90% HA and 10% Collagen/Gelatin were mixed at a ratio of 1:3:1 
respectively to gelatin, Hyaluronan/Carbylan, and crosslinker, and the cell 
suspension was made in the pH adjusted mixtures.  Addition of laminin was made 
prior to the addition of the crosslinker allowing it to diffuse throughout the 
hyaluronan/collagen complex.  It was added at a concentration of 1.5 mg/ml (1.5 
µg/cm2).  The final volume for each loading was 30 µg/0.2 cm3.   
Sterilization of the Matrix/Hyaluronan Hydrogels 
The starting materials from Glycosan are steriled at the time of production 
with a 2 micron filter and tested for bioburden.  The use of special care for routine 
sterile procedures during set-up and seeding of cells was found to minimize the need 
for sterilization procedures.  This simple strategy proved very successful such that no 
infectious organisms found in any culture.  However, if sterilization is deemed 
necessary, then sterilization of the hydrogels can be done either in solution phase or 
in solid phase.  If done while in solution (that is prior to cross-linking), it was filtered 
through a 0.45 mm syringe filter.  Once cross-linked, the complex was sterilized by 
exposure to UV light.  Theoretically it can be sterilized by40 Grey of radiation from a 
Cesium source.   
 
Substrata of Matrix/Hyaluronan Hydrogels 
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The solutions of the hydrogel/matrix mixtures were placed into 6-well 
polystyrene culture dishes (Falcon – Beckton-Dickinson, Franklin Lakes, NJ) just 
after addition of the cross-linker and prior to gelation.  After 16 hours initial 
incubation at 37oC in a CO2 incubator (Forma Scientific, Baton Rouge, LA) to allow 
the gel to solidify, 1ml of serum-free KM was added to the top of each hydrogel.  The 
hHpSCs and hepatoblasts were prepared as described above and were suspended in 
KM.  The cells were placed onto or into the hydrogels at seeding densities of 1 
million/hydrogel (volume 0.5 ml).  If placed into the hydrogel/matrix complexes, 
cells are seeded prior to cross-linking; if cells are suspended within the 
hydrogel/matrix complex, the cells remain as small aggregates of cells throughout 
the hydrogel.  Cells were cultured for 4 weeks under these same conditions, with 
changes of the medium every day.   
 
5.5.6 Measurement of Albumin and Urea Production 
The medium was collected from control (plastic) cultures and from the 
hydrogels every day for the duration of the culture period.  Samples were labeled, 
frozen, and stored at -20ºC until analyzed. 
 
5.5.6.1 Albumin Production  
Albumin production was measured by enzyme-linked immunosorbent assay 
(ELISA). Purified human albumin (Serologicals, Norcross, Georgia) was used as the 
standard, peroxidase-conjugated antibody (ICN Biomedicals/MP Biomedicals, 
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Irvine, CA) was used as the fluoroprobe against albumin and measured with a 
Spectromax 250 multi-well plate reader (Molecular Devices, Sunnyvale, CA).  
 
5.5.6.2 Urea Production  
Urea Production was analyzed using the urea nitrogen sensitivity assays, 
based on direct interaction of urea with diacetyl monoxime (Sigma, St. Louis, MO). 
Urea concentration was measured spectrophotometrically at 515 - 540 nm with a 
cytofluor Spectromax 250 multi-well plate reader. 
 
 
 
5.5.7 Nuclear Magnetic Resonance Spectroscopy (NMR) 
Sample Collection. Samples were taken in triplicate from each study condition 
and control on days 2, 8, and 12. Samples were stored at -80°C immediately 
following collection.  
 
Sample Preparation. After thawing at room temperature, an aliquot of 540 µL 
of each sample was added to 5 mm MR tubes (Wilmad Lab-Glass Inc. Buena, NJ) 
along with 60 µL of a D2O (Cambridge Isotope Laboratories, Andover, MA) solution 
containing 81.84 mM formate (Alfa Aesar, Ward Hill, MA) for ratiometric peak 
quantitization, 8.94 mM 3-(trimethylsily)propionic-2,2,3,3-d4 acid sodium salt (TSP) 
(Aldrich, St. Louis, MO) for a chemical shift reference, and 0.2% NaN3 (Sigma, St. 
Louis, MO) to inhibit bacterial growth.   
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1H NMR Spectroscopy: All 1H NMR spectra were obtained using a Varian 
INOVA 400 MHz NMR spectrometer (Varian Inc., Palo Alto, CA). A standard one 
pulse sequence with a 1.5 s H2O presaturation was used with a interpulse delay of 4 s, 
acquisition time of 2.558 sec, a sweep width of 4650.08 Hz and the transmitter offset 
centered on the H2O signal.   The spectra were digitized with 24K points.   
 
Spectral Processing. Processing of all NMR spectra was done in ACD/1D NMR 
Manager version 8.0 (Advanced Chemistry Development, Inc., Toronto).  
Exponential line broadening of 0.1Hz and zero filling to 32K points were applied to 
each spectrum. After Fourier transformation spectra were auto-phased and baseline 
corrected using uniform settings applied to all spectra.  All spectra were referenced 
to the TSP peak at 0.00 ppm.  Regions of the spectra associated with TSP (0.25 ppm 
and upfield), formate (8.23 – 8.51 ppm), and water (4.55 – 5.03 ppm) were excluded 
from the spectra for the purposes of spectral binning.  The spectra were integrated 
using the Intelligent Bucketing method in the ACD software with bin sizes of 0.02 – 
0.06 ppm.  This resulted in 250 bins.  Bin area values for each bin were then used as 
inputs into PCA.   
 
Principal Component Analysis:  Principal Component Analysis (PCA) was 
used to identify the effects of various substrates and times of incubation on the 1H 
NMR spectra of the media.  PCA was performed using standard procedures (Jolliffe, 
2002).  Each spectral bin was mean-centered and auto-scaled by subtracting its 
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mean and dividing by its standard deviation.  The covariance matrix was computed 
using all spectrum samples from all three livers, seven substrates, and three days.  
The 250 eigenvectors of this covariance matrix were sorted in the descending order 
by their eigenvalues.  These eigenvectors define the new dimensions, or principal 
components, of the 250-dimensional data space originally defined by the 250 
spectral bins.  Unlike the coordinate system defined by the values of individual bins, 
the new coordinate system – defined by the principal components – maximizes the 
data variance along the first principal components.  For analysis, the data samples 
(represented in the data space by single points) are projected onto a two-
dimensional plane defined by two among the first several principal components so as 
to reveal any groupings of samples with respect to substrate of incubation time.  
 
Post PCA Spectral Binning Modifications:  Full batch manual integrations 
were applied to the PCA identified regions of interest to allow for sufficient bin 
broadening to fully capture integral values that may have been diminished due to the 
upper bin limit of 0.06 ppm.  Care was taken to ensure that resonances adjacent to 
bins of interest were not captured in this process.   
 
Spectral Assignments: Spectral assignments were made by reference to 
literature values of chemical shifts in various media and biological fluids.   
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5.5.8 Statistical Analyses 
For each metabolite, a mixed model was fit with metabolite as the response. 
Time (2, 8 and 12 days) and scaffold: plastic (PL), Carbylan (C), Carbylan/Laminin 
(C+L), Carbylan/Gelatin (C+G), Carbylan/Gelatin/Laminin (C+G+L), 
Hyaluronan/Gelatin (H), and Hyaluronan/Gelatin/Laminin  (H+L).  Fixed time 
points were used for assessing substrata effects, so that data for different matrices 
were compared at the same time point. Major variables that were impossible to 
control in the samples were the distinctions in the human livers from one donor to 
another.  Those variations were managed in the statistical analyses as a random 
effect.  Five hundred and sixty pairwise comparisons were made between scaffolds 
all falling in the classes of (C v CL; C v GC; C v Plastic; CL v GCL; GC v H; GCL v HL; 
GCL v Pla; H v HL; H v Plastic; HL v Plastic) for each of the samples for three times 
as well as for overall comparisons for all times combined.  Since ten comparisons 
were being made for each time point, a Bonferroni correction was done to account 
for multiple comparisons and consequently only those p-values less than 0.05 / 10 = 
0.005 were considered statistically significant. 
 
Model 
 The Statistical Model [Yijkl = ά + βi + γj + λk + ∆i·j + εijkl] can be 
expressed as the equation shown where alpha (ά) is the overall mean response of the 
metabolite. Beta (β) is a fixed substrate effect and the subscript (i) indicates the 
seven substrates numbered from 1 to 7.  Gamma (γ) is a fixed effect of time and is 
denoted by the subscript j which is numbered from 1 to 3, and indicates the day 
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where 1 is day 2, j = 2 is day 8, and j = 3 is day 12.  Lambda (λ) is the random effect of 
liver, which is interpreted by recognition that all livers in the study are considered to 
be random samples of all possible livers. The subscript k, which is labeled from 1 to 3 
indicates which of the three livers in the study is being used.  Delta (∆) is the 
interaction effect of substrate and day and consequently has the subscripts i and j.  
Epsilon (ε) is the random error associated with the lth repetition of any set of 
substrate, day, and liver.  The subscript l also registers from 1 to 3 to indicate the 
repetition.   
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Abbreviations: 
KM = Hiroshi Kubota’s Medium, a serum-free, hormonally defined medium for 
progenitors 
NMR = Nuclear Magnetic Resonance 
1H = Proton 
CMHA = Chemically-Modified Hyaluronan  
TSP = 3-(trimethylsily)propionic-2,2,3,3-d4 acid sodium salt 
PCA = Principle Component Analysis 
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PC1 = Principle Component 1 
PC2 = Principle Component 2 
TCA = Tricarboxylic acid cycle (aka citric acid cycle) 
GAG = Glycosaminoglycan 
HA = Hyaluronan 
FBS = Fetal Bovine Serum 
PBS = Phosphate Buffered Solution 
RT = Room Temperature 
ECM = Extracellular Matrix 
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5.5.9 Figure Legends 
Figure 1.  1H NMR spectra  
Spectra and peak identification of culture media obtained at 9.4T.  Metabolite 
assignments are shown in the upper left corner and correspond to the numbered 
spectra peaks.  Chemical Shift (ppm) is shown at the bottom from 0 to 9 from left to 
right.  Sized bins are immediately above and parallel to the horizontal Chemical Shift 
axis except in dark regions.  Dark regions fall in ppm regions of less than 0.02, 4.06 
to 5.02, and 8.24 to 8.48 eliminating peaks for TSP, water and formate respectively. 
Many of the significant metabolites fall within the boxed region from 0.84 to 4.46, 
and this area is expanded for better visualization.   
 
Figure 2.  Scores plots from PCA of all 187 samples of 1H NMR spectra.  Each 
point represents an individual supernatant sample, color-coded according to its 
incubation age.  A:  shown are all 187 samples.  B:  shown are 124 samples 
originated from livers 1 and 2.  C:  shown are 63 samples originated from liver 3.  
Note that samples in C are less dispersed than in B and they are also shifted overall 
relative to samples in B.  Despite these differences, B and C show the same trend of 
day 12 samples being partially shifted relative to day 8 samples, which in turn are 
shifted relative to day 2 samples.  
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Figure 3.  An average scores plot. Each point represents the average position 
of all samples of a given day and a given treatment.  Points representing successive 
days of the same treatment are connected by lines.  Note similar upward-left paths 
taken by all the differently treated groups of samples. 
 
Figure 4.  Principal component loadings plot.  Loadings are shown for the 
same principal components PC1 and PC2 used to construct scores plots in Figures 2 
and 3.  Each point represents one of the 250 spectral bins.  Note that the bins most 
responsible for the upward-left shift of samples in the scores plots are located in the 
upper-left and bottom-right corners of the loadings plot.  Some of those bins are 
identified by the metabolites they represent. 
 
 
Figure 5a-f.  Formate Normalize Metabolites of glucose, alanine, 
lactate, arginine glutamine, and glutamate are shown as they vary with time with 
respect to each substratum.  The substrata are listed along the horizontal axis: 
Carbylan (C), Carbylan/Laminin (C+L), Carbylan/Gelatin (C+G), 
Carbylan/Gelatin/Laminin (C+G+L), Hyaluronan/Gelatin (H), Hyaluronan/Gelatin/ 
Laminin (H+G+L), Plastic (PL).  Normal amounts of metabolites found within fresh 
KM media are reported as baseline (Controls).  Days are demarcated as individual 
colors with every 3 bar sets forming the pattern of Day 2 on the left, Day 8 in the 
middle and Day 12 on the right.  Y axis is representative of the percent of metabolite 
normalized to the formate control. 
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Figure 6 (Insert)  
Metabolomic Pathways represented schematically within a normal cell.  
The block diagram denotes principle component identified metabolites.  Glucose 
consumption produces pyruvate which in turn produces Alanine and Lactate as well 
as Acetyl-CoA.  Acetyl-CoA is shunted into the TCA cycle which is tied to key 
metabolites of alpha-ketogluterate and oxaloacetate.  Alpha-ketogluterate is tied to 
production of  glutamine and albumin through the common pathway divergent at 
glutamate.  Metabolites of the TCA cycle  act on aspartate and affect the urea cycle, 
tying Arginine consumption to urea production. 
 
Figure 6a.  Urea production as compared to arginine.  The normalized 
data to formate for the concentration of arginine in the system has been averaged 
over the substrates.  KM media contains a base amount of Arginine of 200mg/L 
which correlates to an extracted value of .0066 concentration.  From Day 2 (.058988 
percent Formate / 178.7516 mg/dl concentration)  through Day 12 (.010146 percent 
Formate / 30.74449 mg/dl concentration)  there is production of arginine in the 
system however the net time effect in the system is a loss of production of arginine  
  
 
Figure 6b.  Albumin production is represented graphically with the 
graph representation of glutamine and glutamate.  As diagrammed in figure 6, both 
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of these can effect the production of the albumin.  Glutamine is consumed by the 
culture system, where the cells on day 2 consume almost all of the glutamine in the 
KM media.  By days 8 and 12 the consumption has subsided to just over half of the 
available glutamine in the media.  Glutamate, production still occurs throughout the 
longevity of the culture, but decreases as the cultures age.  Albumin production 
drops also with time. 
 
Table 1.  Model Derived Significant Data for Metabolites based on 
Substratum.  This table is the summation of the significance of effects for Carbylan 
versus Plastic in each metabolite as a factor or overall effect, day 2 effect, day 8 effect 
and day 12 effect.  A single ‘X’ represents a significant value where the p-value is 0.05 
or less, and the double ‘XX’ represents a significant value where the p-value is less 
that 0.01.  Because multiple peaks of the same metabolite can be discerned, there are 
multiples of some metabolites, which include Lactate, Glutamate, and Glucose.  It 
should be noted that not all metabolites are included.  In the Supplement Table 1 are 
NMR data on other metabolites not presented here.  Their data are part of the total 
summation analysis.  
 
Supplement Table 1.  Metabolites Footprint for the different substrata 
as compared to formate.  The metabolites as identified by the PCA data are labeled 
across the top of the table (in three repeated sections) and are made up of lactate, 
alanine, acetoacetate, glutamine, choline, glucose, arginine and glutamate.  The 
vertical axis of the table is labeled as Treatments and consists of the 7 substrata 
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(Hyaluronan/Collagen I; Hyalurnona/Collagen I/Laminin; Carbylan; 
Carbylan/Collagen I; Carbylan/Laminin; Carbylan/Collagen I/Laminin, Plastic, and 
KM Media). With the exception of the data KM, each block is represented by three 
values +/- a standard error.  The value is the mean percentage formate of that 
metabolite as identified by NMR.  The sequence of values is given in order by day, 
corresponding to the measurements at days 2, 8, and 12.  Values for pyruvate, 
glycine, and valine were not calculated as to the end relationship of other metabolites 
in the pathways described by Figure 6. 
Tables: 
Table 1: 
Carbylan (HA – disulfide cross-linkage) vs Plastic Culturning Conditions 
Metabolite Overall 
Effect 
Day 2 Day 8 Day 12 
Arginine  XX   
Choline XX   XX 
Ethanol    XX 
Lactate/Threonine XX XX XX  
Alanine XX XX XX X 
Lactate XX XX XX  
Glucose-alpha X   XX 
Glutamate-2    X 
Gluatmate-3    XX 
Glucose-2 X   XX 
Gluatmine    X 
P values X < .05 XX < .01 
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Table 2:   Supplemental (On line, not submitted) 
 
  
6 CHAPTER VI.  Summary Discussion  
Establishment of normal human liver tissue ex vivo from hepatic stem cells 
(hHpSCs) and their progeny is the strategy being pursued by the Reid lab and a 
strategy in which I have been a participant.  The several years of work have enabled 
the identification and isolation of purified hHpSCS and their expansion ex vivo.  The 
goals now are to convert to differentiation studies in which the purified hHpSCs are 
lineage restricted and differentiated into fully mature parenchymal cells.  Towards 
these goals, three-dimensional (3-D) culture systems are requisite.   Hyaluronans, a 
natural component of stem cell niches throughout the body, have been explored as a 
base scaffold for ex vivo maintenance of human hepatic stem cells and hepatoblasts 
in a 3-D format.    
The hyaluronan hydrogel from Glycosan Biosciences, based upon technologies 
established by Glenn Prestwich and associates[255, 429-436] proved the best form of 
hyaluronans tested to date, offering many attributes that include non-
immunogenicity, incorporation of  other matrix molecules of relevance to liver tissue 
engineering  such as collagen I or heparins and, most importantly, the stabilization 
by disulfide cross-linking enabling one to disperse the hydrogel readily and safely.  
The hydrogel chemistry established by Prestwich and associates is well defined and 
involves only purified components.  Hyaluronan hydrogels offer distinct advantages 
over other 3-D matrices such as tissue extracts with many contaminants, such as 
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Matrigel [437]; the tissue extracts may work for experimental purposes but cannot 
be envisaged as a scaffold for clinical programs.  The same issue applies to  synthetic 
3-D scaffolds such as microspun fibers[438] and hydroxyapetite[439] that can be 
used only for ex vivo experimental applications.   They are even an advantage over 
the popular polylactide scaffolds[440], since they can be tailored in their chemistry 
for precise responses known for specific maturational lineage stages of cells by 
making mixtures of matrix molecules and soluble signals found in vivo in association 
with the specific lineage stage.   
  The use of the hyaluronan hydrogels was successful in combination with 
serum-free media meaning that defined mixtures of soluble signals can be used 
together with the defined hyaluronan hydrogel scaffold to yield a 3-D culture system 
in which all components are known.  This may prove one of the most important 
outcomes of the dissertation work, given that serum, a biological fluid found only in 
wounds, and one that can drive cells towards undesired fates (e.g. fibrotic 
responses).  By having a serum-free system, there is elimination of concerns that 
residual serum components might affect andy enzymatic or chemical digestion of the 
hydrogels.  The methods for recovery of the cells from the hyaluronan hydrogel 
stabilized by dithiol chemistry were developed in my studies and complement those 
found previously by others.   
Characterization of the hepatic progenitors was accomplished by means of 
immunochemistry for protein expression, rt-PCR for messenger RNAs, and 
metabolomics.  Expression under all means of analyses led to the same conclusions 
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that the cells embedded in the hydrogel were  proliferating and maintaining a state 
that was closely related to that of hHpSCs or their immediate progeny, hepatoblasts.    
The use of metabolomics to evaluate stem cell lineage systems is essentially in 
its infancy.  The application of NMR to the hepatic lineage system to evaluate the 
effects of matrix chemistry perturbations is the first known to have been done.  
Finally, the specific aim of application of hydrogels as a scaffold to a bioreactor were 
accomplished in pilot studies.  This being a long range goal for the expansion of 
many cells types intended to be used in cell therapies.  It is the logical first step for 
application of the findings from my studies.     
  
Future directions 
The use of the hydrogels will be expanded in future studies and include 
exploration of many different combinations of matrix components and soluble 
signals.  Studies in which different combinations of matrix and soluble signals 
should lead to knowledge of how to design the 3-D scaffolds in order to elicit desired 
behaviors and responses by the cells. For example, will combinations of type III 
collagen and the hydrogel along with Kubota’s Medium enable the cells to expand 3-
dimensionally with the speed found when they are plated onto monolayers of type III 
collagen.    
 
Usage of the hydrogels in more sophisticated bioartificial devices are logical 
next steps for the tissue engineering programs.  Those devices are designed to 
support solid tissue by using perfusion for mass transport of nutrients and oxygen.  
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Thus, the microenvironment is being designed to combine the requisite extracellular 
matrix components, hormones and paracrine signals with highly regulated supply of 
nutrients and gases, all essential variables needed for tissue engineering.  The ease of 
recovery of cells from the hydrogels, allows investigators to do the customary cellular 
and molecular analyses on the cells at any stage of the experiment.   
 
Exploration of the cell-hydrogel interactions needs to be further explored.  
The responses of the cells in hydrogels with different forms of crosslinking used in 
stabilizing the gels showed that there is a significant difference between those gels 
that possess one site for linkage per disaccharide unit (Extracell) as opposed to those 
that have two sites per unit (Carbylan).  Possible methods for analyzing this include 
the use of Atomic Force Microscopy analysis of cells cultured  on or in hydrogels 
versus other surfaces.  From an engineering perspective, the AFM can define the 
stiffness of a specific substrate.   
 
Metabolomics should provide a wealth of information especially with such a 
novel and unexplored model system as maturational lineage stages of human liver.  
My initial foray into such a project has proven that it is a feasible approach for 
explorations of stem cells and their progeny.  Such applications of known analytical 
technologies to biological systems are some of the advantages of using NMR.  
Alternate technologies (e.g. gas chromatography-mass spectrometry, liquid 
chromatography-mass spectrometry) can complement the findings reported here 
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and offer results that will help to fully characterize the stem cells and each lineage 
stage of their descendents.   
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